<?xml version="1.0" encoding="UTF-8"?><xmi:XMI xmlns:cas="http:///uima/cas.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:tcas="http:///uima/tcas.ecore" xmlns:types="http:///edu/cmu/lti/qalab/types.ecore" xmi:version="2.0"><cas:NULL xmi:id="0"/><cas:Sofa xmi:id="11" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="PLoS ONE: Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified Œ≥-Secretase ComplexesOpen AccessResearch ArticleAlzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified Œ≥-Secretase ComplexesMatthias Cacquevel, Lor√®ne Aeschbach, Jemila Houacine, Patrick C. Fraering*√âcole Polytechnique F√©d√©rale de Lausanne, Brain Mind Institute, Laboratory of Molecular and Cellular Biology of Alzheimer's Disease, Lausanne, SwitzerlandAbstract Top BackgroundMutations linked to early onset, familial forms of Alzheimer's disease (FAD) are found most frequently in PSEN1, the gene encoding presenilin-1 (PS1). Together with nicastrin (NCT), anterior pharynx-defective protein 1 (APH1), and presenilin enhancer 2 (PEN2), the catalytic subunit PS1 constitutes the core of the Œ≥-secretase complex and contributes to the proteolysis of the amyloid precursor protein (APP) into amyloid-beta (AŒ≤) peptides. Although there is a growing consensus that FAD-linked PS1 mutations affect AŒ≤ production by enhancing the AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio, it remains unclear whether and how they affect the generation of APP intracellular domain (AICD). Moreover, controversy exists as to how PS1 mutations exert their effects in different experimental systems, by either increasing AŒ≤1‚Äì42 production, decreasing AŒ≤1‚Äì40 production, or both. Because it could be explained by the heterogeneity in the composition of Œ≥-secretase, we purified to homogeneity complexes made of human NCT, APH1aL, PEN2, and the pathogenic PS1 mutants L166P, ŒîE9, or P436Q.Methodology/Principal FindingsWe took advantage of a mouse embryonic fibroblast cell line lacking PS1 and PS2 to generate different stable cell lines overexpressing human Œ≥-secretase complexes with different FAD-linked PS1 mutations. A multi-step affinity purification procedure was used to isolate semi-purified or highly purified Œ≥-secretase complexes. The functional characterization of these complexes revealed that all PS1 FAD-linked mutations caused a loss of Œ≥-secretase activity phenotype, in terms of AŒ≤1‚Äì40, AŒ≤1‚Äì42 and APP intracellular domain productions in vitro.Conclusion/SignificanceOur data support the view that PS1 mutations lead to a strong Œ≥-secretase loss-of-function phenotype and an increased AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio, two mechanisms that are potentially involved in the pathogenesis of Alzheimer's disease.Citation: Cacquevel M, Aeschbach L, Houacine J, Fraering PC (2012) Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified Œ≥-Secretase Complexes. PLoS ONE 7(4): e35133. doi:10.1371/journal.pone.0035133Editor: Stefano L. Sensi, University G. D'Annunzio, ItalyReceived: February 20, 2012; Accepted: March 13, 2012; Published: April 18, 2012Copyright: ¬© 2012 Cacquevel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Funding: This work was supported by the Swiss National Foundation (to and LA and PCF; grant 31003A_134938/1) and the National Centre for Competence in Research (‚ÄúNeuronal Plasticity and Repair‚Äù (to JH and PCF)), and the Strauss foundation (to PCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist.* E-mail: patrick.fraering@epfl.chIntroduction Top Since their discovery in 1995 and their association with early onset familial Alzheimer's disease (FAD) [1], [2], the presenilin genes PSEN1 and PSEN2 have been widely studied, and the complexity of their biological role is becoming increasingly evident. PSEN1 and PSEN2 encode transmembrane proteins PS1 and PS2, respectively, that constitute the catalytic core of Œ≥-secretase, the founding member of an emerging class of unconventional, Intramembrane-Cleaving Proteases (I-CLiPs) [3]. Active Œ≥-secretase is a multiprotein complex composed of PS1 or PS2 together with nicastrin (NCT), the anterior pharynx-defective protein 1 (APH1), and the presenilin enhancer 2 (PEN2). Experimental evidence such as the binding of transition-state analogue Œ≥-secretase inhibitors to PS1 [4], as well as the abolishment of Œ≥-secretase activity when PS1 lacks the aspartate residues critical for proteolysis [4], [5], [6], have confirmed that presenilins harbour the active site of the enzymatic complex.PS1 and PS2 play fundamental roles in cell signalling as part of the Œ≥-secretase complex. The latter cleaves numerous type-I membrane proteins in their transmembrane domain [7], releasing their corresponding intracellular domains, which are capable of influencing gene expression. For some substrates like NOTCH1 or ERBB4, the Œ≥-secretase cleavage is essential for their biological function, whereas for other substrates like DCC or NEUREXIN-3Œ≤ [8], the possible role of the cleavage in signalling events has not been formally established (see [9] for a review). The amyloid precursor protein (APP) is processed by the successive actions of Œ≤-secretase (BACE1) and Œ≥-secretase, generating amyloid-beta peptides (AŒ≤) of different lengths, ranging from 37 to 46 amino acids [10]. Cleavage of the APP C-terminal fragments (APP-CTFs) by Œ≥-secretase also releases the APP intracellular domain (AICD), which has been recently involved in the regulation of brain ApoE expression, a major genetic determinant of AD, and in cholesterol metabolism [11]. In addition, PS1 has been shown to interact with a growing list of proteins that modulate Œ≥-secretase activity [9], [12], [13], [14].In a pathological context, 185 missense mutations in PSEN1 and 13 mutations in PSEN2 have been identified and found to be associated with FAD (www.molgen.ua.ac.be/ADMutations). It was initially suggested that such mutations lead to a toxic gain of function because they are associated with a relative increased production of longer and more hydrophobic AŒ≤ species, mainly AŒ≤1‚Äì42, that accumulate and aggregate early in the course of the disease [15], [16]. Similar phenotypes have been observed by independent groups in cell-based studies performed with different mammalian cell lines [17], [18], [19], [20], [21], [22]. Despite this growing consensus, the above-mentioned studies provided conflicting results regarding the relative proportions of AŒ≤42, AŒ≤40, and AICD resulting from the PSEN mutations. On one hand, a gain-of-function phenotype was suggested due to the observed increase in AŒ≤42 production, accompanied or not with reduced AŒ≤40 production, thereby leading to an increased AŒ≤42/AŒ≤40 ratio. On the other hand, reduced AICD production suggested a loss-of-function phenotype [20]. Differences in the methodologies and cell types used to assess the effects of PSEN mutations on AŒ≤ and AICD productions can explain this controversy as to how PS mutations exert their effects. For example, endogenous PS has been suggested to affect such analysis, as the FAD-linked PSEN1 mutations led to a decrease in the total amount of AŒ≤ generated in PS1 and PS2 double knockout cells [23]. Next, it has been reported that Œ≥-secretase complexes are heterogeneous in composition (with two PS genes and three APH1 isoforms, six combinations of Œ≥-secretase are possible), with distinct functional properties influencing the relative amount of AŒ≤ species generated [24]. In order to investigate the biochemical and functional properties of Œ≥-secretase in cell-free systems, we and others have recently purified this enzymatic complex to homogeneity [25], [26], [27]. In particular, protocols for the high-grade purification of proteolytically active Œ≥-secretase constituted of NCT, APH1aL, PEN2 and wild-type PS1 [26], [27] allowed the reconstitution of 3D structures at 15 √Ö and 12 √Ö resolution by EM and cryo-EM and gave new insights on the structure and activity of the enzyme [28], [29]. However, these studies were exclusively focused on the wild-type PS1. Here, we report for the first time the functional characterization of highly purified and homogenous human Œ≥-secretase particles carrying different FAD-linked PS1 mutants. Our biochemical and functional findings strongly suggest that pathogenic mutations in PSEN1 cause a loss of Œ≥-secretase activity.Results Top Generation, selection and characterization of stable cell lines overexpressing Œ≥-secretase complexes with FAD-linked PS1 mutantsIn order to facilitate high-grade purification of homogenous human Œ≥-secretase complexes containing different PS1 variants, we took advantage of a previously generated mouse embryonic fibroblast (MEF) cell line that lacks the two presenilins (PS1/2‚àí/‚àí) [30], [31]. Our global strategy consisted in producing stable cell lines, on a PS1/2‚àí/‚àí background, that overexpress tagged versions of the three human Œ≥-secretase subunits NCT, APH1 and PEN2 together with different variants of human PS1, and to purify the different human Œ≥-secretase complexes by three sequential affinity purification steps. This strategy allowed us to exclude a possible co-purification of mouse Œ≥-secretase components. First, a parental cell line was generated by co-transducing lentiviral vectors of human NCT-V5 (hNCT-V5), human APH1aL-HA (hAPH1aL-HA) and human Flag-PEN2 (Flag-hPEN2) into MEF PS1/2‚àí/‚àí. Lentivectors are stably integrated into the cell genome and allow the generation of cell lines overexpressing multiple genes in a short period of time. Next, the clone expressing the highest levels of all three recombinant proteins was selected (designated Œ≥ - PS1/2) and used as the parental cell line that was further transduced with lentivectors carrying the following different human PS1 variants: PS1-WT, three dominant-negative forms of PS1 that lack the crucial, catalytic site aspartate residues (D257A, D385A, and both D257A/D385A referred to as DDAA later in the article), and three FAD-linked PS1 mutants (L166P, ŒîE9 and P436Q, with mean disease onset at 24 years, 45.5 years and 28.3 years, respectively).For each PS1 variant, two individual clones were selected based on the expression levels of the recombinant proteins, and extensively characterized (Figure 1). To distinguish those cell lines overexpressing all Œ≥-sectease components from wild-type MEFs, they are collectively designated Œ≥-MEFs. As shown in Figure 1A, the analysis of total protein extracts confirmed that PS is required for the maturation of NCT and the stability of PEN2 [23], [32]. As expected, and when compared to the parental Œ≥- PS1/2 cell line, higher levels of the mature form of NCT were observed in all PS1-overexpressing clones. In contrast to PEN2, APH1aL levels were relatively similar in all PS1 clones and the parental cell line. Indeed, and as previously reported [23], [32], PEN2 levels were higher in the clones overexpressing WT PS1 and FAD-linked PS1 mutants, and to a lesser extent in the clones overexpressing the dominant negative forms of PS1. Interestingly, PEN2 migrated on the gel as an apparent double band, possibly reflecting a post-translational modification. Different patterns of PS1 expression and autoproteolysis were observed in the different clones. First, and in sharp contrast to the other clones, those expressing PS1-WT or PS1-L166P displayed higher levels of PS1-NTF and PS1-CTF fragments compared with full-length PS1 (PS1-FL; Figure 1A). As estimated by densitometry, the NTF fragments of PS1-WT and PS1-L166P account for 87¬±2% and 79¬±7% of total PS1 (PS1-NTF+PS1-FL), respectively. Next, the PS1-ŒîE9 clones did not show any detectable NTF or CTF fragments, as previously described [33], while P436Q and the three dominant negative variants of PS1 were characterized by low levels of PS1-NTF and PS1-CTF fragments, suggesting that these variants were less prone to endoproteolysis.thumbnailFigure 1. Generation of stable cell lines overexpressing all human Œ≥-secretase components with FAD-linked PS1 variants.MEF PS1/2‚àí/‚àí were stably co-transduced with lentiviral vectors carrying genes encoding hNCT-V5, Flag-hPEN2, hAPH1aL-HA and clones were isolated by limiting dilution to generate a cell line, designated as Œ≥- PS1/2, that overexpresses high amount of the three subunits. Œ≥- PS1/2 MEFs were further transduced with hPS1 variants harbouring FAD-linked mutations or mutations in the catalytic aspartate residue(s), or PS1-WT, and cloned. Each clone, derived form the Œ≥- PS1/2, was conveniently named according to the mutation present in PS1 preceded by the symbol Œ≥ and followed by the number of the clone (Œ≥-MEF) in order to distinguish them from wild-type MEF (WT MEF) and MEF PS1/2‚àí/‚àí. Two clones per Œ≥-secretase variant were selected for characterization. (A‚ÄìB) Whole cell protein extracts of the different cell lines were prepared in 1% NP40-HEPES buffer, separated by SDS-PAGE on 4‚Äì12% Bis-Tris or 12% Tris-Glycine gels and analysed by immunostaining to detect the Œ≥-secretase core components NCT (NCT164), PS1 (NTF, MAB1563; CTF; MAB5232), APH1aL-HA (3F10), and Flag-PEN2 (M2) (A), and endogenous APP (A8717) (B). Œ≤-Actin was used as a loading control. Each lane represents one selected clone. CTF: C-terminal fragment, FL: full-length, im.: immature NCT; m.: mature NCT, N: N-glycosylated, NTF: N-terminal fragment, O: O-glycosylated.doi:10.1371/journal.pone.0035133.g001 We next investigated the effects of PSEN1 mutations on the processing of endogenous APP. As expected, and as indicated by increased levels of intracellular APP-CTFs (a common characteristic among known substrates in response to Œ≥-secretase pharmacological inhibition), the activity of Œ≥-secretase was significantly altered in the PS deficient parental Œ≥ - PS1/2 cell line as well as in all clones expressing dominant negative forms of PS1 (Figure 1B). In the clones expressing PS1-WT, APP-CTFs were almost undetectable due to high Œ≥-secretase activity, while clones expressing PS1-L166P or PS1-P436Q displayed APP-CTF accumulation. In PS1-ŒîE9 clones, a mild APP-CTF accumulation was observed (Figure 1B). Although a poor recovery of Œ≥-secretase activity for the PS1-L166P and a comparatively better performance of PS1-ŒîE9 have been reported by others under similar experimental conditions [23], the potential of PS1-P436Q mutation to restore the processing of endogenous APP-CTFs has never been assessed [34], [35]. Importantly, all observations described above for the cells overexpressing simultaneously hNCT-V5, hAPH1aL-HA, Flag-hPEN2 and the different PS1 variants are very consistent with those made in MEF PS1/2‚àí/‚àí cells overexpressing only the PS1 variants, in the absence of the other Œ≥-secretase components (cf. Figure S1A). These data suggest that the effect of FAD mutations in PS1 on APP-CTFs accumulation was similar in presence or absence of other human components of the Œ≥-secretase.Next, we further investigated the effect of PS1 variants on the cellular production/secretion of AŒ≤ species. For this purpose, and as described elsewhere [36], we used an APP-based Œ≥-secretase substrate with a Flag tag at its C-terminus (SPA4CT-Flag). This substrate was transduced in the above-described Œ≥-secretase overexpressing stable cell lines (Œ≥-MEFs) as well as in wild-type MEFs, and APP-CTFs and AŒ≤ levels were measured in cell lysate and cell media, respectively (Figure 2). Under these conditions, the overexpression of SPA4CT-Flag led to an accumulation of two bands corresponding to the exogenous substrate, associated with a concomitant decrease of endogenous APP-CTFs levels (Figure 2A and Figure S2). As estimated by ELISA, a three-fold increase in AŒ≤1‚Äì40 and AŒ≤1‚Äì42 levels was observed in the cell culture media of cell lines overexpressing human Œ≥-secretase (Œ≥-MEF WT), in comparison to untransduced WT MEFs (Figure 2B). Also, the average AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios were not significantly different in those cell lines (Mean ¬± SD: Œ≥-MEF WT#5: 0.30¬±0.01; Œ≥-MEF WT#8: 0.29¬±0.01; WT MEF: 0.19¬±0.06). Next, overexpression of SPA4CT-Flag in Œ≥-MEFs led to the pronounced intracellular accumulation of APP-CTFs in cells overexpressing the PS1 aspartate mutants (Figure 2C), and to the secretion in the cell culture media of different AŒ≤ levels as measured by ELISA (Figure 2D). First, only traces of both AŒ≤1‚Äì40 and AŒ≤1‚Äì42 were detected in Œ≥-MEFs overexpressing PS1 with aspartate mutants. Next, Œ≥-MEFs overexpressing PS1 with FAD-linked mutations displayed a pronounced variability in AŒ≤ levels when compared to the wild-type clones. Overall, the average AŒ≤1‚Äì40 levels were decreased in these cell lines (Mean of two clones in pg/mL ¬± SD: WT: 224.6¬±0.1, L166P: 84.3¬±34.2, ŒîE9: 167.2¬±40.7, P436Q: 82.8¬±74.7), while the AŒ≤1‚Äì42 levels were increased (Mean of two clones in pg/mL ¬± SD: WT: 69.9¬±7.9, L166P: 310.7¬±81.0, ŒîE9: 94.4¬±18.5, P436Q: 141.1¬±98.5). Consistent with previously reported data, the AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios were increased in all Œ≥-MEF clonesoverexpressing PS1 with FAD-linked mutations (Figure 2D) (Mean of two clones pg/mL ¬± SD: WT: 0.31¬±0.03, L166P: 3.8¬±0.58, ŒîE9: 0.6¬±0.03, P436Q: 2.0¬±0.59).thumbnailFigure 2. AŒ≤ production in cell lines overexpressing human Œ≥-secretase components with FAD-linked PS1 variants.WT MEF, Œ≥-MEF and Œ≥ - PS1/2 were transduced with an APP-based substrate corresponding to the 99 C-terminal residues of human APP fused to the APP signal peptide in N-terminus (SPA4CT [36]) and a Flag Tag in C-terminus. Cell proteins were extracted in 1% NP40-HEPES buffer, separated by SDS-PAGE on 12% Tris-Glycine gels and analysed by immunostaining with an antibody targeting the C-terminal part of APP (A8717) (A, C). AŒ≤1‚Äì40 and AŒ≤1‚Äì42 levels were also measured in the corresponding cell culture media (B, D). Data corresponds to three independent experiments (Mean ¬± SEM).doi:10.1371/journal.pone.0035133.g002 FAD-linked PS1 mutations alter the activity of semi-purified Œ≥-secretase complexesWe next assessed the activity of Œ≥-secretase with FAD-linked PS1 mutations in microsomal extracts of Œ≥-MEFs. Membrane protein extracts were prepared and Œ≥-secretase activity was assayed on an exogenous recombinant APP-based substrate consisting of the C-terminal 99 amino acid residues of APP, and referred to as C100-Flag (Figure 3A). The generation of the cleavage product AICD-Flag was detected by Western blot analysis and measured by densitometry. As shown in Figure 3A, the levels of AICD-Flag generated from the PS1-L166P and PS1-ŒîE9 clones accounted for 42¬±1% and 13¬±6% of that in the PS1-WT clones, respectively. AICD-Flag was undetectable in the clones expressing PS1-P436Q as well as in the three dominant negative aspartate PS1 variants. Similar results were observed in MEF PS1/2‚àí/‚àí cells overexpressing only the PS1 variants, in the absence of the other human Œ≥-secretase components (Figure S1B).thumbnailFigure 3. Enzymatic activity of partially purified Œ≥-secretase complexes with FAD-linked PS1 mutants.(A) Œ≥-Secretase activity assays performed with Œ≥-MEF and Œ≥ - PS1/2 microsomal extracts prepared in 1% CHAPSO-HEPES buffer. Equal protein levels from the different extracts were diluted to 0.25% CHAPSO-HEPES buffer and incubated for 4 h at 37¬∞C with lipids and 1 ¬µM of recombinant human APP-based substrate (C100-Flag). Samples were analyzed by SDS-PAGE and immunostained with anti-Flag (M2) or anti-PS1 (MAB1563). The relative amounts of AICD-Flag generated in the reactions, reflecting Œ≥-secretase activity, were estimated by densitometry. PS1 immunostaining was used to assess the amount of input material. (B) Equal amounts of microsomal proteins were immunoprecipitated overnight at 4¬∞C with either anti-Flag M2 or anti-HA affinity resins, and submitted to a C100-His assay according to the same protocol as in (A). Protein samples were separated by SDS-PAGE and analysed by immunostaining for Œ≥-secretase subunits ((NCT164 (NCT), MAB1563 (PS1-NTF), or UD1 (PEN2)). AICD-His cleavage products were immunostained with an anti-APP-CTF antibody (A8717). *Indicates a non-specific band corresponding to the IgG light chains. (C) AŒ≤1‚Äì40 and AŒ≤1‚Äì42 were quantified by sandwich ELISA and represented in pg/mL (left Y-axis) or in percentage (right Y-axis) of the mean of AŒ≤1‚Äì40 levels generated by the two wild-type clones. AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios are indicated on the top of the bars. The results were confirmed in three independent experiments and a representative dataset is shown.doi:10.1371/journal.pone.0035133.g003 We next performed activity assays under semi-purified conditions. To do so, Œ≥-secretase complexes from the different clones were co-immunoprecipitated from microsomal extracts and their activities were assayed in vitro with the C100-His substrate. Two immunoprecipitation protocols using two affinity resins (anti-Flag M2 and anti-HA 3F10, targeting respectively Flag-PEN2 and APH1aL-HA) were compared to exclude a possible heterogeneity of Œ≥-secretase complexes potentially generated under such conditions. As shown in Figure 3B, the anti-Flag and anti-HA resins immunoprecipitated similar levels of NCT, PS1 and PEN2 and the activity of the Œ≥-secretase complexes was similar regardless of the affinity resins used (Figures 3B). In agreement with the assays performed using microsomal extracts (Figure 3A), those performed with semi-purified complexes revealed that FAD-linked mutants drastically reduced AICD generation, when compared to PS1-WT (Figure 3B). Furthermore, levels of AŒ≤1‚Äì40 produced from PS1-L166P, PS1-ŒîE9 and P436Q variants fell respectively to ~6%, ~1.5% and ~0.5%, when compared to these produced from PS1-WT Œ≥-secretase. Following the same tendency, AŒ≤1‚Äì42 levels generated from PS1-L166P, PS1-ŒîE9 and PS1-P436Q Œ≥-secretase variants were respectively estimated to ~20%, ~5% and ~3% of these produced with PS1-WT-containing complexes. The AŒ≤1-42/AŒ≤1‚Äì40 ratio measured for WT Œ≥-MEFs was consistent with our cell-based data (compare Figures 2D and 3C), validating our in vitro experimental conditions. Interestingly, an overall AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio of ~1 was estimated for all PS1 mutants, with the exception of P436Q#4 (~2). However, in the latter, the ratio may have been overestimated because the AŒ≤1‚Äì40 levels measured were at the detection limit. This similarity in the AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios generated by the different mutants has, to the best of our knowledge, never been observed in previous studies.Highly purified Œ≥-secretase complexes with FAD-linked PS1 mutants display a loss-of-function phenotypeIn order to further investigate how PS1 variants affect APP-CTF cleavage and to validate our observations performed in semi-purified conditions, we purified to homogeneity Œ≥-secretase complexes from the selected clones described in Figure 1. The purification process (described in details under Materials &amp; Methods and depicted in Figure 4A) involved three sequential affinity purifications starting from microsomal extracts. Since all cell lines were generated on a PS knockout background, this strategy allowed us to purify exclusively and selectively Œ≥-secretase complexes made of human components. As highlighted in Figure 4B, our protocol led to the production of stable, high molecular weight Œ≥-secretase complexes (HMWCs) with an apparent molecular mass on Blue Native (BN)-PAGE of ~350 kDa, which is consistent with previous reports [26], [27], [37]. The silver stained particles on the BN gel confirmed the high purity of these complexes (Figure 4B, upper panel), for which the identity was established by cross-reactivity with antibodies specific to NCT and PS1 (Figure 4B, lower panels). As the main goal of this experiment was to compare the efficacy of the different Œ≥-secretase complexes to process APP-based substrates, it is important to note that the final yields of the complexes purified from the different clones were very similar (Figure 4B), thus facilitating further comparative analyses. The immunoblot analysis of the purified complexes (Figure 4C) confirmed the presence of all core components (NCT-V5, APH1aL-HA, Flag-PEN2 and PS1) and globally recapitulates the maturation processes observed in the Figure 1. Interestingly, the relative PS1-NTF/CTF to PS1-FL ratios in the purified Œ≥-secretase complexes containing the three PS1 dominant-negative or the PS1-P436Q variants were higher than those estimated in the whole cell extracts before purification (Figure 1A), indicating that endoproteolysis of PS1 was not completely abolished by these mutations. To assess how FAD-linked mutations in PS1 affect Œ≥-secretase activity in these purified complexes, we performed in vitro assays by using C100-Flag substrate (Figure 3A) and equal amounts of the different purified complexes, immediately after the purification to avoid freezing/thawing cycles that might affect enzymatic activity. As shown in Figure 5A, Œ≥-secretase activity based on AICD-Flag production was easily detected in complexes purified from the two PS1-WT clones. This is in sharp contrast to the other purified complexes that did not generate detectable AICD under our experimental conditions (Figure 5A). Next, sandwich ELISAs directed against AŒ≤1‚Äì40 and AŒ≤1‚Äì42 were performed in order to further characterize the specific activity of the purified complexes. Reflecting the levels of AICD and considering the detection limits of our sandwich ELISA, the production of both AŒ≤ species by Œ≥-secretase complexes containing PS1-WT was at least 10-fold higher than in complexes with the FAD-linked or dominant-negative PS1 variants (Figure 5B). The AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio measured in PS1-WT Œ≥-secretase complexes (~0.22) was similar to that previously reported [26], [27], thus excluding a possible qualitative alteration of Œ≥-secretase activity with this protocol. Together, our results strongly support the hypothesis that the pathogenic L166P, ŒîE9, and P436Q mutations in PSEN1 cause a drastic loss (at least 90% as estimated by ELISA) of Œ≥-secretase activity.thumbnailFigure 4. High-grade purification of human Œ≥-secretase complexes with FAD-linked PS1 mutants.(A) Schematic representation of the Œ≥-secretase purification process. Briefly, Presenilin double-knockout MEFs were used to first generate cell lines that stably overexpress human Œ≥-secretase complexes containing different PS1 variants. Next, these cell lines were used for a multi-step purification procedure as described in the material and methods. (B) Blue-Native PAGE analysis of purified Œ≥-secretase complexes made of different PS1 variants. Equal volumes of the different purified Œ≥-secretase preparations were separated by native-PAGE on a 4‚Äì16% Bis-Tris gel, and stained with silver nitrate (top panel), or immunostained for NCT (NCT164, middle panel) or PS1-NTF (ab10281, bottom panel) as indicated. Œ≥-Secretase complexes appeared on the gel as high molecular weight complexes (HMWCs) of ~350 kDa. Note that the levels of HMWCs were similar for all clones. (C) Equal volumes of purified Œ≥-secretase complexes with FAD-linked PS1 mutants were separated under denaturing conditions (SDS-PAGE) and immunostained with anti-NCT (NCT164), anti-PS1-NTF (MAB1563), anti-PS1-CTF (MAB5232), anti-HA (3F10), or anti-Flag (M2) antibodies. Two independent purifications were performed on each clone with similar results. A representative dataset is shown.doi:10.1371/journal.pone.0035133.g004 thumbnailFigure 5. Enzymatic activity of highly purified Œ≥-secretase complexes with FAD-linked or aspartate PS1 mutants.Equal amounts of the different purified Œ≥-secretase preparations characterized in Figure 4 were tested for activity on C100-Flag, as described in Figure 3. The resulting cleavage products were separated by SDS-PAGE and detected by immunostaining with an anti-Flag antibody (M2) for C100-Flag or AICD-Flag (A), and by sandwich ELISA for AŒ≤1‚Äì40 or AŒ≤1‚Äì42 (B). Note that the levels of AŒ≤ produced from FAD-linked Œ≥-secretase complexes were all in the non-linear range of the ELISA standards, close to the detection limit. Whenever possible, AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios were quantified and indicated on the top of the bars. Two independent purifications were performed on each clone and similar results were obtained. A representative dataset is shown.doi:10.1371/journal.pone.0035133.g005 Discussion Top Several conflicting results as to how Alzheimer's disease-linked mutations in PSEN1 affect the processing of APP by Œ≥-secretase have been reported. First, it has been previously reported that transgenic animals with FAD-linked PS1 mutations show increasing brain levels of AŒ≤1‚Äì42 [15], [38]. Since AŒ≤1‚Äì42, the first AŒ≤ specie deposited in the brain of AD patients [16], [39], is more prone to aggregation when compared to shorter AŒ≤ species [40], [41], [42], it has been implicated in the seeding of amyloid plaques in AD patients with PSEN1 mutations [43]. This was further validated in vivo as the overexpression of PS1 mutants in APP transgenic mice accelerated the rate of AŒ≤ accumulation and deposition in the brain [44], [45]. However, Bentahir and colleagues challenged this view by showing that several PSEN1 mutations were also capable to decrease total AŒ≤ production in PS1/PS2 knockout cells [23]. These findings suggested that endogenous PS1 and PS2 may influence the mutant phenotype in cells or in vivo. By extension, we hypothesized that the other components of Œ≥-secretase, namely APH1, NCT and PEN2, may influence the mutant phenotype as well. Indeed, Œ≥-secretase complexes are heterogeneous in composition due to the existence of two human APH1 genes, APH1a and APH1b, and two splicing isoforms of APH1a (S and L), as well as two presenilin genes, PSEN1 and PSEN2. Therefore, it is plausible that a single mutation in PSEN1 confers different catalytic properties to distinct Œ≥-secretase subtypes. This hypothesis is supported by recent investigations showing that APH1 variants can modulate AŒ≤ profiles. When compared to APH1aS or L, overexpression of APH1b in MEF knockout for all APH1 genes led to increased production of longer AŒ≤ species [24]. With this regard, it is important to note that all four mouse variants of APH1 are expressed in the MEF cell line used in previous studies [23] and employed here (cf. Figure S3). Since the phenotype of PS1 mutations have mainly been assessed in vivo or in cell-based systems, we investigated the effects of FAD-linked PS1 mutants on the processing of APP-CTFs in cell-free systems, by using semi-purified and purified enzymatic complexes isolated from MEF PS1/PS2 double knockout cells stably overexpressing differentially tagged human Œ≥-secretase components. Under these conditions, the biochemical and functional properties of Œ≥-secretase complexes bearing either FAD-linked PS1 mutants (L166P, ŒîE9, and P436Q), dominant-negative forms of PS1 or wild-type PS1 were characterized. The activity of Œ≥-secretase with PS1-WT was similar to that reported for Œ≥-secretase purified from our CHO cells overexpressing NCT-V5, APH1aL, Flag-PEN2 and PS1-WT [26], [27], that resulted in AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios between 0.1 and 0.3. In contrast, we found a major loss in the activity of Œ≥-secretase complexes containing either the dominant-negative PS1 variants or the FAD-linked PS1 mutants. Although a total loss of activity was expected for the dominant negative forms of Œ≥-secretase [5], [6], [32], the drastic loss of activity seen here with the FAD-linked PS1 mutants was unexpected. Indeed, the PS1-L166P variant has previously been reported to increase AŒ≤1‚Äì42 levels both in vivo [46] and in vitro [20], in the presence of endogenous PS1, PS2 and APH1 components. In contrast, Bentahir and colleagues found that PS1-L166P decreased both AŒ≤1‚Äì40 and AŒ≤1‚Äì42 production in a PS knockout background. These results are consistent with our in vitro data, although the reduction in AŒ≤1‚Äì42 and AŒ≤1‚Äì40 production was more pronounced in our system. However, they differ from our cell-based data in which we observed an increase in AŒ≤1‚Äì42 associated with a decrease in AŒ≤1‚Äì40. Taken together, these data suggest that the overexpression of the other human components of Œ≥-secretase can influence the phenotype of FAD-linked mutations. Another possible explanation for these discrepancies comes from the use, in previously described cellular systems, of APP carrying the Swedish mutation (K670M/N671L) [20], [23], [46]. Initially, this APP variant was shown to enhance the production of all AŒ≤ species by favouring its Œ≤-secretase cleavage [47], [48]. However, Munter and colleagues recently demonstrated that the APP Swedish mutation can also affect the specificity of the Œ≥-secretase cleavage [49]. In particular, these authors showed that over-expression of APP Swedish in a neuronal cell line led to a 4-fold increase in secreted AŒ≤42, associated with only a 2-fold increase of total AŒ≤, compared with the wild-type APP. Therefore, one cannot exclude the possibility of differential interactions between PS1-WT or PS1 variants and different APP variants, as suggested earlier [50].As far as the PS1-ŒîE9 mutant is concerned, previous cell-based studies have reported a decrease in AŒ≤40 levels associated with an increase in AŒ≤42 levels [51], [52], or no changes in AŒ≤40 levels despite increased AŒ≤42 levels [53], or a decrease in both AŒ≤ species [23]. In the present study, AŒ≤1‚Äì40, AŒ≤1‚Äì42, as well as AICD levels generated from purified Œ≥-secretase complexes with PS1-ŒîE9 were close to the limit of detection, resulting in a loss of at least 95% of the Œ≥-secretase activity compared to wild-type PS1. Similarly, we found a near to complete loss of Œ≥-secretase activity for complexes with the aggressive PS1-P436Q mutant (mean onset: 28.3 years) [54]. Consistent with a recent study [35], and in contrast to PS1-L166P, the maturation of the full-length PS1-P436Q protein into PS1-NTF and PS1-CTF was impaired. Interestingly, the same study also reported that P436Q variant showed a decreased Œ≥-secretase activity and AŒ≤40 and AŒ≤42 secretion in PS1/PS2 double knockout cells (~75% or ~50% of the control for AŒ≤40 or AŒ≤42, respectively), but to a lesser extent than what we measured in this study (more than 97% for both AŒ≤ species).Overall, our data show that, under our experimental conditions, the FAD-linked PS1 mutants cause a drastic loss of activity (at least 90%) in the highly purified and homogeneous as well as semi-purified Œ≥-secretase complexes. This loss-of-function is asymmetrical as AŒ≤1‚Äì42 levels were relatively less affected than AŒ≤1‚Äì40 levels. Interestingly, the ratio between the two AŒ≤ species was similar for the variants tested here (~1), suggesting a common modulatory mechanism. Our findings further support a model in which the subtype of Œ≥-secretase containing APH1aL and FAD-linked PS1 mutants generates a higher AŒ≤42/AŒ≤40 ratio compared to PS1-WT, as previously observed in vivo [15], [38]. Taken together, the overall reduction in AŒ≤ levels strongly suggest that other regulatory mechanisms or cellular components may exist and account for the strong amyloid pathology observed in AD patients carrying these FAD-linked PSEN1 mutations. In agreement with this hypothesis, we report that the phenotype of FAD-linked PSEN1 mutations is different whether we consider the cell-based or the cell-free conditions. Indeed, even if AŒ≤42/AŒ≤40 ratios were globally increased in both experimental conditions, AŒ≤ production was strikingly different.One possible explanation would be that specific subtypes of Œ≥-secretase complexes are less affected than others by PSEN1 mutations. For instance, it remains unknown whether Œ≥-secretase complexes carrying APH1b or APH1aS are similarly affected by PSEN1 mutations. In support to that regard, Winkler and colleagues recently purified human Œ≥-secretase with PS1-L166P and observed that such complexes, containing both APH1a and AHP1b, led to increased AŒ≤1‚Äì42 production associated with decreased AŒ≤1‚Äì40 production, as compared to the PS1-WT complexes. Another possible explanation would be that purified Œ≥-secretase complexes lack binding partners modulating the processing of APP-based substrates, due to purification conditions affecting physical interactions of proteins. These include TMP21 or the recently reported Œ≥-secretase activating protein (GSAP) [12], [13]. Further biochemical analyses are needed to test this hypothesis.The loss of activity in Œ≥-secretase containing PS1 variants also leads to decreased generation of AICD. As AICD is involved in the transcriptional regulation of several genes, including the neprilysin [55], and the lipoprotein receptor, LRP1 [11], it is likely that mutations in PSEN1 impair the regulation of these genes in vivo. For instance, it is possible that unknown genes transcriptionally regulated in vivo by the AICD might influence AŒ≤ metabolism in return. In support to these views, Veeraraghavalu and colleagues recently demonstrated that Notch signalling was impaired in transgenic mice overexpressing PS1 mutants, albeit in the presence of endogenous PS1-WT and all APH1 isoforms [56]. They found decreased self-renewal and differentiation of neuronal precursor cells in the subventricular zone, suggesting that the loss-of-function phenotype of PSEN1 mutations can also be observed in heterogeneous conditions. These results are reminiscent of the previous report from Saura and colleagues showing that conditional inactivation of both presenilins in vivo induces age-dependent neurodegeneration associated with memory impairment [57]. Altogether, the above-described data suggest that alternative pathways of neurodegeneration related to loss of Œ≥-secretase functions are possible and relevant to AD. They further support the concept that modulating rather than inhibiting Œ≥-secretase activity would be a more appropriate therapeutic strategy for AD [58]. Supporting this view, the Œ≥-secretase inhibitor Semagacestat tested in phase III clinical trials not only failed to slow cognitive decline in patients with mild-to-moderate AD, but actually made it worse [59].Collectively, our findings support a model in which FAD-linked mutations in PSEN1 likely induce AŒ≤ pathology by perturbing the relative ratio between AŒ≤ species and by impairing developmental and cellular signalling pathways controlled by Œ≥-secretase substrates. This deleterious dual effect might explain why FAD-linked PSEN1 mutations cause early onset Alzheimer's disease. Since it has been established that AŒ≤ and AICD are generated following the processing by Œ≥-secretase at two distinct gamma- and epsilon-cleavage sites in APP [60], further investigation is now required to better understand whether and how FAD mutations in PS1 differentially affect the epsilon versus gamma-cleavage sites in APP, as well as in other known Œ≥-secretase substrates.Materials and Methods Top DNA Constructs and mutagenesisNCT-V5, Flag-PEN2, APH1aL-HA, wild-type PS1 human cDNAs (PS1-WT) were obtained from D. Selkoe (Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA). PS1 ŒîE9 cDNA was obtained from C. Saura (Universitat Aut√≤noma de Barcelona, Spain). PS1 D257A and PS1 D385A cDNAs were obtained from M. Wolfe (Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA). Mutations in PSEN1, namely, L166P and P436Q, were generated by PCR-based mutagenesis on the plasmid pcDNA3.1/Zeo(+)-PS1-WT using T7 or BGH primers (specific to the plasmid DNA sequence) together with the corresponding primers: L166P Rv: 5‚Ä≤ CAG CAA CAA Taa gct tGA TAT AAT AGG 3‚Ä≤; L166P Fw: 5‚Ä≤ CTT ATT ATA TCa agc ttA TTG TTG CTG 3‚Ä≤; P436Q Rv: 5‚Ä≤ TCG AGT TTA Gaa gct tTC TTG AAA ATG GCA AGG AG 3‚Ä≤; P436Q Fw: 5‚Ä≤ TCG AGT TTA Gaa gct tTG CCA GCT CTT CAA ATC TCC 3‚Ä≤. The sequences corresponding to enzyme restriction sites are given in small letters. The PCR fragments were next digested with BamHI/HindIII and HindIII/XhoI respectively, and were subcloned into pcDNA3. PS1 D257A/D385A (DDAA) was obtained by subcloning the DraI/XhoI digested fragment of PS1 D385A into pcDNA3.1-PS1 D257A. The APP based substrate SPA4CT-Flag, corresponding to the signal peptide of APP fused to the APP-C99-Flag with a small linker region (DA) [36], was obtained by removing the HindIII/EcoRI fragment of pcDNA3-APP695-Flag and inserting the following annealed primers: 5‚Ä≤ AGC TTA TGC TGC CCG GTT TG GCA CTG CTC CTG CTG GCC GCC TGG ACG GCT CGG GCG GAT GCA GAT GCA G 3‚Ä≤ and 5‚Ä≤ AAT TCT GCA TCT GCA TCC GCC CGA GCC GTC CAG GCG GCC AGC AGG AGC AGT GCC AAA CCG GGC AGC ATA 3‚Ä≤. All constructs were next subcloned into the self-inactivated vector pSIN-PGK-WHV cassette (a kind gift from R. Zufferey, Brain Mind Institute, EPFL, Lausanne, Switzerland). Inserts for plasmids pET21-C100-Flag, and pET21-C100-His were generated by PCR as previously described [27]. Plasmids pMD2G and psPAX2 were obtained from D. Trono (Global Health Institute, EPFL, Lausanne, Switzerland).Lentivector productionReplication-defective lentiviral particles were produced by a three-plasmid transient transfection of cells from the human embryonic kidney HEK 293T cell line [61]. Briefly, cells were incubated in 10 cm dishes until they reached 70% confluence and were transiently co-transfected by the calcium phosphate method, with 5 ¬µg of envelope plasmid (pMD2G), 15 ¬µg of packaging plasmid (psPAX2), and 20 ¬µg of vector plasmids (pSIN-PGK-WHV). Cells were incubated overnight with DNA-calcium precipitates, washed twice with Dulbecco's modified Eagle's medium (DMEM, Invitrogen) and incubated with 7 mL of DMEM. After 24 h, the conditioned medium was harvested and cells were incubated a second time with 7 mL of DMEM for 24 h. Media were then pooled, passed through 0.45 ¬µm filter, and stored at ‚àí80¬∞C as 2 mL aliquots until use. A p24 ELISA (Zeptometrix corporation) was performed on each batch of media in order to evaluate the number of viral particles generated.Generation of stable cell lines through multiple gene transductionsMouse Embryonic Fibroblasts (MEFs, obtained from B. De Strooper, Flanders University Institute of Biotechnology, Belgium) defective in PSEN1 and PSEN2 [30], [31] were cultivated in 10 cm dishes in DMEM, supplemented with 10% foetal bovine serum (FBS) and penicillin/streptomycin (P/S) (Invitrogen). A first set of stable cell lines was generated by co-transducing NCT-V5, APH1aL-HA, and Flag-PEN2 containing lentiviral vectors (LV) repeatedly for two weeks at each passage (1/20). Ten clones were isolated by the limiting dilution method and were further screened for NCT-V5, Flag-PEN2 and APH1aL-HA expression by immunodetection. The clone that showed the highest expression of the three proteins (designated Œ≥ - PS1/2) was used as the parental cell line to generate the stable cell lines expressing different PS1 variants, by the same method and by using lentiviral vectors carrying human PS1-WT, PS1-L166P, PS1-ŒîE9, PS1-P436Q, PS1-D257A, PS1-D385A, and PS1-DDAA. For each PS1 variant, five clones were selected for a full characterization and two of them were further used for Œ≥-secretase purification. For SPA4CT overexpression experiments, 500,000 cells of each clone were exposed to the same arbitrary dose of lentiviral vectors carrying human SPA4CT-Flag in 2 mL of DMEM, 1% FBS, P/S and were plated in 6-wells plates for 72 h. The medium was next replaced by fresh DMEM, 2% FBS, P/S for 24 h. Finally, cell culture medium was harvested, supplemented with protease inhibitor cocktail (Roche), centrifuged for 3 min at 1,000√ó rpm and frozen at ‚àí80¬∞C until further processing. Cells were washed in PBS and submitted to protein extraction.Protein extractionTotal protein extracts were prepared in 1% NP40 - HEPES buffer (50 mM HEPES, pH 7.0, 150 mM NaCl, 5 mM MgCl2, 5 mM CaCl2), supplemented with protease inhibitor cocktail (Roche), and were clarified by centrifugation for 1 h at 16,000√ó g, 4¬∞C. Cell membranes were obtained as described below and solubilised in 1% CHAPSO - HEPES buffer and centrifuged at 16,000√ó g for 1 h. Supernatants corresponding to the microsomal protein extracts were harvested and stored at ‚àí80¬∞C. Protein content of the extracts was estimated by the BCA protein assay reagent kit (Pierce).Multi-step purification of human Œ≥-secretase complexes with FAD-linked PS1 variants1) Cell membrane preparation. MEF PS1/PS2 DKO cells (1.0√ó109 cells) expressing NCT-V5, Flag-PEN2, APH1aL-HA and different forms of PS1: wild type (WT), or with FAD-linked variants or lacking the critical aspartate residues, were collected from 15 cm dishes and fully resuspended in 40 mL of MES buffer (50 mM MES, pH 6.0, 150 mM NaCl, 5 mM MgCl2, 5 mM CaCl2), supplemented with protease inhibitor cocktail (Roche). Next, cells were passed four times through a high-pressure homogenizer (Emulsiflex-C5, Avestin Inc, ON Canada) at a pressure greater than 1,000 psi. Nuclei and unbroken cells were removed by centrifugation at 3,000√ó g for 20 min at 4¬∞C in a Beckman Coulter Allegra X-15R centrifuge. The supernatant was collected and centrifuged at 100,000√ó g for 1 h at 4¬∞C in a SW32Ti rotor using a Beckman Coulter Optima L-80 ultracentrifuge to recover the membrane preparation in the pellet. 2) Bicarbonate wash. The membrane pellet was fully resuspended in 1.6 mL of ice cold sodium bicarbonate buffer (0.1 M NaHCO3, pH 11.3) by pipetting up and down at least 30 times, and incubated at 4¬∞C for 20 min. The washed membranes were then centrifuged at 100,000√óg for 1 h at 4¬∞C and stored at ‚àí80¬∞C until use. 3) Solubilisation of Œ≥-secretase complexes. The bicarbonate-washed membranes were fully resuspended in 1.7 mL of 1% CHAPSO - HEPES buffer by pipetting up and down at least 30 times. The membranes were then incubated at 4¬∞C for 1 h. To pellet the insoluble material, the solution was centrifuged at 16,000√ó g at 4¬∞C for 1 h, the pellet was discarded, and the supernatant saved. This lysate is defined as ‚Äúsolubilised Œ≥-secretase preparation‚Äù. Next, these freshly prepared solubilised preparations were used for affinity purification of Œ≥-secretase complexes as described below. 4) Anti-Flag M2 affinity purification. The solubilised Œ≥-secretase preparations were first diluted 1:2 with HEPES buffer, and further diluted 1:6 with 0.1% digitonin - TBS buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl) (final detergent concentration: 0.08% CHAPSO, 0.08% digitonin) and incubated overnight at 4¬∞C with agitation after adding 200 ¬µL of anti-Flag M2 affinity resin beads (Sigma-Aldrich) that had been pre-equilibrated in 0.1% Digitonin - TBS buffer. The beads were washed 3 times in the same buffer, and the bound proteins were eluted over 4 h at 4¬∞C with 0.4 mL of this buffer containing 200 ¬µg/mL of Flag peptides (Sigma-Aldrich). This elution step was repeated once for 1 h at 4¬∞C and the eluted fractions were pooled and designated ‚ÄúM2 pooled 800 ¬µL fractions‚Äù. 5) Anti-V5 affinity purification. The M2 pooled fractions (volume made up to 1 mL with 0.1% Digitonin - TBS buffer) were next incubated overnight at 4¬∞C under agitation with 200 ¬µL of anti-V5 affinity resin beads (Sigma-Aldrich), pre-equilibrated in 0.1% digitonin-TBS buffer. The beads were washed 3 times in the same buffer, and the bound proteins were eluted for 1 h at 4¬∞C with 0.4 mL of this buffer containing 500 ¬µg/mL of V5 peptides (Sigma-Aldrich). This elution step was repeated 4 times, and the eluted fractions were pooled and designated ‚ÄúV5 pooled 1.6 mL fractions‚Äù. 6) Anti-HA affinity purification. As a final purification step, the V5 pooled fractions (volume made up to 1.8 mL with 0.1% digitonin - TBS buffer) were next incubated overnight at 4¬∞C under agitation with 200 ¬µL of anti-HA affinity resin beads (Sigma-Aldrich), pre-equilibrated in 0.1% digitonin - TBS buffer. The beads were washed 3 times in the same buffer, and the bound proteins were eluted overnight at 4¬∞C with 0.2 mL of this buffer containing 200 ¬µg/mL of HA peptides (Sigma-Aldrich). This elution step was repeated once, for 1 h at 4¬∞C, and the two eluted fractions were kept separately, designated ‚ÄúHA fraction E1‚Äù and ‚ÄúHA fraction E2‚Äù.Co-immunoprecipitationCo-IPs were performed on microsomal protein extracts. Briefly, 100 ¬µg of proteins were diluted in a final volume of 1 mL of 1% CHAPSO - HEPES extraction buffer containing protease inhibitors (Roche), and 50 ¬µL of pre-equilibrated anti-Flag or anti-HA affinity beads (Sigma-Aldrich) were added. Samples were next incubated overnight at 4¬∞C on a rotator wheel and were washed three times in 0.2% CHAPSO - HEPES buffer. Finally, beads were resuspended in 50 ¬µL of 0.2% CHAPSO - HEPES buffer and were used for in vitro Œ≥-secretase assays.In vitro Œ≥-secretase activity assaysIn vitro Œ≥-secretase activity assays were performed as previously described [27]. Œ≥-Secretase APP-based substrates were expressed in E. coli transfected with plasmids pET21-C100-Flag or pET21-C100-His as a fusion protein consisting of a Met for translation initiation, and either the Flag tag sequence (C100-Flag) or the His tag sequence (C100-His), and were affinity purified using an anti-Flag resin (M2, Sigma-Aldrich) or an Ni-NTA agarose resin (Invitrogen), respectively. In vitro assays were performed at 37¬∞C for 4 h, with 1 ¬µM of recombinant substrate, 0.025% phosphatidylethanolamine (PE) and 0.1% phosphatidylcholine (PC). Œ≥-Secretase activity was quantified by measuring the amount of AICD and AŒ≤ generated during the reaction, by immunoblot or sandwich ELISA respectively, as described below.SDS-PAGE, Native PAGE, Western blotting and antibodiesTotal or microsomal protein extracts were resolved by electrophoresis on NuPAGE¬Æ Novex¬Æ 4‚Äì12% Bis-Tris Gels (Invitrogen) or on standard 12% acrylamide/bisacrylamide Tris Glycine gels for SDS-PAGE analysis. Purified Œ≥-secretase was resolved by electrophoresis on NativePAGE‚Ñ¢ Novex¬Æ Bis-Tris 4‚Äì16% Gels for Blue Native (BN)-PAGE analysis (Invitrogen). Silver staining was performed directly on gel according to manufacturer instructions (Biorad). For immunoblot analysis, gels were transferred to nitrocellulose or PVDF membranes (Whatman), and probed with the following antibodies: anti-Nicastrin NCT164 (BD Bioscience), anti-V5-tag for NCT-V5 (Covance), MAB1563 (Millipore) or ab10281 (Abcam) for PS1 NTF, MAB5232 for PS1 CTF (Millipore), 3F10 for APH1aL-HA (Roche), anti-Flag M2 for Flag-PEN-2 or C100-Flag (Sigma-Aldrich), A8717 for APP CTF (Sigma-Aldrich), and A2066 for Œ≤-actin (Sigma-Aldrich). Anti-mouse/rabbit/rat IgG conjugated to Alexa 680 were purchased from Invitrogen. The Odyssey infrared imaging system (LICOR) was used to detect the fluorescent signal.Quantification of AŒ≤ peptidesAŒ≤ peptides from the Œ≥-secretase assays described above were quantified by sandwich ELISA according to the protocol provided by the manufacturer. Three kits were used to detect human AŒ≤1‚Äì40 (Invitrogen KHB3481) and AŒ≤1‚Äì42 (Invitrogen KHB3544 and Wako 269-64401).Supporting Information Top Figure S1. Characterization of stable cell lines overexpressing human FAD-linked PS1 variants in MEF PS1/2‚àí/‚àí. Presenilin double-knockout mouse embryonic fibroblasts were stably transduced with lentiviral vectors carrying genes encoding hPS1 variants harbouring FAD-linked mutations or mutations in the catalytic aspartate residue(s), or PS1-WT, and cloned. Two clones per PS1 variant were selected for characterization. (A) Whole cell protein extracts of the different cell lines were prepared in 1% NP40-HEPES buffer, separated by SDS-PAGE on 12% Tris-Glycine gels and analysed by immunostaining with various antibodies to detect the endogenous Œ≥-secretase core components: NCT (NCT164), hPS1 (NTF, MAB1563), and PEN2 (UD1), and with an antibody for APP (A8717). Œ≤-Actin was used as a loading control. Each lane represents one selected clone. (B) Œ≥-Secretase activity assays were performed with microsomal extracts prepared in 1% CHAPSO-HEPES buffer. Equal protein levels from the different extracts were diluted to 0.25% CHAPSO-HEPES buffer and incubated for 4 h at 37¬∞C with lipids and 1 ¬µM of recombinant human APP-based substrate (C100-Flag). Samples were analyzed by SDS-PAGE and immunostained with anti-Flag (M2) or anti-PS1 (MAB1563). PS1 immunostaining was used to assess the amount of input material. * Indicates a non-specific band, which was not detected in microsomal protein extracts of the same cell lines using the same antibody (MAB1563) (B). CTF: C-terminal fragment, FL: full-length, im.: immature NCT; m.: mature NCT, N: N-glycosylated, NTF: N-terminal fragment, O: O-glycosylated.(TIF)Figure S2. APP-CTF profiles in WT MEF, MEF PS1/2‚àí/‚àí and Œ≥ - PS1/2 transduced with the SPA4CT construct. WT MEF, MEF PS1/2‚àí/‚àí and Œ≥ - PS1/2 were transduced with an APP-based substrate corresponding to the 99 C-terminal residues of human APP fused to the APP signal peptide in N-terminus (SPA4CT [36]). Cell proteins were extracted in 1% NP40-HEPES buffer, separated by SDS-PAGE on 12% Tris-Glycine gels and analysed by immunostaining with an antibody targeting the C-terminal part of APP (A8717).(TIF)Figure S3. APH1 isoforms expressed in MEF PS1/2‚àí/‚àí. Total RNAs were extracted from presenilin double-knockout MEFs, using standard procedures (Qiagen RNAeasy kit) and were quantified by spectrophotometry. One microgram of total RNAs was reverse transcribed for 1 h at 42¬∞C by using the ImProm-II reverse transcription system (Promega) and oligo-dT primer in a final volume of 20 ¬µL. PCR was next performed for each APH1 isoform on 1 ¬µL of RT reaction by using the Roche PCR kit under standard conditions and the primers described in Table S1. The following cycling conditions were applied for all reactions: 94¬∞C, 3 min; 30 cycles of [94¬∞C, 30 s; 58¬∞C, 30 s; 70¬∞C, 40 s]; 70¬∞C, 10 min. PCR products were separated on a 2% agarose gel and visualized using Alpha Innotech UV imager.(TIF)Table S1. Primers used to detect APH1 isoforms in MEF PS1/2‚àí/‚àí. F: Forward, R: Reverse.(DOC)Acknowledgments Top We are grateful to B. De Strooper for the WT and PS1‚àí/‚àí PS2‚àí/‚àí KO mouse embryonic fibroblasts, to C. Saura for the PS1 ŒîE9, to M. Wolfe for the PS1 D257A and PS1 D385A cDNAs, and to D. Selkoe for the APH1aL-HA, NCT-V5, and Flag-PEN2 cDNAs. We also thank J.R. Alattia, C. Schweizer, and A. Alahari for critical readings of the manuscript.Author Contributions Top Conceived and designed the experiments: MC PCF. Performed the experiments: MC LA JH. Analyzed the data: MC LA JH PCF. Wrote the paper: MC PCF. Edited the manuscript: MC LA JH PCF. Supervised the project: PCF.References Top Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775‚Äì778. Find this article online Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754‚Äì760. Find this article online Weihofen A, Martoglio B (2003) Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides. Trends Cell Biol 13: 71‚Äì78. Find this article online Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, et al. (2000) Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat Cell Biol 2: 428‚Äì434. Find this article online Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, et al. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398: 513‚Äì517. Find this article online Kimberly WT, Xia W, Rahmati T, Wolfe MS, Selkoe DJ (2000) The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. J Biol Chem 275: 3173‚Äì3178. Find this article online Beel AJ, Sanders CR (2008) Substrate specificity of gamma-secretase and other intramembrane proteases. Cell Mol Life Sci 65: 1311‚Äì1334. Find this article online Bot N, Schweizer C, Ben Halima S, Fraering PC (2010) Processing of the synaptic cell-adhesion molecule neurexin-3{beta} by Alzheimer's disease {alpha}- and {gamma}-secretases. J Biol Chem. Find this article online Parks AL, Curtis D (2007) Presenilin diversifies its portfolio. Trends Genet 23: 140‚Äì150. Find this article online Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, et al. (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci 25: 436‚Äì445. Find this article online Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, et al. (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56: 66‚Äì78. Find this article online Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, et al. (2006) TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440: 1208‚Äì1212. Find this article online He G, Luo W, Li P, Remmers C, Netzer WJ, et al. (2010) Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 467: 95‚Äì98. Find this article online Wakabayashi T, De Strooper B (2008) Presenilins: members of the gamma-secretase quartets, but part-time soloists too. Physiology (Bethesda) 23: 194‚Äì204. Find this article online Citron M, Westaway D, Xia W, Carlson G, Diehl T, et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. NatMed 3: 67‚Äì72. Find this article online Delacourte A, Sergeant N, Champain D, Wattez A, Maurage CA, et al. (2002) Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology 59: 398‚Äì407. Find this article online Mehta ND, Refolo LM, Eckman C, Sanders S, Yager D, et al. (1998) Increased Abeta42(43) from cell lines expressing presenilin 1 mutations. Ann Neurol 43: 256‚Äì258. Find this article online Murayama O, Tomita T, Nihonmatsu N, Murayama M, Sun X, et al. (1999) Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci Lett 265: 61‚Äì63. Find this article online Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, et al. (2000) Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci 20: 8717‚Äì8726. Find this article online Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A 99: 8025‚Äì8030. Find this article online Qi Y, Morishima-Kawashima M, Sato T, Mitsumori R, Ihara Y (2003) Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells. Biochemistry 42: 1042‚Äì1052. Find this article online Dowjat WK, Kuchna I, Wisniewski T, Wegiel J (2004) A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations. J Alzheimers Dis 6: 31‚Äì43. Find this article online Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, et al. (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96: 732‚Äì742. Find this article online Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horre K, et al. (2009) gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 324: 639‚Äì642. Find this article online Farmery MR, Tjernberg LO, Pursglove SE, Bergman A, Winblad B, et al. (2003) Partial purification and characterization of gamma-secretase from post-mortem human brain. J Biol Chem 278: 24277‚Äì24284. Find this article online Fraering PC, Ye W, Strub JM, Dolios G, LaVoie MJ, et al. (2004) Purification and characterization of the human gamma-secretase complex. Biochemistry 43: 9774‚Äì9789. Find this article online Cacquevel M, Aeschbach L, Osenkowski P, Li D, Ye W, et al. (2008) Rapid purification of active gamma-secretase, an intramembrane protease implicated in Alzheimer's disease. J Neurochem 104: 210‚Äì220. Find this article online Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ, et al. (2006) Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci U S A 103: 6889‚Äì6894. Find this article online Osenkowski P, Li H, Ye W, Li D, Aeschbach L, et al. (2009) Cryoelectron microscopy structure of purified gamma-secretase at 12 A resolution. J Mol Biol 385: 642‚Äì652. Find this article online Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A 96: 11872‚Äì11877. Find this article online Herreman A, Van Gassen G, Bentahir M, Nyabi O, Craessaerts K, et al. (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci 116: 1127‚Äì1136. Find this article online Nyabi O, Bentahir M, Horre K, Herreman A, Gottardi-Littell N, et al. (2003) Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 278: 43430‚Äì43436. Find this article online Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181‚Äì190. Find this article online Nelson O, Tu H, Lei T, Bentahir M, de Strooper B, et al. (2007) Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J Clin Invest 117: 1230‚Äì1239. Find this article online Heilig EA, Xia W, Shen J, Kelleher RJ (2010) A presenilin-1 mutation identified in familial Alzheimer's disease with cotton wool plaques causes nearly complete loss of {gamma}-secretase activity. J Biol Chem. Find this article online Lichtenthaler SF, Multhaup G, Masters CL, Beyreuther K (1999) A novel substrate for analyzing Alzheimer's disease gamma-secretase. FEBS letters 453: 288‚Äì292. Find this article online Fraering PC, LaVoie MJ, Ye W, Ostaszewski BL, Kimberly WT, et al. (2004) Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 43: 323‚Äì333. Find this article online Duff K, Eckman C, Zehr C, Yu X, Prada CM, et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710‚Äì713. Find this article online Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, et al. (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13: 45‚Äì53. Find this article online Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, et al. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267: 546‚Äì554. Find this article online Jan A, Gokce O, Luthi-Carter R, Lashuel HA (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283: 28176‚Äì28189. Find this article online Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693‚Äì4697. Find this article online Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864‚Äì870. Find this article online Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97‚Äì100. Find this article online Borchelt DR, Lee MK, Gonzales V, Slunt HH, Ratovitski T, et al. (2002)"/><tcas:DocumentAnnotation xmi:id="1119" sofa="11" begin="0" end="65300" language="x-unspecified"/><types:TestDocument xmi:id="1124" sofa="11" begin="0" end="0" text="PLoS ONE: Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified Œ≥-Secretase Complexes&#10;Open Access&#10;Research Article&#10;Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified Œ≥-Secretase Complexes&#10;Matthias Cacquevel, Lor√®ne Aeschbach, Jemila Houacine, Patrick C. Fraering*√âcole Polytechnique F√©d√©rale de Lausanne, Brain Mind Institute, Laboratory of Molecular and Cellular Biology of Alzheimer's Disease, Lausanne, Switzerland&#10;Abstract Top Background&#10;Mutations linked to early onset, familial forms of Alzheimer's disease (FAD) are found most frequently in PSEN1, the gene encoding presenilin-1 (PS1). Together with nicastrin (NCT), anterior pharynx-defective protein 1 (APH1), and presenilin enhancer 2 (PEN2), the catalytic subunit PS1 constitutes the core of the Œ≥-secretase complex and contributes to the proteolysis of the amyloid precursor protein (APP) into amyloid-beta (AŒ≤) peptides. Although there is a growing consensus that FAD-linked PS1 mutations affect AŒ≤ production by enhancing the AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio, it remains unclear whether and how they affect the generation of APP intracellular domain (AICD). Moreover, controversy exists as to how PS1 mutations exert their effects in different experimental systems, by either increasing AŒ≤1‚Äì42 production, decreasing AŒ≤1‚Äì40 production, or both. Because it could be explained by the heterogeneity in the composition of Œ≥-secretase, we purified to homogeneity complexes made of human NCT, APH1aL, PEN2, and the pathogenic PS1 mutants L166P, ŒîE9, or P436Q.Methodology/Principal Findings&#10;We took advantage of a mouse embryonic fibroblast cell line lacking PS1 and PS2 to generate different stable cell lines overexpressing human Œ≥-secretase complexes with different FAD-linked PS1 mutations. A multi-step affinity purification procedure was used to isolate semi-purified or highly purified Œ≥-secretase complexes. The functional characterization of these complexes revealed that all PS1 FAD-linked mutations caused a loss of Œ≥-secretase activity phenotype, in terms of AŒ≤1‚Äì40, AŒ≤1‚Äì42 and APP intracellular domain productions in vitro.Conclusion/Significance&#10;Our data support the view that PS1 mutations lead to a strong Œ≥-secretase loss-of-function phenotype and an increased AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio, two mechanisms that are potentially involved in the pathogenesis of Alzheimer's disease.Citation: Cacquevel M, Aeschbach L, Houacine J, Fraering PC (2012) Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified Œ≥-Secretase Complexes. PLoS ONE 7(4): e35133. doi:10.1371/journal.pone.0035133&#10;Editor: Stefano L. Sensi, University G. D'Annunzio, Italy&#10;Received: February 20, 2012; Accepted: March 13, 2012; Published: April 18, 2012&#10;Copyright: ¬© 2012 Cacquevel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Funding: This work was supported by the Swiss National Foundation (to and LA and PCF; grant 31003A_134938/1) and the National Centre for Competence in Research (‚ÄúNeuronal Plasticity and Repair‚Äù (to JH and PCF)), and the Strauss foundation (to PCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist.* E-mail: patrick.fraering@epfl.ch&#10;Introduction Top Since their discovery in 1995 and their association with early onset familial Alzheimer's disease (FAD) [1], [2], the presenilin genes PSEN1 and PSEN2 have been widely studied, and the complexity of their biological role is becoming increasingly evident. PSEN1 and PSEN2 encode transmembrane proteins PS1 and PS2, respectively, that constitute the catalytic core of Œ≥-secretase, the founding member of an emerging class of unconventional, Intramembrane-Cleaving Proteases (I-CLiPs) [3]. Active Œ≥-secretase is a multiprotein complex composed of PS1 or PS2 together with nicastrin (NCT), the anterior pharynx-defective protein 1 (APH1), and the presenilin enhancer 2 (PEN2). Experimental evidence such as the binding of transition-state analogue Œ≥-secretase inhibitors to PS1 [4], as well as the abolishment of Œ≥-secretase activity when PS1 lacks the aspartate residues critical for proteolysis [4], [5], [6], have confirmed that presenilins harbour the active site of the enzymatic complex.PS1 and PS2 play fundamental roles in cell signalling as part of the Œ≥-secretase complex. The latter cleaves numerous type-I membrane proteins in their transmembrane domain [7], releasing their corresponding intracellular domains, which are capable of influencing gene expression. For some substrates like NOTCH1 or ERBB4, the Œ≥-secretase cleavage is essential for their biological function, whereas for other substrates like DCC or NEUREXIN-3Œ≤ [8], the possible role of the cleavage in signalling events has not been formally established (see [9] for a review). The amyloid precursor protein (APP) is processed by the successive actions of Œ≤-secretase (BACE1) and Œ≥-secretase, generating amyloid-beta peptides (AŒ≤) of different lengths, ranging from 37 to 46 amino acids [10]. Cleavage of the APP C-terminal fragments (APP-CTFs) by Œ≥-secretase also releases the APP intracellular domain (AICD), which has been recently involved in the regulation of brain ApoE expression, a major genetic determinant of AD, and in cholesterol metabolism [11]. In addition, PS1 has been shown to interact with a growing list of proteins that modulate Œ≥-secretase activity [9], [12], [13], [14].In a pathological context, 185 missense mutations in PSEN1 and 13 mutations in PSEN2 have been identified and found to be associated with FAD (www.molgen.ua.ac.be/ADMutations). It was initially suggested that such mutations lead to a toxic gain of function because they are associated with a relative increased production of longer and more hydrophobic AŒ≤ species, mainly AŒ≤1‚Äì42, that accumulate and aggregate early in the course of the disease [15], [16]. Similar phenotypes have been observed by independent groups in cell-based studies performed with different mammalian cell lines [17], [18], [19], [20], [21], [22]. Despite this growing consensus, the above-mentioned studies provided conflicting results regarding the relative proportions of AŒ≤42, AŒ≤40, and AICD resulting from the PSEN mutations. On one hand, a gain-of-function phenotype was suggested due to the observed increase in AŒ≤42 production, accompanied or not with reduced AŒ≤40 production, thereby leading to an increased AŒ≤42/AŒ≤40 ratio. On the other hand, reduced AICD production suggested a loss-of-function phenotype [20]. Differences in the methodologies and cell types used to assess the effects of PSEN mutations on AŒ≤ and AICD productions can explain this controversy as to how PS mutations exert their effects. For example, endogenous PS has been suggested to affect such analysis, as the FAD-linked PSEN1 mutations led to a decrease in the total amount of AŒ≤ generated in PS1 and PS2 double knockout cells [23]. Next, it has been reported that Œ≥-secretase complexes are heterogeneous in composition (with two PS genes and three APH1 isoforms, six combinations of Œ≥-secretase are possible), with distinct functional properties influencing the relative amount of AŒ≤ species generated [24]. In order to investigate the biochemical and functional properties of Œ≥-secretase in cell-free systems, we and others have recently purified this enzymatic complex to homogeneity [25], [26], [27]. In particular, protocols for the high-grade purification of proteolytically active Œ≥-secretase constituted of NCT, APH1aL, PEN2 and wild-type PS1 [26], [27] allowed the reconstitution of 3D structures at 15 √Ö and 12 √Ö resolution by EM and cryo-EM and gave new insights on the structure and activity of the enzyme [28], [29]. However, these studies were exclusively focused on the wild-type PS1. Here, we report for the first time the functional characterization of highly purified and homogenous human Œ≥-secretase particles carrying different FAD-linked PS1 mutants. Our biochemical and functional findings strongly suggest that pathogenic mutations in PSEN1 cause a loss of Œ≥-secretase activity.Results Top Generation, selection and characterization of stable cell lines overexpressing Œ≥-secretase complexes with FAD-linked PS1 mutants&#10;In order to facilitate high-grade purification of homogenous human Œ≥-secretase complexes containing different PS1 variants, we took advantage of a previously generated mouse embryonic fibroblast (MEF) cell line that lacks the two presenilins (PS1/2‚àí/‚àí) [30], [31]. Our global strategy consisted in producing stable cell lines, on a PS1/2‚àí/‚àí background, that overexpress tagged versions of the three human Œ≥-secretase subunits NCT, APH1 and PEN2 together with different variants of human PS1, and to purify the different human Œ≥-secretase complexes by three sequential affinity purification steps. This strategy allowed us to exclude a possible co-purification of mouse Œ≥-secretase components. First, a parental cell line was generated by co-transducing lentiviral vectors of human NCT-V5 (hNCT-V5), human APH1aL-HA (hAPH1aL-HA) and human Flag-PEN2 (Flag-hPEN2) into MEF PS1/2‚àí/‚àí. Lentivectors are stably integrated into the cell genome and allow the generation of cell lines overexpressing multiple genes in a short period of time. Next, the clone expressing the highest levels of all three recombinant proteins was selected (designated Œ≥ - PS1/2) and used as the parental cell line that was further transduced with lentivectors carrying the following different human PS1 variants: PS1-WT, three dominant-negative forms of PS1 that lack the crucial, catalytic site aspartate residues (D257A, D385A, and both D257A/D385A referred to as DDAA later in the article), and three FAD-linked PS1 mutants (L166P, ŒîE9 and P436Q, with mean disease onset at 24 years, 45.5 years and 28.3 years, respectively).For each PS1 variant, two individual clones were selected based on the expression levels of the recombinant proteins, and extensively characterized (Figure 1). To distinguish those cell lines overexpressing all Œ≥-sectease components from wild-type MEFs, they are collectively designated Œ≥-MEFs. As shown in Figure 1A, the analysis of total protein extracts confirmed that PS is required for the maturation of NCT and the stability of PEN2 [23], [32]. As expected, and when compared to the parental Œ≥- PS1/2 cell line, higher levels of the mature form of NCT were observed in all PS1-overexpressing clones. In contrast to PEN2, APH1aL levels were relatively similar in all PS1 clones and the parental cell line. Indeed, and as previously reported [23], [32], PEN2 levels were higher in the clones overexpressing WT PS1 and FAD-linked PS1 mutants, and to a lesser extent in the clones overexpressing the dominant negative forms of PS1. Interestingly, PEN2 migrated on the gel as an apparent double band, possibly reflecting a post-translational modification. Different patterns of PS1 expression and autoproteolysis were observed in the different clones. First, and in sharp contrast to the other clones, those expressing PS1-WT or PS1-L166P displayed higher levels of PS1-NTF and PS1-CTF fragments compared with full-length PS1 (PS1-FL; Figure 1A). As estimated by densitometry, the NTF fragments of PS1-WT and PS1-L166P account for 87¬±2% and 79¬±7% of total PS1 (PS1-NTF+PS1-FL), respectively. Next, the PS1-ŒîE9 clones did not show any detectable NTF or CTF fragments, as previously described [33], while P436Q and the three dominant negative variants of PS1 were characterized by low levels of PS1-NTF and PS1-CTF fragments, suggesting that these variants were less prone to endoproteolysis.thumbnail&#10;Figure 1. Generation of stable cell lines overexpressing all human Œ≥-secretase components with FAD-linked PS1 variants.MEF PS1/2‚àí/‚àí were stably co-transduced with lentiviral vectors carrying genes encoding hNCT-V5, Flag-hPEN2, hAPH1aL-HA and clones were isolated by limiting dilution to generate a cell line, designated as Œ≥- PS1/2, that overexpresses high amount of the three subunits. Œ≥- PS1/2 MEFs were further transduced with hPS1 variants harbouring FAD-linked mutations or mutations in the catalytic aspartate residue(s), or PS1-WT, and cloned. Each clone, derived form the Œ≥- PS1/2, was conveniently named according to the mutation present in PS1 preceded by the symbol Œ≥ and followed by the number of the clone (Œ≥-MEF) in order to distinguish them from wild-type MEF (WT MEF) and MEF PS1/2‚àí/‚àí. Two clones per Œ≥-secretase variant were selected for characterization. (A‚ÄìB) Whole cell protein extracts of the different cell lines were prepared in 1% NP40-HEPES buffer, separated by SDS-PAGE on 4‚Äì12% Bis-Tris or 12% Tris-Glycine gels and analysed by immunostaining to detect the Œ≥-secretase core components NCT (NCT164), PS1 (NTF, MAB1563; CTF; MAB5232), APH1aL-HA (3F10), and Flag-PEN2 (M2) (A), and endogenous APP (A8717) (B). Œ≤-Actin was used as a loading control. Each lane represents one selected clone. CTF: C-terminal fragment, FL: full-length, im.: immature NCT; m.: mature NCT, N: N-glycosylated, NTF: N-terminal fragment, O: O-glycosylated.doi:10.1371/journal.pone.0035133.g001 We next investigated the effects of PSEN1 mutations on the processing of endogenous APP. As expected, and as indicated by increased levels of intracellular APP-CTFs (a common characteristic among known substrates in response to Œ≥-secretase pharmacological inhibition), the activity of Œ≥-secretase was significantly altered in the PS deficient parental Œ≥ - PS1/2 cell line as well as in all clones expressing dominant negative forms of PS1 (Figure 1B). In the clones expressing PS1-WT, APP-CTFs were almost undetectable due to high Œ≥-secretase activity, while clones expressing PS1-L166P or PS1-P436Q displayed APP-CTF accumulation. In PS1-ŒîE9 clones, a mild APP-CTF accumulation was observed (Figure 1B). Although a poor recovery of Œ≥-secretase activity for the PS1-L166P and a comparatively better performance of PS1-ŒîE9 have been reported by others under similar experimental conditions [23], the potential of PS1-P436Q mutation to restore the processing of endogenous APP-CTFs has never been assessed [34], [35]. Importantly, all observations described above for the cells overexpressing simultaneously hNCT-V5, hAPH1aL-HA, Flag-hPEN2 and the different PS1 variants are very consistent with those made in MEF PS1/2‚àí/‚àí cells overexpressing only the PS1 variants, in the absence of the other Œ≥-secretase components (cf. Figure S1A). These data suggest that the effect of FAD mutations in PS1 on APP-CTFs accumulation was similar in presence or absence of other human components of the Œ≥-secretase.Next, we further investigated the effect of PS1 variants on the cellular production/secretion of AŒ≤ species. For this purpose, and as described elsewhere [36], we used an APP-based Œ≥-secretase substrate with a Flag tag at its C-terminus (SPA4CT-Flag). This substrate was transduced in the above-described Œ≥-secretase overexpressing stable cell lines (Œ≥-MEFs) as well as in wild-type MEFs, and APP-CTFs and AŒ≤ levels were measured in cell lysate and cell media, respectively (Figure 2). Under these conditions, the overexpression of SPA4CT-Flag led to an accumulation of two bands corresponding to the exogenous substrate, associated with a concomitant decrease of endogenous APP-CTFs levels (Figure 2A and Figure S2). As estimated by ELISA, a three-fold increase in AŒ≤1‚Äì40 and AŒ≤1‚Äì42 levels was observed in the cell culture media of cell lines overexpressing human Œ≥-secretase (Œ≥-MEF WT), in comparison to untransduced WT MEFs (Figure 2B). Also, the average AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios were not significantly different in those cell lines (Mean ¬± SD: Œ≥-MEF WT#5: 0.30¬±0.01; Œ≥-MEF WT#8: 0.29¬±0.01; WT MEF: 0.19¬±0.06). Next, overexpression of SPA4CT-Flag in Œ≥-MEFs led to the pronounced intracellular accumulation of APP-CTFs in cells overexpressing the PS1 aspartate mutants (Figure 2C), and to the secretion in the cell culture media of different AŒ≤ levels as measured by ELISA (Figure 2D). First, only traces of both AŒ≤1‚Äì40 and AŒ≤1‚Äì42 were detected in Œ≥-MEFs overexpressing PS1 with aspartate mutants. Next, Œ≥-MEFs overexpressing PS1 with FAD-linked mutations displayed a pronounced variability in AŒ≤ levels when compared to the wild-type clones. Overall, the average AŒ≤1‚Äì40 levels were decreased in these cell lines (Mean of two clones in pg/mL ¬± SD: WT: 224.6¬±0.1, L166P: 84.3¬±34.2, ŒîE9: 167.2¬±40.7, P436Q: 82.8¬±74.7), while the AŒ≤1‚Äì42 levels were increased (Mean of two clones in pg/mL ¬± SD: WT: 69.9¬±7.9, L166P: 310.7¬±81.0, ŒîE9: 94.4¬±18.5, P436Q: 141.1¬±98.5). Consistent with previously reported data, the AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios were increased in all Œ≥-MEF clonesoverexpressing PS1 with FAD-linked mutations (Figure 2D) (Mean of two clones pg/mL ¬± SD: WT: 0.31¬±0.03, L166P: 3.8¬±0.58, ŒîE9: 0.6¬±0.03, P436Q: 2.0¬±0.59).thumbnail&#10;Figure 2. AŒ≤ production in cell lines overexpressing human Œ≥-secretase components with FAD-linked PS1 variants.WT MEF, Œ≥-MEF and Œ≥ - PS1/2 were transduced with an APP-based substrate corresponding to the 99 C-terminal residues of human APP fused to the APP signal peptide in N-terminus (SPA4CT [36]) and a Flag Tag in C-terminus. Cell proteins were extracted in 1% NP40-HEPES buffer, separated by SDS-PAGE on 12% Tris-Glycine gels and analysed by immunostaining with an antibody targeting the C-terminal part of APP (A8717) (A, C). AŒ≤1‚Äì40 and AŒ≤1‚Äì42 levels were also measured in the corresponding cell culture media (B, D). Data corresponds to three independent experiments (Mean ¬± SEM).doi:10.1371/journal.pone.0035133.g002 FAD-linked PS1 mutations alter the activity of semi-purified Œ≥-secretase complexes&#10;We next assessed the activity of Œ≥-secretase with FAD-linked PS1 mutations in microsomal extracts of Œ≥-MEFs. Membrane protein extracts were prepared and Œ≥-secretase activity was assayed on an exogenous recombinant APP-based substrate consisting of the C-terminal 99 amino acid residues of APP, and referred to as C100-Flag (Figure 3A). The generation of the cleavage product AICD-Flag was detected by Western blot analysis and measured by densitometry. As shown in Figure 3A, the levels of AICD-Flag generated from the PS1-L166P and PS1-ŒîE9 clones accounted for 42¬±1% and 13¬±6% of that in the PS1-WT clones, respectively. AICD-Flag was undetectable in the clones expressing PS1-P436Q as well as in the three dominant negative aspartate PS1 variants. Similar results were observed in MEF PS1/2‚àí/‚àí cells overexpressing only the PS1 variants, in the absence of the other human Œ≥-secretase components (Figure S1B).thumbnail&#10;Figure 3. Enzymatic activity of partially purified Œ≥-secretase complexes with FAD-linked PS1 mutants.(A) Œ≥-Secretase activity assays performed with Œ≥-MEF and Œ≥ - PS1/2 microsomal extracts prepared in 1% CHAPSO-HEPES buffer. Equal protein levels from the different extracts were diluted to 0.25% CHAPSO-HEPES buffer and incubated for 4 h at 37¬∞C with lipids and 1 ¬µM of recombinant human APP-based substrate (C100-Flag). Samples were analyzed by SDS-PAGE and immunostained with anti-Flag (M2) or anti-PS1 (MAB1563). The relative amounts of AICD-Flag generated in the reactions, reflecting Œ≥-secretase activity, were estimated by densitometry. PS1 immunostaining was used to assess the amount of input material. (B) Equal amounts of microsomal proteins were immunoprecipitated overnight at 4¬∞C with either anti-Flag M2 or anti-HA affinity resins, and submitted to a C100-His assay according to the same protocol as in (A). Protein samples were separated by SDS-PAGE and analysed by immunostaining for Œ≥-secretase subunits ((NCT164 (NCT), MAB1563 (PS1-NTF), or UD1 (PEN2)). AICD-His cleavage products were immunostained with an anti-APP-CTF antibody (A8717). *Indicates a non-specific band corresponding to the IgG light chains. (C) AŒ≤1‚Äì40 and AŒ≤1‚Äì42 were quantified by sandwich ELISA and represented in pg/mL (left Y-axis) or in percentage (right Y-axis) of the mean of AŒ≤1‚Äì40 levels generated by the two wild-type clones. AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios are indicated on the top of the bars. The results were confirmed in three independent experiments and a representative dataset is shown.doi:10.1371/journal.pone.0035133.g003 We next performed activity assays under semi-purified conditions. To do so, Œ≥-secretase complexes from the different clones were co-immunoprecipitated from microsomal extracts and their activities were assayed in vitro with the C100-His substrate. Two immunoprecipitation protocols using two affinity resins (anti-Flag M2 and anti-HA 3F10, targeting respectively Flag-PEN2 and APH1aL-HA) were compared to exclude a possible heterogeneity of Œ≥-secretase complexes potentially generated under such conditions. As shown in Figure 3B, the anti-Flag and anti-HA resins immunoprecipitated similar levels of NCT, PS1 and PEN2 and the activity of the Œ≥-secretase complexes was similar regardless of the affinity resins used (Figures 3B). In agreement with the assays performed using microsomal extracts (Figure 3A), those performed with semi-purified complexes revealed that FAD-linked mutants drastically reduced AICD generation, when compared to PS1-WT (Figure 3B). Furthermore, levels of AŒ≤1‚Äì40 produced from PS1-L166P, PS1-ŒîE9 and P436Q variants fell respectively to ~6%, ~1.5% and ~0.5%, when compared to these produced from PS1-WT Œ≥-secretase. Following the same tendency, AŒ≤1‚Äì42 levels generated from PS1-L166P, PS1-ŒîE9 and PS1-P436Q Œ≥-secretase variants were respectively estimated to ~20%, ~5% and ~3% of these produced with PS1-WT-containing complexes. The AŒ≤1-42/AŒ≤1‚Äì40 ratio measured for WT Œ≥-MEFs was consistent with our cell-based data (compare Figures 2D and 3C), validating our in vitro experimental conditions. Interestingly, an overall AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio of ~1 was estimated for all PS1 mutants, with the exception of P436Q#4 (~2). However, in the latter, the ratio may have been overestimated because the AŒ≤1‚Äì40 levels measured were at the detection limit. This similarity in the AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios generated by the different mutants has, to the best of our knowledge, never been observed in previous studies.Highly purified Œ≥-secretase complexes with FAD-linked PS1 mutants display a loss-of-function phenotype&#10;In order to further investigate how PS1 variants affect APP-CTF cleavage and to validate our observations performed in semi-purified conditions, we purified to homogeneity Œ≥-secretase complexes from the selected clones described in Figure 1. The purification process (described in details under Materials &amp; Methods and depicted in Figure 4A) involved three sequential affinity purifications starting from microsomal extracts. Since all cell lines were generated on a PS knockout background, this strategy allowed us to purify exclusively and selectively Œ≥-secretase complexes made of human components. As highlighted in Figure 4B, our protocol led to the production of stable, high molecular weight Œ≥-secretase complexes (HMWCs) with an apparent molecular mass on Blue Native (BN)-PAGE of ~350 kDa, which is consistent with previous reports [26], [27], [37]. The silver stained particles on the BN gel confirmed the high purity of these complexes (Figure 4B, upper panel), for which the identity was established by cross-reactivity with antibodies specific to NCT and PS1 (Figure 4B, lower panels). As the main goal of this experiment was to compare the efficacy of the different Œ≥-secretase complexes to process APP-based substrates, it is important to note that the final yields of the complexes purified from the different clones were very similar (Figure 4B), thus facilitating further comparative analyses. The immunoblot analysis of the purified complexes (Figure 4C) confirmed the presence of all core components (NCT-V5, APH1aL-HA, Flag-PEN2 and PS1) and globally recapitulates the maturation processes observed in the Figure 1. Interestingly, the relative PS1-NTF/CTF to PS1-FL ratios in the purified Œ≥-secretase complexes containing the three PS1 dominant-negative or the PS1-P436Q variants were higher than those estimated in the whole cell extracts before purification (Figure 1A), indicating that endoproteolysis of PS1 was not completely abolished by these mutations. To assess how FAD-linked mutations in PS1 affect Œ≥-secretase activity in these purified complexes, we performed in vitro assays by using C100-Flag substrate (Figure 3A) and equal amounts of the different purified complexes, immediately after the purification to avoid freezing/thawing cycles that might affect enzymatic activity. As shown in Figure 5A, Œ≥-secretase activity based on AICD-Flag production was easily detected in complexes purified from the two PS1-WT clones. This is in sharp contrast to the other purified complexes that did not generate detectable AICD under our experimental conditions (Figure 5A). Next, sandwich ELISAs directed against AŒ≤1‚Äì40 and AŒ≤1‚Äì42 were performed in order to further characterize the specific activity of the purified complexes. Reflecting the levels of AICD and considering the detection limits of our sandwich ELISA, the production of both AŒ≤ species by Œ≥-secretase complexes containing PS1-WT was at least 10-fold higher than in complexes with the FAD-linked or dominant-negative PS1 variants (Figure 5B). The AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratio measured in PS1-WT Œ≥-secretase complexes (~0.22) was similar to that previously reported [26], [27], thus excluding a possible qualitative alteration of Œ≥-secretase activity with this protocol. Together, our results strongly support the hypothesis that the pathogenic L166P, ŒîE9, and P436Q mutations in PSEN1 cause a drastic loss (at least 90% as estimated by ELISA) of Œ≥-secretase activity.thumbnail&#10;Figure 4. High-grade purification of human Œ≥-secretase complexes with FAD-linked PS1 mutants.(A) Schematic representation of the Œ≥-secretase purification process. Briefly, Presenilin double-knockout MEFs were used to first generate cell lines that stably overexpress human Œ≥-secretase complexes containing different PS1 variants. Next, these cell lines were used for a multi-step purification procedure as described in the material and methods. (B) Blue-Native PAGE analysis of purified Œ≥-secretase complexes made of different PS1 variants. Equal volumes of the different purified Œ≥-secretase preparations were separated by native-PAGE on a 4‚Äì16% Bis-Tris gel, and stained with silver nitrate (top panel), or immunostained for NCT (NCT164, middle panel) or PS1-NTF (ab10281, bottom panel) as indicated. Œ≥-Secretase complexes appeared on the gel as high molecular weight complexes (HMWCs) of ~350 kDa. Note that the levels of HMWCs were similar for all clones. (C) Equal volumes of purified Œ≥-secretase complexes with FAD-linked PS1 mutants were separated under denaturing conditions (SDS-PAGE) and immunostained with anti-NCT (NCT164), anti-PS1-NTF (MAB1563), anti-PS1-CTF (MAB5232), anti-HA (3F10), or anti-Flag (M2) antibodies. Two independent purifications were performed on each clone with similar results. A representative dataset is shown.doi:10.1371/journal.pone.0035133.g004 thumbnail&#10;Figure 5. Enzymatic activity of highly purified Œ≥-secretase complexes with FAD-linked or aspartate PS1 mutants.Equal amounts of the different purified Œ≥-secretase preparations characterized in Figure 4 were tested for activity on C100-Flag, as described in Figure 3. The resulting cleavage products were separated by SDS-PAGE and detected by immunostaining with an anti-Flag antibody (M2) for C100-Flag or AICD-Flag (A), and by sandwich ELISA for AŒ≤1‚Äì40 or AŒ≤1‚Äì42 (B). Note that the levels of AŒ≤ produced from FAD-linked Œ≥-secretase complexes were all in the non-linear range of the ELISA standards, close to the detection limit. Whenever possible, AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios were quantified and indicated on the top of the bars. Two independent purifications were performed on each clone and similar results were obtained. A representative dataset is shown.doi:10.1371/journal.pone.0035133.g005 Discussion Top Several conflicting results as to how Alzheimer's disease-linked mutations in PSEN1 affect the processing of APP by Œ≥-secretase have been reported. First, it has been previously reported that transgenic animals with FAD-linked PS1 mutations show increasing brain levels of AŒ≤1‚Äì42 [15], [38]. Since AŒ≤1‚Äì42, the first AŒ≤ specie deposited in the brain of AD patients [16], [39], is more prone to aggregation when compared to shorter AŒ≤ species [40], [41], [42], it has been implicated in the seeding of amyloid plaques in AD patients with PSEN1 mutations [43]. This was further validated in vivo as the overexpression of PS1 mutants in APP transgenic mice accelerated the rate of AŒ≤ accumulation and deposition in the brain [44], [45]. However, Bentahir and colleagues challenged this view by showing that several PSEN1 mutations were also capable to decrease total AŒ≤ production in PS1/PS2 knockout cells [23]. These findings suggested that endogenous PS1 and PS2 may influence the mutant phenotype in cells or in vivo. By extension, we hypothesized that the other components of Œ≥-secretase, namely APH1, NCT and PEN2, may influence the mutant phenotype as well. Indeed, Œ≥-secretase complexes are heterogeneous in composition due to the existence of two human APH1 genes, APH1a and APH1b, and two splicing isoforms of APH1a (S and L), as well as two presenilin genes, PSEN1 and PSEN2. Therefore, it is plausible that a single mutation in PSEN1 confers different catalytic properties to distinct Œ≥-secretase subtypes. This hypothesis is supported by recent investigations showing that APH1 variants can modulate AŒ≤ profiles. When compared to APH1aS or L, overexpression of APH1b in MEF knockout for all APH1 genes led to increased production of longer AŒ≤ species [24]. With this regard, it is important to note that all four mouse variants of APH1 are expressed in the MEF cell line used in previous studies [23] and employed here (cf. Figure S3). Since the phenotype of PS1 mutations have mainly been assessed in vivo or in cell-based systems, we investigated the effects of FAD-linked PS1 mutants on the processing of APP-CTFs in cell-free systems, by using semi-purified and purified enzymatic complexes isolated from MEF PS1/PS2 double knockout cells stably overexpressing differentially tagged human Œ≥-secretase components. Under these conditions, the biochemical and functional properties of Œ≥-secretase complexes bearing either FAD-linked PS1 mutants (L166P, ŒîE9, and P436Q), dominant-negative forms of PS1 or wild-type PS1 were characterized. The activity of Œ≥-secretase with PS1-WT was similar to that reported for Œ≥-secretase purified from our CHO cells overexpressing NCT-V5, APH1aL, Flag-PEN2 and PS1-WT [26], [27], that resulted in AŒ≤1‚Äì42/AŒ≤1‚Äì40 ratios between 0.1 and 0.3. In contrast, we found a major loss in the activity of Œ≥-secretase complexes containing either the dominant-negative PS1 variants or the FAD-linked PS1 mutants. Although a total loss of activity was expected for the dominant negative forms of Œ≥-secretase [5], [6], [32], the drastic loss of activity seen here with the FAD-linked PS1 mutants was unexpected. Indeed, the PS1-L166P variant has previously been reported to increase AŒ≤1‚Äì42 levels both in vivo [46] and in vitro [20], in the presence of endogenous PS1, PS2 and APH1 components. In contrast, Bentahir and colleagues found that PS1-L166P decreased both AŒ≤1‚Äì40 and AŒ≤1‚Äì42 production in a PS knockout background. These results are consistent with our in vitro data, although the reduction in AŒ≤1‚Äì42 and AŒ≤1‚Äì40 production was more pronounced in our system. However, they differ from our cell-based data in which we observed an increase in AŒ≤1‚Äì42 associated with a decrease in AŒ≤1‚Äì40. Taken together, these data suggest that the overexpression of the other human components of Œ≥-secretase can influence the phenotype of FAD-linked mutations. Another possible explanation for these discrepancies comes from the use, in previously described cellular systems, of APP carrying the Swedish mutation (K670M/N671L) [20], [23], [46]. Initially, this APP variant was shown to enhance the production of all AŒ≤ species by favouring its Œ≤-secretase cleavage [47], [48]. However, Munter and colleagues recently demonstrated that the APP Swedish mutation can also affect the specificity of the Œ≥-secretase cleavage [49]. In particular, these authors showed that over-expression of APP Swedish in a neuronal cell line led to a 4-fold increase in secreted AŒ≤42, associated with only a 2-fold increase of total AŒ≤, compared with the wild-type APP. Therefore, one cannot exclude the possibility of differential interactions between PS1-WT or PS1 variants and different APP variants, as suggested earlier [50].As far as the PS1-ŒîE9 mutant is concerned, previous cell-based studies have reported a decrease in AŒ≤40 levels associated with an increase in AŒ≤42 levels [51], [52], or no changes in AŒ≤40 levels despite increased AŒ≤42 levels [53], or a decrease in both AŒ≤ species [23]. In the present study, AŒ≤1‚Äì40, AŒ≤1‚Äì42, as well as AICD levels generated from purified Œ≥-secretase complexes with PS1-ŒîE9 were close to the limit of detection, resulting in a loss of at least 95% of the Œ≥-secretase activity compared to wild-type PS1. Similarly, we found a near to complete loss of Œ≥-secretase activity for complexes with the aggressive PS1-P436Q mutant (mean onset: 28.3 years) [54]. Consistent with a recent study [35], and in contrast to PS1-L166P, the maturation of the full-length PS1-P436Q protein into PS1-NTF and PS1-CTF was impaired. Interestingly, the same study also reported that P436Q variant showed a decreased Œ≥-secretase activity and AŒ≤40 and AŒ≤42 secretion in PS1/PS2 double knockout cells (~75% or ~50% of the control for AŒ≤40 or AŒ≤42, respectively), but to a lesser extent than what we measured in this study (more than 97% for both AŒ≤ species).Overall, our data show that, under our experimental conditions, the FAD-linked PS1 mutants cause a drastic loss of activity (at least 90%) in the highly purified and homogeneous as well as semi-purified Œ≥-secretase complexes. This loss-of-function is asymmetrical as AŒ≤1‚Äì42 levels were relatively less affected than AŒ≤1‚Äì40 levels. Interestingly, the ratio between the two AŒ≤ species was similar for the variants tested here (~1), suggesting a common modulatory mechanism. Our findings further support a model in which the subtype of Œ≥-secretase containing APH1aL and FAD-linked PS1 mutants generates a higher AŒ≤42/AŒ≤40 ratio compared to PS1-WT, as previously observed in vivo [15], [38]. Taken together, the overall reduction in AŒ≤ levels strongly suggest that other regulatory mechanisms or cellular components may exist and account for the strong amyloid pathology observed in AD patients carrying these FAD-linked PSEN1 mutations. In agreement with this hypothesis, we report that the phenotype of FAD-linked PSEN1 mutations is different whether we consider the cell-based or the cell-free conditions. Indeed, even if AŒ≤42/AŒ≤40 ratios were globally increased in both experimental conditions, AŒ≤ production was strikingly different.One possible explanation would be that specific subtypes of Œ≥-secretase complexes are less affected than others by PSEN1 mutations. For instance, it remains unknown whether Œ≥-secretase complexes carrying APH1b or APH1aS are similarly affected by PSEN1 mutations. In support to that regard, Winkler and colleagues recently purified human Œ≥-secretase with PS1-L166P and observed that such complexes, containing both APH1a and AHP1b, led to increased AŒ≤1‚Äì42 production associated with decreased AŒ≤1‚Äì40 production, as compared to the PS1-WT complexes. Another possible explanation would be that purified Œ≥-secretase complexes lack binding partners modulating the processing of APP-based substrates, due to purification conditions affecting physical interactions of proteins. These include TMP21 or the recently reported Œ≥-secretase activating protein (GSAP) [12], [13]. Further biochemical analyses are needed to test this hypothesis.The loss of activity in Œ≥-secretase containing PS1 variants also leads to decreased generation of AICD. As AICD is involved in the transcriptional regulation of several genes, including the neprilysin [55], and the lipoprotein receptor, LRP1 [11], it is likely that mutations in PSEN1 impair the regulation of these genes in vivo. For instance, it is possible that unknown genes transcriptionally regulated in vivo by the AICD might influence AŒ≤ metabolism in return. In support to these views, Veeraraghavalu and colleagues recently demonstrated that Notch signalling was impaired in transgenic mice overexpressing PS1 mutants, albeit in the presence of endogenous PS1-WT and all APH1 isoforms [56]. They found decreased self-renewal and differentiation of neuronal precursor cells in the subventricular zone, suggesting that the loss-of-function phenotype of PSEN1 mutations can also be observed in heterogeneous conditions. These results are reminiscent of the previous report from Saura and colleagues showing that conditional inactivation of both presenilins in vivo induces age-dependent neurodegeneration associated with memory impairment [57]. Altogether, the above-described data suggest that alternative pathways of neurodegeneration related to loss of Œ≥-secretase functions are possible and relevant to AD. They further support the concept that modulating rather than inhibiting Œ≥-secretase activity would be a more appropriate therapeutic strategy for AD [58]. Supporting this view, the Œ≥-secretase inhibitor Semagacestat tested in phase III clinical trials not only failed to slow cognitive decline in patients with mild-to-moderate AD, but actually made it worse [59].Collectively, our findings support a model in which FAD-linked mutations in PSEN1 likely induce AŒ≤ pathology by perturbing the relative ratio between AŒ≤ species and by impairing developmental and cellular signalling pathways controlled by Œ≥-secretase substrates. This deleterious dual effect might explain why FAD-linked PSEN1 mutations cause early onset Alzheimer's disease. Since it has been established that AŒ≤ and AICD are generated following the processing by Œ≥-secretase at two distinct gamma- and epsilon-cleavage sites in APP [60], further investigation is now required to better understand whether and how FAD mutations in PS1 differentially affect the epsilon versus gamma-cleavage sites in APP, as well as in other known Œ≥-secretase substrates.Materials and Methods Top DNA Constructs and mutagenesisNCT-V5, Flag-PEN2, APH1aL-HA, wild-type PS1 human cDNAs (PS1-WT) were obtained from D. Selkoe (Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA). PS1 ŒîE9 cDNA was obtained from C. Saura (Universitat Aut√≤noma de Barcelona, Spain). PS1 D257A and PS1 D385A cDNAs were obtained from M. Wolfe (Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA). Mutations in PSEN1, namely, L166P and P436Q, were generated by PCR-based mutagenesis on the plasmid pcDNA3.1/Zeo(+)-PS1-WT using T7 or BGH primers (specific to the plasmid DNA sequence) together with the corresponding primers: L166P Rv: 5‚Ä≤ CAG CAA CAA Taa gct tGA TAT AAT AGG 3‚Ä≤; L166P Fw: 5‚Ä≤ CTT ATT ATA TCa agc ttA TTG TTG CTG 3‚Ä≤; P436Q Rv: 5‚Ä≤ TCG AGT TTA Gaa gct tTC TTG AAA ATG GCA AGG AG 3‚Ä≤; P436Q Fw: 5‚Ä≤ TCG AGT TTA Gaa gct tTG CCA GCT CTT CAA ATC TCC 3‚Ä≤. The sequences corresponding to enzyme restriction sites are given in small letters. The PCR fragments were next digested with BamHI/HindIII and HindIII/XhoI respectively, and were subcloned into pcDNA3. PS1 D257A/D385A (DDAA) was obtained by subcloning the DraI/XhoI digested fragment of PS1 D385A into pcDNA3.1-PS1 D257A. The APP based substrate SPA4CT-Flag, corresponding to the signal peptide of APP fused to the APP-C99-Flag with a small linker region (DA) [36], was obtained by removing the HindIII/EcoRI fragment of pcDNA3-APP695-Flag and inserting the following annealed primers: 5‚Ä≤ AGC TTA TGC TGC CCG GTT TG GCA CTG CTC CTG CTG GCC GCC TGG ACG GCT CGG GCG GAT GCA GAT GCA G 3‚Ä≤ and 5‚Ä≤ AAT TCT GCA TCT GCA TCC GCC CGA GCC GTC CAG GCG GCC AGC AGG AGC AGT GCC AAA CCG GGC AGC ATA 3‚Ä≤. All constructs were next subcloned into the self-inactivated vector pSIN-PGK-WHV cassette (a kind gift from R. Zufferey, Brain Mind Institute, EPFL, Lausanne, Switzerland). Inserts for plasmids pET21-C100-Flag, and pET21-C100-His were generated by PCR as previously described [27]. Plasmids pMD2G and psPAX2 were obtained from D. Trono (Global Health Institute, EPFL, Lausanne, Switzerland).Lentivector production&#10;Replication-defective lentiviral particles were produced by a three-plasmid transient transfection of cells from the human embryonic kidney HEK 293T cell line [61]. Briefly, cells were incubated in 10 cm dishes until they reached 70% confluence and were transiently co-transfected by the calcium phosphate method, with 5 ¬µg of envelope plasmid (pMD2G), 15 ¬µg of packaging plasmid (psPAX2), and 20 ¬µg of vector plasmids (pSIN-PGK-WHV). Cells were incubated overnight with DNA-calcium precipitates, washed twice with Dulbecco's modified Eagle's medium (DMEM, Invitrogen) and incubated with 7 mL of DMEM. After 24 h, the conditioned medium was harvested and cells were incubated a second time with 7 mL of DMEM for 24 h. Media were then pooled, passed through 0.45 ¬µm filter, and stored at ‚àí80¬∞C as 2 mL aliquots until use. A p24 ELISA (Zeptometrix corporation) was performed on each batch of media in order to evaluate the number of viral particles generated.Generation of stable cell lines through multiple gene transductions&#10;Mouse Embryonic Fibroblasts (MEFs, obtained from B. De Strooper, Flanders University Institute of Biotechnology, Belgium) defective in PSEN1 and PSEN2 [30], [31] were cultivated in 10 cm dishes in DMEM, supplemented with 10% foetal bovine serum (FBS) and penicillin/streptomycin (P/S) (Invitrogen). A first set of stable cell lines was generated by co-transducing NCT-V5, APH1aL-HA, and Flag-PEN2 containing lentiviral vectors (LV) repeatedly for two weeks at each passage (1/20). Ten clones were isolated by the limiting dilution method and were further screened for NCT-V5, Flag-PEN2 and APH1aL-HA expression by immunodetection. The clone that showed the highest expression of the three proteins (designated Œ≥ - PS1/2) was used as the parental cell line to generate the stable cell lines expressing different PS1 variants, by the same method and by using lentiviral vectors carrying human PS1-WT, PS1-L166P, PS1-ŒîE9, PS1-P436Q, PS1-D257A, PS1-D385A, and PS1-DDAA. For each PS1 variant, five clones were selected for a full characterization and two of them were further used for Œ≥-secretase purification. For SPA4CT overexpression experiments, 500,000 cells of each clone were exposed to the same arbitrary dose of lentiviral vectors carrying human SPA4CT-Flag in 2 mL of DMEM, 1% FBS, P/S and were plated in 6-wells plates for 72 h. The medium was next replaced by fresh DMEM, 2% FBS, P/S for 24 h. Finally, cell culture medium was harvested, supplemented with protease inhibitor cocktail (Roche), centrifuged for 3 min at 1,000√ó rpm and frozen at ‚àí80¬∞C until further processing. Cells were washed in PBS and submitted to protein extraction.Protein extraction&#10;Total protein extracts were prepared in 1% NP40 - HEPES buffer (50 mM HEPES, pH 7.0, 150 mM NaCl, 5 mM MgCl2, 5 mM CaCl2), supplemented with protease inhibitor cocktail (Roche), and were clarified by centrifugation for 1 h at 16,000√ó g, 4¬∞C. Cell membranes were obtained as described below and solubilised in 1% CHAPSO - HEPES buffer and centrifuged at 16,000√ó g for 1 h. Supernatants corresponding to the microsomal protein extracts were harvested and stored at ‚àí80¬∞C. Protein content of the extracts was estimated by the BCA protein assay reagent kit (Pierce).Multi-step purification of human Œ≥-secretase complexes with FAD-linked PS1 variants1) Cell membrane preparation. MEF PS1/PS2 DKO cells (1.0√ó109 cells) expressing NCT-V5, Flag-PEN2, APH1aL-HA and different forms of PS1: wild type (WT), or with FAD-linked variants or lacking the critical aspartate residues, were collected from 15 cm dishes and fully resuspended in 40 mL of MES buffer (50 mM MES, pH 6.0, 150 mM NaCl, 5 mM MgCl2, 5 mM CaCl2), supplemented with protease inhibitor cocktail (Roche). Next, cells were passed four times through a high-pressure homogenizer (Emulsiflex-C5, Avestin Inc, ON Canada) at a pressure greater than 1,000 psi. Nuclei and unbroken cells were removed by centrifugation at 3,000√ó g for 20 min at 4¬∞C in a Beckman Coulter Allegra X-15R centrifuge. The supernatant was collected and centrifuged at 100,000√ó g for 1 h at 4¬∞C in a SW32&#10;Ti rotor using a Beckman Coulter Optima L-80 ultracentrifuge to recover the membrane preparation in the pellet. 2) Bicarbonate wash. The membrane pellet was fully resuspended in 1.6 mL of ice cold sodium bicarbonate buffer (0.1 M NaHCO3, pH 11.3) by pipetting up and down at least 30 times, and incubated at 4¬∞C for 20 min. The washed membranes were then centrifuged at 100,000√óg for 1 h at 4¬∞C and stored at ‚àí80¬∞C until use. 3) Solubilisation of Œ≥-secretase complexes. The bicarbonate-washed membranes were fully resuspended in 1.7 mL of 1% CHAPSO - HEPES buffer by pipetting up and down at least 30 times. The membranes were then incubated at 4¬∞C for 1 h. To pellet the insoluble material, the solution was centrifuged at 16,000√ó g at 4¬∞C for 1 h, the pellet was discarded, and the supernatant saved. This lysate is defined as ‚Äúsolubilised Œ≥-secretase preparation‚Äù. Next, these freshly prepared solubilised preparations were used for affinity purification of Œ≥-secretase complexes as described below. 4) Anti-Flag M2 affinity purification. The solubilised Œ≥-secretase preparations were first diluted 1:2 with HEPES buffer, and further diluted 1:6 with 0.1% digitonin - TBS buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl) (final detergent concentration: 0.08% CHAPSO, 0.08% digitonin) and incubated overnight at 4¬∞C with agitation after adding 200 ¬µL of anti-Flag M2 affinity resin beads (Sigma-Aldrich) that had been pre-equilibrated in 0.1% Digitonin - TBS buffer. The beads were washed 3 times in the same buffer, and the bound proteins were eluted over 4 h at 4¬∞C with 0.4 mL of this buffer containing 200 ¬µg/mL of Flag peptides (Sigma-Aldrich). This elution step was repeated once for 1 h at 4¬∞C and the eluted fractions were pooled and designated ‚ÄúM2 pooled 800 ¬µL fractions‚Äù. 5) Anti-V5 affinity purification. The M2 pooled fractions (volume made up to 1 mL with 0.1% Digitonin - TBS buffer) were next incubated overnight at 4¬∞C under agitation with 200 ¬µL of anti-V5 affinity resin beads (Sigma-Aldrich), pre-equilibrated in 0.1% digitonin-TBS buffer. The beads were washed 3 times in the same buffer, and the bound proteins were eluted for 1 h at 4¬∞C with 0.4 mL of this buffer containing 500 ¬µg/mL of V5 peptides (Sigma-Aldrich). This elution step was repeated 4 times, and the eluted fractions were pooled and designated ‚ÄúV5 pooled 1.6 mL fractions‚Äù. 6) Anti-HA affinity purification. As a final purification step, the V5 pooled fractions (volume made up to 1.8 mL with 0.1% digitonin - TBS buffer) were next incubated overnight at 4¬∞C under agitation with 200 ¬µL of anti-HA affinity resin beads (Sigma-Aldrich), pre-equilibrated in 0.1% digitonin - TBS buffer. The beads were washed 3 times in the same buffer, and the bound proteins were eluted overnight at 4¬∞C with 0.2 mL of this buffer containing 200 ¬µg/mL of HA peptides (Sigma-Aldrich). This elution step was repeated once, for 1 h at 4¬∞C, and the two eluted fractions were kept separately, designated ‚ÄúHA fraction E1‚Äù and ‚ÄúHA fraction E2‚Äù.Co-immunoprecipitation&#10;Co-IPs were performed on microsomal protein extracts. Briefly, 100 ¬µg of proteins were diluted in a final volume of 1 mL of 1% CHAPSO - HEPES extraction buffer containing protease inhibitors (Roche), and 50 ¬µL of pre-equilibrated anti-Flag or anti-HA affinity beads (Sigma-Aldrich) were added. Samples were next incubated overnight at 4¬∞C on a rotator wheel and were washed three times in 0.2% CHAPSO - HEPES buffer. Finally, beads were resuspended in 50 ¬µL of 0.2% CHAPSO - HEPES buffer and were used for in vitro Œ≥-secretase assays.In vitro Œ≥-secretase activity assays&#10;In vitro Œ≥-secretase activity assays were performed as previously described [27]. Œ≥-Secretase APP-based substrates were expressed in E. coli transfected with plasmids pET21-C100-Flag or pET21-C100-His as a fusion protein consisting of a Met for translation initiation, and either the Flag tag sequence (C100-Flag) or the His tag sequence (C100-His), and were affinity purified using an anti-Flag resin (M2, Sigma-Aldrich) or an Ni-NTA agarose resin (Invitrogen), respectively. In vitro assays were performed at 37¬∞C for 4 h, with 1 ¬µM of recombinant substrate, 0.025% phosphatidylethanolamine (PE) and 0.1% phosphatidylcholine (PC). Œ≥-Secretase activity was quantified by measuring the amount of AICD and AŒ≤ generated during the reaction, by immunoblot or sandwich ELISA respectively, as described below.SDS-PAGE, Native PAGE, Western blotting and antibodies&#10;Total or microsomal protein extracts were resolved by electrophoresis on NuPAGE¬Æ Novex¬Æ 4‚Äì12% Bis-Tris Gels (Invitrogen) or on standard 12% acrylamide/bisacrylamide Tris Glycine gels for SDS-PAGE analysis. Purified Œ≥-secretase was resolved by electrophoresis on NativePAGE‚Ñ¢ Novex¬Æ Bis-Tris 4‚Äì16% Gels for Blue Native (BN)-PAGE analysis (Invitrogen). Silver staining was performed directly on gel according to manufacturer instructions (Biorad). For immunoblot analysis, gels were transferred to nitrocellulose or PVDF membranes (Whatman), and probed with the following antibodies: anti-Nicastrin NCT164 (BD Bioscience), anti-V5-tag for NCT-V5 (Covance), MAB1563 (Millipore) or ab10281 (Abcam) for PS1 NTF, MAB5232 for PS1 CTF (Millipore), 3F10 for APH1aL-HA (Roche), anti-Flag M2 for Flag-PEN-2 or C100-Flag (Sigma-Aldrich), A8717 for APP CTF (Sigma-Aldrich), and A2066 for Œ≤-actin (Sigma-Aldrich). Anti-mouse/rabbit/rat IgG conjugated to Alexa 680 were purchased from Invitrogen. The Odyssey infrared imaging system (LICOR) was used to detect the fluorescent signal.Quantification of AŒ≤ peptidesAŒ≤ peptides from the Œ≥-secretase assays described above were quantified by sandwich ELISA according to the protocol provided by the manufacturer. Three kits were used to detect human AŒ≤1‚Äì40 (Invitrogen KHB3481) and AŒ≤1‚Äì42 (Invitrogen KHB3544 and Wako 269-64401).Supporting Information Top Figure S1. Characterization of stable cell lines overexpressing human FAD-linked PS1 variants in MEF PS1/2‚àí/‚àí. Presenilin double-knockout mouse embryonic fibroblasts were stably transduced with lentiviral vectors carrying genes encoding hPS1 variants harbouring FAD-linked mutations or mutations in the catalytic aspartate residue(s), or PS1-WT, and cloned. Two clones per PS1 variant were selected for characterization. (A) Whole cell protein extracts of the different cell lines were prepared in 1% NP40-HEPES buffer, separated by SDS-PAGE on 12% Tris-Glycine gels and analysed by immunostaining with various antibodies to detect the endogenous Œ≥-secretase core components: NCT (NCT164), hPS1 (NTF, MAB1563), and PEN2 (UD1), and with an antibody for APP (A8717). Œ≤-Actin was used as a loading control. Each lane represents one selected clone. (B) Œ≥-Secretase activity assays were performed with microsomal extracts prepared in 1% CHAPSO-HEPES buffer. Equal protein levels from the different extracts were diluted to 0.25% CHAPSO-HEPES buffer and incubated for 4 h at 37¬∞C with lipids and 1 ¬µM of recombinant human APP-based substrate (C100-Flag). Samples were analyzed by SDS-PAGE and immunostained with anti-Flag (M2) or anti-PS1 (MAB1563). PS1 immunostaining was used to assess the amount of input material. * Indicates a non-specific band, which was not detected in microsomal protein extracts of the same cell lines using the same antibody (MAB1563) (B). CTF: C-terminal fragment, FL: full-length, im.: immature NCT; m.: mature NCT, N: N-glycosylated, NTF: N-terminal fragment, O: O-glycosylated.(TIF)Figure S2. APP-CTF profiles in WT MEF, MEF PS1/2‚àí/‚àí and Œ≥ - PS1/2 transduced with the SPA4CT construct. WT MEF, MEF PS1/2‚àí/‚àí and Œ≥ - PS1/2 were transduced with an APP-based substrate corresponding to the 99 C-terminal residues of human APP fused to the APP signal peptide in N-terminus (SPA4CT [36]). Cell proteins were extracted in 1% NP40-HEPES buffer, separated by SDS-PAGE on 12% Tris-Glycine gels and analysed by immunostaining with an antibody targeting the C-terminal part of APP (A8717).(TIF)Figure S3. APH1 isoforms expressed in MEF PS1/2‚àí/‚àí. Total RNAs were extracted from presenilin double-knockout MEFs, using standard procedures (Qiagen RNAeasy kit) and were quantified by spectrophotometry. One microgram of total RNAs was reverse transcribed for 1 h at 42¬∞C by using the ImProm-II reverse transcription system (Promega) and oligo-dT primer in a final volume of 20 ¬µL. PCR was next performed for each APH1 isoform on 1 ¬µL of RT reaction by using the Roche PCR kit under standard conditions and the primers described in Table S1. The following cycling conditions were applied for all reactions: 94¬∞C, 3 min; 30 cycles of [94¬∞C, 30 s; 58¬∞C, 30 s; 70¬∞C, 40 s]; 70¬∞C, 10 min. PCR products were separated on a 2% agarose gel and visualized using Alpha Innotech UV imager.(TIF)Table S1. Primers used to detect APH1 isoforms in MEF PS1/2‚àí/‚àí. F: Forward, R: Reverse.(DOC)Acknowledgments Top We are grateful to B. De Strooper for the WT and PS1‚àí/‚àí PS2‚àí/‚àí KO mouse embryonic fibroblasts, to C. Saura for the PS1 ŒîE9, to M. Wolfe for the PS1 D257A and PS1 D385A cDNAs, and to D. Selkoe for the APH1aL-HA, NCT-V5, and Flag-PEN2 cDNAs. We also thank J.R. Alattia, C. Schweizer, and A. Alahari for critical readings of the manuscript.Author Contributions Top Conceived and designed the experiments: MC PCF. Performed the experiments: MC LA JH. Analyzed the data: MC LA JH PCF. Wrote the paper: MC PCF. Edited the manuscript: MC LA JH PCF. Supervised the project: PCF.References Top Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775‚Äì778. Find this article online Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754‚Äì760. Find this article online Weihofen A, Martoglio B (2003) Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides. Trends Cell Biol 13: 71‚Äì78. Find this article online Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, et al. (2000) Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat Cell Biol 2: 428‚Äì434. Find this article online Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, et al. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398: 513‚Äì517. Find this article online Kimberly WT, Xia W, Rahmati T, Wolfe MS, Selkoe DJ (2000) The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. J Biol Chem 275: 3173‚Äì3178. Find this article online Beel AJ, Sanders CR (2008) Substrate specificity of gamma-secretase and other intramembrane proteases. Cell Mol Life Sci 65: 1311‚Äì1334. Find this article online Bot N, Schweizer C, Ben Halima S, Fraering PC (2010) Processing of the synaptic cell-adhesion molecule neurexin-3{beta} by Alzheimer's disease {alpha}- and {gamma}-secretases. J Biol Chem. Find this article online Parks AL, Curtis D (2007) Presenilin diversifies its portfolio. Trends Genet 23: 140‚Äì150. Find this article online Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, et al. (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci 25: 436‚Äì445. Find this article online Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, et al. (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56: 66‚Äì78. Find this article online Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, et al. (2006) TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440: 1208‚Äì1212. Find this article online He G, Luo W, Li P, Remmers C, Netzer WJ, et al. (2010) Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 467: 95‚Äì98. Find this article online Wakabayashi T, De Strooper B (2008) Presenilins: members of the gamma-secretase quartets, but part-time soloists too. Physiology (Bethesda) 23: 194‚Äì204. Find this article online Citron M, Westaway D, Xia W, Carlson G, Diehl T, et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. NatMed 3: 67‚Äì72. Find this article online Delacourte A, Sergeant N, Champain D, Wattez A, Maurage CA, et al. (2002) Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology 59: 398‚Äì407. Find this article online Mehta ND, Refolo LM, Eckman C, Sanders S, Yager D, et al. (1998) Increased Abeta42(43) from cell lines expressing presenilin 1 mutations. Ann Neurol 43: 256‚Äì258. Find this article online Murayama O, Tomita T, Nihonmatsu N, Murayama M, Sun X, et al. (1999) Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci Lett 265: 61‚Äì63. Find this article online Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, et al. (2000) Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci 20: 8717‚Äì8726. Find this article online Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A 99: 8025‚Äì8030. Find this article online Qi Y, Morishima-Kawashima M, Sato T, Mitsumori R, Ihara Y (2003) Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells. Biochemistry 42: 1042‚Äì1052. Find this article online Dowjat WK, Kuchna I, Wisniewski T, Wegiel J (2004) A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117&#10;Leu and Pro117&#10;Ser mutations. J Alzheimers Dis 6: 31‚Äì43. Find this article online Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, et al. (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96: 732‚Äì742. Find this article online Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horre K, et al. (2009) gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 324: 639‚Äì642. Find this article online Farmery MR, Tjernberg LO, Pursglove SE, Bergman A, Winblad B, et al. (2003) Partial purification and characterization of gamma-secretase from post-mortem human brain. J Biol Chem 278: 24277‚Äì24284. Find this article online Fraering PC, Ye W, Strub JM, Dolios G, LaVoie MJ, et al. (2004) Purification and characterization of the human gamma-secretase complex. Biochemistry 43: 9774‚Äì9789. Find this article online Cacquevel M, Aeschbach L, Osenkowski P, Li D, Ye W, et al. (2008) Rapid purification of active gamma-secretase, an intramembrane protease implicated in Alzheimer's disease. J Neurochem 104: 210‚Äì220. Find this article online Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ, et al. (2006) Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci U S A 103: 6889‚Äì6894. Find this article online Osenkowski P, Li H, Ye W, Li D, Aeschbach L, et al. (2009) Cryoelectron microscopy structure of purified gamma-secretase at 12 A resolution. J Mol Biol 385: 642‚Äì652. Find this article online Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A 96: 11872‚Äì11877. Find this article online Herreman A, Van Gassen G, Bentahir M, Nyabi O, Craessaerts K, et al. (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci 116: 1127‚Äì1136. Find this article online Nyabi O, Bentahir M, Horre K, Herreman A, Gottardi-Littell N, et al. (2003) Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 278: 43430‚Äì43436. Find this article online Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181‚Äì190. Find this article online Nelson O, Tu H, Lei T, Bentahir M, de Strooper B, et al. (2007) Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J Clin Invest 117: 1230‚Äì1239. Find this article online Heilig EA, Xia W, Shen J, Kelleher RJ (2010) A presenilin-1 mutation identified in familial Alzheimer's disease with cotton wool plaques causes nearly complete loss of {gamma}-secretase activity. J Biol Chem. Find this article online Lichtenthaler SF, Multhaup G, Masters CL, Beyreuther K (1999) A novel substrate for analyzing Alzheimer's disease gamma-secretase. FEBS letters 453: 288‚Äì292. Find this article online Fraering PC, LaVoie MJ, Ye W, Ostaszewski BL, Kimberly WT, et al. (2004) Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 43: 323‚Äì333. Find this article online Duff K, Eckman C, Zehr C, Yu X, Prada CM, et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710‚Äì713. Find this article online Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, et al. (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13: 45‚Äì53. Find this article online Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, et al. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267: 546‚Äì554. Find this article online Jan A, Gokce O, Luthi-Carter R, Lashuel HA (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283: 28176‚Äì28189. Find this article online Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693‚Äì4697. Find this article online Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864‚Äì870. Find this article online Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97‚Äì100. Find this article online Borchelt DR, Lee MK, Gonzales V, Slunt HH, Ratovitski T, et al. (2002)" id="QA4MRE-2012_BIOMEDICAL_GS.xml_4" filteredText="" sentenceList="" qaList="14975 14998 15021 15044 15067 15090 15113 15136 15159 15182"/><types:Sentence xmi:id="1136" sofa="11" begin="0" end="134" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1148" sofa="11" begin="0" end="11" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1160" sofa="11" begin="0" end="16" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1172" sofa="11" begin="0" end="124" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1184" sofa="11" begin="0" end="233" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1196" sofa="11" begin="0" end="23" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1208" sofa="11" begin="0" end="150" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1220" sofa="11" begin="151" end="443" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1232" sofa="11" begin="444" end="675" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1244" sofa="11" begin="676" end="868" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1256" sofa="11" begin="869" end="1079" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1268" sofa="11" begin="1079" end="1109" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1280" sofa="11" begin="0" end="204" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1292" sofa="11" begin="205" end="326" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1304" sofa="11" begin="327" end="554" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1316" sofa="11" begin="554" end="577" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1328" sofa="11" begin="0" end="234" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1340" sofa="11" begin="234" end="426" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1352" sofa="11" begin="427" end="449" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1364" sofa="11" begin="450" end="470" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1376" sofa="11" begin="470" end="482" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1388" sofa="11" begin="0" end="57" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1400" sofa="11" begin="0" end="80" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1412" sofa="11" begin="0" end="35" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1424" sofa="11" begin="36" end="271" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1436" sofa="11" begin="271" end="523" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1448" sofa="11" begin="524" end="730" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1460" sofa="11" begin="730" end="764" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1472" sofa="11" begin="0" end="271" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1484" sofa="11" begin="272" end="504" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1496" sofa="11" begin="505" end="691" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1508" sofa="11" begin="692" end="1010" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1520" sofa="11" begin="1010" end="1100" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1532" sofa="11" begin="1101" end="1291" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1544" sofa="11" begin="1292" end="1575" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1556" sofa="11" begin="1576" end="1793" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1568" sofa="11" begin="1794" end="2060" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1580" sofa="11" begin="2061" end="2195" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1592" sofa="11" begin="2195" end="2371" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1604" sofa="11" begin="2372" end="2655" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1616" sofa="11" begin="2656" end="2819" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1628" sofa="11" begin="2820" end="3004" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1640" sofa="11" begin="3005" end="3211" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1652" sofa="11" begin="3212" end="3299" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1664" sofa="11" begin="3300" end="3493" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1676" sofa="11" begin="3494" end="3696" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1688" sofa="11" begin="3697" end="3975" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1700" sofa="11" begin="3976" end="4172" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1712" sofa="11" begin="4173" end="4500" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1724" sofa="11" begin="4501" end="4570" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1736" sofa="11" begin="4571" end="4743" id="22" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1748" sofa="11" begin="4744" end="4874" id="23" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1760" sofa="11" begin="4874" end="5015" id="24" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1772" sofa="11" begin="0" end="269" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1784" sofa="11" begin="270" end="607" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1796" sofa="11" begin="608" end="704" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1808" sofa="11" begin="705" end="895" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1820" sofa="11" begin="896" end="1047" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1832" sofa="11" begin="1048" end="1615" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1844" sofa="11" begin="1615" end="1774" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1856" sofa="11" begin="1775" end="1911" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1868" sofa="11" begin="1912" end="2067" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1880" sofa="11" begin="2068" end="2223" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1892" sofa="11" begin="2224" end="2328" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1904" sofa="11" begin="2329" end="2551" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1916" sofa="11" begin="2552" end="2674" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1928" sofa="11" begin="2675" end="2770" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1940" sofa="11" begin="2771" end="2965" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1952" sofa="11" begin="2966" end="3112" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1964" sofa="11" begin="3113" end="3412" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1976" sofa="11" begin="3412" end="3421" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="1988" sofa="11" begin="0" end="9" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2000" sofa="11" begin="10" end="120" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2012" sofa="11" begin="120" end="392" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2024" sofa="11" begin="393" end="557" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2036" sofa="11" begin="558" end="815" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2048" sofa="11" begin="816" end="887" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2060" sofa="11" begin="888" end="1253" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2072" sofa="11" begin="1254" end="1293" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2084" sofa="11" begin="1294" end="1334" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2096" sofa="11" begin="1335" end="1476" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2108" sofa="11" begin="1476" end="1496" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2120" sofa="11" begin="1496" end="1509" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2132" sofa="11" begin="1509" end="1602" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2144" sofa="11" begin="1603" end="1968" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2156" sofa="11" begin="1969" end="2149" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2168" sofa="11" begin="2150" end="2223" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2180" sofa="11" begin="2224" end="2536" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2192" sofa="11" begin="2537" end="2859" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2204" sofa="11" begin="2860" end="3025" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2216" sofa="11" begin="3025" end="3134" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2228" sofa="11" begin="3135" end="3278" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2240" sofa="11" begin="3279" end="3515" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2252" sofa="11" begin="3516" end="3747" id="22" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2264" sofa="11" begin="3748" end="3977" id="23" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2276" sofa="11" begin="3978" end="4159" id="24" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2288" sofa="11" begin="4160" end="4435" id="25" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2300" sofa="11" begin="4436" end="4554" id="26" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2312" sofa="11" begin="4555" end="4701" id="27" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2324" sofa="11" begin="4702" end="5036" id="28" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2336" sofa="11" begin="5037" end="5304" id="29" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2348" sofa="11" begin="5304" end="5313" id="30" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2360" sofa="11" begin="0" end="9" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2372" sofa="11" begin="10" end="113" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2384" sofa="11" begin="113" end="333" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2396" sofa="11" begin="334" end="535" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2408" sofa="11" begin="536" end="633" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2420" sofa="11" begin="634" end="698" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2432" sofa="11" begin="698" end="718" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2444" sofa="11" begin="718" end="731" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2456" sofa="11" begin="731" end="819" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2468" sofa="11" begin="0" end="110" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2480" sofa="11" begin="111" end="338" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2492" sofa="11" begin="339" end="455" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2504" sofa="11" begin="456" end="627" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2516" sofa="11" begin="628" end="755" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2528" sofa="11" begin="756" end="921" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2540" sofa="11" begin="921" end="930" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2552" sofa="11" begin="0" end="9" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2576" sofa="11" begin="102" end="227" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2588" sofa="11" begin="228" end="425" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2600" sofa="11" begin="426" end="520" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2612" sofa="11" begin="521" end="648" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2624" sofa="11" begin="649" end="716" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2636" sofa="11" begin="717" end="928" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2648" sofa="11" begin="929" end="1079" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2660" sofa="11" begin="1080" end="1164" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2672" sofa="11" begin="1165" end="1234" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2684" sofa="11" begin="1235" end="1438" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2696" sofa="11" begin="1439" end="1503" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2708" sofa="11" begin="1504" end="1602" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2720" sofa="11" begin="1602" end="1622" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2732" sofa="11" begin="1622" end="1635" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2744" sofa="11" begin="1635" end="1705" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2756" sofa="11" begin="1706" end="1888" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2768" sofa="11" begin="1889" end="2149" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2780" sofa="11" begin="2150" end="2372" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2792" sofa="11" begin="2373" end="2602" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2804" sofa="11" begin="2603" end="2789" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2816" sofa="11" begin="2790" end="3007" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2828" sofa="11" begin="3008" end="3177" id="22" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2840" sofa="11" begin="3178" end="3306" id="23" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2852" sofa="11" begin="3307" end="3435" id="24" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2864" sofa="11" begin="3436" end="3596" id="25" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2876" sofa="11" begin="3596" end="3699" id="26" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2888" sofa="11" begin="0" end="242" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2900" sofa="11" begin="243" end="426" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2912" sofa="11" begin="427" end="603" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2924" sofa="11" begin="604" end="861" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2936" sofa="11" begin="862" end="1101" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2948" sofa="11" begin="1102" end="1415" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2960" sofa="11" begin="1416" end="1640" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2972" sofa="11" begin="1641" end="1986" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2984" sofa="11" begin="1987" end="2317" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="2996" sofa="11" begin="2318" end="2462" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3008" sofa="11" begin="2463" end="2605" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3020" sofa="11" begin="2606" end="2765" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3032" sofa="11" begin="2766" end="3047" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3044" sofa="11" begin="3048" end="3273" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3056" sofa="11" begin="3274" end="3473" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3068" sofa="11" begin="3473" end="3482" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3080" sofa="11" begin="0" end="9" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3104" sofa="11" begin="94" end="164" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3116" sofa="11" begin="165" end="332" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3128" sofa="11" begin="333" end="447" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3140" sofa="11" begin="448" end="544" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3152" sofa="11" begin="545" end="809" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3164" sofa="11" begin="810" end="908" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3176" sofa="11" begin="909" end="967" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3188" sofa="11" begin="968" end="1238" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3200" sofa="11" begin="1239" end="1319" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3212" sofa="11" begin="1320" end="1354" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3224" sofa="11" begin="1354" end="1374" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3236" sofa="11" begin="1374" end="1387" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3248" sofa="11" begin="1387" end="1401" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3260" sofa="11" begin="0" end="9" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3272" sofa="11" begin="10" end="112" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3284" sofa="11" begin="112" end="268" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3296" sofa="11" begin="269" end="476" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3308" sofa="11" begin="477" end="639" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3320" sofa="11" begin="640" end="739" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3332" sofa="11" begin="740" end="833" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3344" sofa="11" begin="834" end="868" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3356" sofa="11" begin="868" end="888" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3368" sofa="11" begin="888" end="901" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3380" sofa="11" begin="901" end="1069" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3392" sofa="11" begin="1070" end="1216" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3404" sofa="11" begin="1217" end="1487" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3416" sofa="11" begin="1488" end="1663" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3428" sofa="11" begin="1664" end="1840" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3440" sofa="11" begin="1841" end="1949" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3452" sofa="11" begin="1950" end="2093" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3464" sofa="11" begin="2094" end="2316" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3476" sofa="11" begin="2317" end="2449" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3488" sofa="11" begin="2450" end="2557" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3500" sofa="11" begin="2558" end="2702" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3512" sofa="11" begin="2703" end="2881" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3524" sofa="11" begin="2882" end="3263" id="22" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3536" sofa="11" begin="3264" end="3487" id="23" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3548" sofa="11" begin="3488" end="3731" id="24" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3560" sofa="11" begin="3732" end="3892" id="25" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3572" sofa="11" begin="3893" end="4090" id="26" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3584" sofa="11" begin="4091" end="4275" id="27" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3596" sofa="11" begin="4276" end="4412" id="28" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3608" sofa="11" begin="4413" end="4561" id="29" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3620" sofa="11" begin="4562" end="4694" id="30" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3632" sofa="11" begin="4695" end="4852" id="31" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3644" sofa="11" begin="4853" end="5036" id="32" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3656" sofa="11" begin="5037" end="5170" id="33" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3668" sofa="11" begin="5171" end="5320" id="34" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3680" sofa="11" begin="5321" end="5546" id="35" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3692" sofa="11" begin="5547" end="5707" id="36" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3704" sofa="11" begin="5707" end="5982" id="37" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3716" sofa="11" begin="5983" end="6240" id="38" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3728" sofa="11" begin="6241" end="6391" id="39" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3740" sofa="11" begin="6392" end="6549" id="40" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3752" sofa="11" begin="6550" end="6877" id="41" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3764" sofa="11" begin="6877" end="7103" id="42" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3776" sofa="11" begin="7104" end="7214" id="43" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3788" sofa="11" begin="7215" end="7356" id="44" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3800" sofa="11" begin="7357" end="7575" id="45" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3812" sofa="11" begin="7576" end="7822" id="46" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3824" sofa="11" begin="7823" end="7993" id="47" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3836" sofa="11" begin="7994" end="8126" id="48" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3848" sofa="11" begin="8126" end="8258" id="49" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3860" sofa="11" begin="8259" end="8390" id="50" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3872" sofa="11" begin="8391" end="8682" id="51" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3884" sofa="11" begin="8683" end="8906" id="52" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3896" sofa="11" begin="8907" end="9002" id="53" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3908" sofa="11" begin="9003" end="9067" id="54" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3920" sofa="11" begin="9067" end="9171" id="55" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3932" sofa="11" begin="9172" end="9398" id="56" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3944" sofa="11" begin="9399" end="9536" id="57" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3956" sofa="11" begin="9537" end="9769" id="58" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3968" sofa="11" begin="9770" end="9995" id="59" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3980" sofa="11" begin="9996" end="10220" id="60" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="3992" sofa="11" begin="10221" end="10387" id="61" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4004" sofa="11" begin="10388" end="10543" id="62" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4016" sofa="11" begin="10544" end="10754" id="63" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4028" sofa="11" begin="10754" end="11019" id="64" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4040" sofa="11" begin="11020" end="11132" id="65" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4052" sofa="11" begin="11133" end="11515" id="66" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4064" sofa="11" begin="11515" end="11740" id="67" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4076" sofa="11" begin="11741" end="11826" id="68" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4088" sofa="11" begin="11827" end="11960" id="69" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4100" sofa="11" begin="11961" end="12438" id="70" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4112" sofa="11" begin="12439" end="12522" id="71" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4124" sofa="11" begin="12523" end="12641" id="72" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4136" sofa="11" begin="12642" end="12761" id="73" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4148" sofa="11" begin="12762" end="13235" id="74" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4160" sofa="11" begin="13236" end="13408" id="75" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4172" sofa="11" begin="13409" end="13517" id="76" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4184" sofa="11" begin="13518" end="13627" id="77" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4196" sofa="11" begin="13627" end="13649" id="78" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4208" sofa="11" begin="0" end="164" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4220" sofa="11" begin="165" end="437" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4232" sofa="11" begin="438" end="604" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4244" sofa="11" begin="605" end="827" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4256" sofa="11" begin="828" end="964" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4268" sofa="11" begin="964" end="1031" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4280" sofa="11" begin="0" end="298" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4292" sofa="11" begin="299" end="480" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4304" sofa="11" begin="481" end="630" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4316" sofa="11" begin="631" end="967" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4328" sofa="11" begin="968" end="1108" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4340" sofa="11" begin="1109" end="1588" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4352" sofa="11" begin="1589" end="1650" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4364" sofa="11" begin="1650" end="1668" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4376" sofa="11" begin="0" end="568" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4388" sofa="11" begin="568" end="681" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4400" sofa="11" begin="682" end="1067" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4412" sofa="11" begin="1068" end="1216" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4424" sofa="11" begin="1217" end="1352" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4436" sofa="11" begin="1353" end="1439" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4448" sofa="11" begin="0" end="111" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4460" sofa="11" begin="112" end="132" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4472" sofa="11" begin="133" end="324" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4484" sofa="11" begin="325" end="431" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4496" sofa="11" begin="432" end="476" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4508" sofa="11" begin="477" end="614" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4520" sofa="11" begin="615" end="812" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4532" sofa="11" begin="813" end="882" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4544" sofa="11" begin="883" end="1018" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4556" sofa="11" begin="1019" end="1057" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4568" sofa="11" begin="1058" end="1483" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4580" sofa="11" begin="1484" end="1668" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4592" sofa="11" begin="1669" end="1807" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4604" sofa="11" begin="1808" end="1841" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4616" sofa="11" begin="1842" end="2086" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4628" sofa="11" begin="2087" end="2268" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4640" sofa="11" begin="2269" end="2394" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4652" sofa="11" begin="2395" end="2428" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4664" sofa="11" begin="2429" end="2707" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4676" sofa="11" begin="2708" end="2891" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4688" sofa="11" begin="2892" end="3054" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4700" sofa="11" begin="3054" end="3076" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4712" sofa="11" begin="0" end="53" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4724" sofa="11" begin="54" end="295" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4736" sofa="11" begin="296" end="419" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4748" sofa="11" begin="420" end="539" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4760" sofa="11" begin="539" end="576" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4772" sofa="11" begin="0" end="82" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4784" sofa="11" begin="83" end="478" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4796" sofa="11" begin="479" end="636" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4808" sofa="11" begin="637" end="864" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4820" sofa="11" begin="0" end="209" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4832" sofa="11" begin="210" end="359" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4844" sofa="11" begin="360" end="454" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4856" sofa="11" begin="455" end="909" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4868" sofa="11" begin="910" end="991" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4880" sofa="11" begin="992" end="1078" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4892" sofa="11" begin="1078" end="1255" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4904" sofa="11" begin="1256" end="1378" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4916" sofa="11" begin="1378" end="1415" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4928" sofa="11" begin="1416" end="1519" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4940" sofa="11" begin="1520" end="1766" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4952" sofa="11" begin="1767" end="1829" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4964" sofa="11" begin="1830" end="2174" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4976" sofa="11" begin="2175" end="2214" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="4988" sofa="11" begin="2215" end="2255" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5000" sofa="11" begin="2256" end="2364" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5012" sofa="11" begin="2365" end="2562" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5024" sofa="11" begin="2563" end="2657" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5036" sofa="11" begin="2658" end="2725" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5048" sofa="11" begin="2726" end="2874" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5072" sofa="11" begin="3016" end="3031" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5084" sofa="11" begin="3032" end="3129" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5096" sofa="11" begin="3130" end="3331" id="22" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5120" sofa="11" begin="3526" end="3541" id="23" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5132" sofa="11" begin="3542" end="3586" id="24" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5144" sofa="11" begin="3587" end="3739" id="25" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5156" sofa="11" begin="3740" end="3919" id="26" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5168" sofa="11" begin="3920" end="4080" id="27" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5180" sofa="11" begin="4081" end="4228" id="28" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5204" sofa="11" begin="4323" end="4337" id="29" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5216" sofa="11" begin="4338" end="4395" id="30" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5240" sofa="11" begin="4419" end="4692" id="31" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5252" sofa="11" begin="4693" end="4790" id="32" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5264" sofa="11" begin="4790" end="4862" id="33" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5276" sofa="11" begin="4863" end="4899" id="34" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5288" sofa="11" begin="4900" end="4932" id="35" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5300" sofa="11" begin="4933" end="4957" id="36" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5312" sofa="11" begin="4958" end="4994" id="37" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5324" sofa="11" begin="4995" end="5023" id="38" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5336" sofa="11" begin="5023" end="5249" id="39" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5348" sofa="11" begin="5250" end="5272" id="40" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5360" sofa="11" begin="5273" end="5460" id="41" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5372" sofa="11" begin="5461" end="5483" id="42" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5384" sofa="11" begin="5484" end="5631" id="43" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5396" sofa="11" begin="5632" end="5661" id="44" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5408" sofa="11" begin="5662" end="5846" id="45" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5420" sofa="11" begin="5847" end="5874" id="46" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5432" sofa="11" begin="5875" end="6084" id="47" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5444" sofa="11" begin="6085" end="6107" id="48" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5456" sofa="11" begin="6108" end="6322" id="49" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5468" sofa="11" begin="6323" end="6352" id="50" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5480" sofa="11" begin="6353" end="6480" id="51" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5492" sofa="11" begin="6481" end="6515" id="52" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5504" sofa="11" begin="6516" end="6716" id="53" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5516" sofa="11" begin="6717" end="6729" id="54" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5528" sofa="11" begin="6730" end="6818" id="55" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5540" sofa="11" begin="6819" end="6846" id="56" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5552" sofa="11" begin="6847" end="7072" id="57" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5564" sofa="11" begin="7073" end="7098" id="58" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5576" sofa="11" begin="7099" end="7305" id="59" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5588" sofa="11" begin="7306" end="7325" id="60" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5600" sofa="11" begin="7326" end="7526" id="61" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5612" sofa="11" begin="7527" end="7551" id="62" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5624" sofa="11" begin="7552" end="7715" id="63" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5636" sofa="11" begin="7716" end="7736" id="64" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5648" sofa="11" begin="7737" end="7879" id="65" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5660" sofa="11" begin="7880" end="7916" id="66" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5672" sofa="11" begin="7917" end="8148" id="67" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5684" sofa="11" begin="8149" end="8167" id="68" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5696" sofa="11" begin="8168" end="8353" id="69" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5708" sofa="11" begin="8354" end="8378" id="70" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5720" sofa="11" begin="8379" end="8541" id="71" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5732" sofa="11" begin="8542" end="8567" id="72" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5744" sofa="11" begin="8568" end="8774" id="73" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5756" sofa="11" begin="8775" end="8802" id="74" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5768" sofa="11" begin="8803" end="9018" id="75" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5780" sofa="11" begin="9019" end="9046" id="76" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5792" sofa="11" begin="9047" end="9301" id="77" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5804" sofa="11" begin="9302" end="9343" id="78" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5816" sofa="11" begin="9344" end="9583" id="79" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5828" sofa="11" begin="9584" end="9613" id="80" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5840" sofa="11" begin="9614" end="9853" id="81" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5852" sofa="11" begin="0" end="14" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5864" sofa="11" begin="0" end="14" id="0" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5876" sofa="11" begin="15" end="43" id="1" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5888" sofa="11" begin="44" end="224" id="2" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5900" sofa="11" begin="225" end="251" id="3" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5912" sofa="11" begin="252" end="442" id="4" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5924" sofa="11" begin="443" end="466" id="5" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5936" sofa="11" begin="467" end="658" id="6" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5948" sofa="11" begin="659" end="690" id="7" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5960" sofa="11" begin="691" end="851" id="8" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5972" sofa="11" begin="852" end="881" id="9" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5984" sofa="11" begin="882" end="1079" id="10" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="5996" sofa="11" begin="1080" end="1107" id="11" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6008" sofa="11" begin="1108" end="1321" id="12" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6020" sofa="11" begin="1322" end="1364" id="13" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6032" sofa="11" begin="1365" end="1530" id="14" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6044" sofa="11" begin="1531" end="1557" id="15" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6056" sofa="11" begin="1558" end="1841" id="16" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6068" sofa="11" begin="1842" end="1885" id="17" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6080" sofa="11" begin="1886" end="2133" id="18" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6092" sofa="11" begin="2134" end="2162" id="19" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6104" sofa="11" begin="2163" end="2432" id="20" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6116" sofa="11" begin="2433" end="2464" id="21" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6128" sofa="11" begin="2465" end="2642" id="22" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6140" sofa="11" begin="2643" end="2664" id="23" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6152" sofa="11" begin="2665" end="2854" id="24" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6164" sofa="11" begin="2855" end="2886" id="25" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6176" sofa="11" begin="2887" end="3107" id="26" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6188" sofa="11" begin="3108" end="3120" id="27" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6200" sofa="11" begin="3121" end="3276" id="28" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6212" sofa="11" begin="3277" end="3305" id="29" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6224" sofa="11" begin="3306" end="3575" id="30" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6236" sofa="11" begin="3576" end="3603" id="31" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6248" sofa="11" begin="3604" end="3763" id="32" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6260" sofa="11" begin="3764" end="3786" id="33" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6272" sofa="11" begin="3787" end="4042" id="34" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6284" sofa="11" begin="4043" end="4062" id="35" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6296" sofa="11" begin="4063" end="4248" id="36" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6308" sofa="11" begin="4249" end="4276" id="37" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6320" sofa="11" begin="4277" end="4505" id="38" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6332" sofa="11" begin="4506" end="4537" id="39" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6344" sofa="11" begin="4538" end="4764" id="40" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6356" sofa="11" begin="4765" end="4794" id="41" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6368" sofa="11" begin="4795" end="5079" id="42" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6380" sofa="11" begin="5080" end="5101" id="43" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6392" sofa="11" begin="5102" end="5323" id="44" text="" qualityScore="0.0" bFilter="false"/><types:Sentence xmi:id="6404" sofa="11" begin="5324" end="5344" id="45" text="" qualityScore="0.0" bFilter="false"/><cas:NonEmptyFSList xmi:id="6428" head="1136" tail="6431"/><cas:NonEmptyFSList xmi:id="7746" head="7732" tail="7749"/><cas:NonEmptyFSList xmi:id="7767" head="7753" tail="7770"/><cas:NonEmptyFSList xmi:id="7788" head="7774" tail="7791"/><cas:NonEmptyFSList xmi:id="7809" head="7795" tail="7812"/><cas:NonEmptyFSList xmi:id="7830" head="7816" tail="7833"/><cas:NonEmptyFSList xmi:id="7858" head="7837" tail="7861"/><cas:NonEmptyFSList xmi:id="7889" head="7868" tail="7892"/><cas:NonEmptyFSList xmi:id="7920" head="7899" tail="7923"/><cas:NonEmptyFSList xmi:id="7951" head="7930" tail="7954"/><cas:NonEmptyFSList xmi:id="7982" head="7961" tail="7985"/><cas:NonEmptyFSList xmi:id="7999" head="7992" tail="8002"/><cas:NonEmptyFSList xmi:id="8010" head="8003" tail="8013"/><cas:NonEmptyFSList xmi:id="8021" head="8014" tail="8024"/><cas:NonEmptyFSList xmi:id="8032" head="8025" tail="8035"/><cas:NonEmptyFSList xmi:id="8043" head="8036" tail="8046"/><cas:NonEmptyFSList xmi:id="8054" head="8047" tail="8057"/><cas:NonEmptyFSList xmi:id="8072" head="8058" tail="8075"/><cas:NonEmptyFSList xmi:id="8086" head="8079" tail="8089"/><cas:NonEmptyFSList xmi:id="8104" head="8090" tail="8107"/><cas:NonEmptyFSList xmi:id="8125" head="8111" tail="8128"/><cas:NonEmptyFSList xmi:id="8139" head="8132" tail="8142"/><cas:NonEmptyFSList xmi:id="8150" head="8143" tail="8153"/><cas:NonEmptyFSList xmi:id="8161" head="8154" tail="8164"/><cas:NonEmptyFSList xmi:id="8172" head="8165" tail="8175"/><cas:NonEmptyFSList xmi:id="8183" head="8176" tail="8186"/><cas:NonEmptyFSList xmi:id="8194" head="8187" tail="8197"/><cas:NonEmptyFSList xmi:id="8205" head="8198" tail="8208"/><cas:NonEmptyFSList xmi:id="8216" head="8209" tail="8219"/><cas:NonEmptyFSList xmi:id="8227" head="8220" tail="8230"/><cas:NonEmptyFSList xmi:id="8238" head="8231" tail="8241"/><cas:NonEmptyFSList xmi:id="8249" head="8242" tail="8252"/><cas:NonEmptyFSList xmi:id="8260" head="8253" tail="8263"/><cas:NonEmptyFSList xmi:id="8271" head="8264" tail="8274"/><cas:NonEmptyFSList xmi:id="8282" head="8275" tail="8285"/><cas:NonEmptyFSList xmi:id="8293" head="8286" tail="8296"/><cas:NonEmptyFSList xmi:id="8304" head="8297" tail="8307"/><cas:NonEmptyFSList xmi:id="8315" head="8308" tail="8318"/><cas:NonEmptyFSList xmi:id="8326" head="8319" tail="8329"/><cas:NonEmptyFSList xmi:id="8337" head="8330" tail="8340"/><cas:NonEmptyFSList xmi:id="8348" head="8341" tail="8351"/><cas:NonEmptyFSList xmi:id="8359" head="8352" tail="8362"/><cas:NonEmptyFSList xmi:id="8370" head="8363" tail="8373"/><cas:NonEmptyFSList xmi:id="8381" head="8374" tail="8384"/><cas:NonEmptyFSList xmi:id="8392" head="8385" tail="8395"/><cas:NonEmptyFSList xmi:id="8403" head="8396" tail="8406"/><cas:NonEmptyFSList xmi:id="8414" head="8407" tail="8417"/><cas:NonEmptyFSList xmi:id="8425" head="8418" tail="8428"/><cas:NonEmptyFSList xmi:id="8436" head="8429" tail="8439"/><cas:NonEmptyFSList xmi:id="8447" head="8440" tail="8450"/><cas:NonEmptyFSList xmi:id="8458" head="8451" tail="8461"/><cas:NonEmptyFSList xmi:id="8570" head="8472" tail="8573"/><cas:NonEmptyFSList xmi:id="8613" head="8616" tail="8637"/><cas:NonEmptyFSList xmi:id="8993" head="8888" tail="8996"/><cas:NonEmptyFSList xmi:id="9039" head="9042" tail="9063"/><cas:NonEmptyFSList xmi:id="9440" head="9314" tail="9443"/><cas:NonEmptyFSList xmi:id="9495" head="9498" tail="9519"/><cas:NonEmptyFSList xmi:id="9777" head="9770" tail="9780"/><cas:NonEmptyFSList xmi:id="9897" head="9792" tail="9900"/><cas:NonEmptyFSList xmi:id="9943" head="9946" tail="9967"/><cas:NonEmptyFSList xmi:id="10333" head="10242" tail="10336"/><cas:NonEmptyFSList xmi:id="10373" head="10376" tail="10397"/><cas:NonEmptyFSList xmi:id="10715" head="10624" tail="10718"/><cas:NonEmptyFSList xmi:id="10755" head="10758" tail="10779"/><cas:NonEmptyFSList xmi:id="11087" head="10982" tail="11090"/><cas:NonEmptyFSList xmi:id="11133" head="11136" tail="11157"/><cas:NonEmptyFSList xmi:id="11527" head="11408" tail="11530"/><cas:NonEmptyFSList xmi:id="11579" head="11582" tail="11603"/><cas:NonEmptyFSList xmi:id="12014" head="11902" tail="12017"/><cas:NonEmptyFSList xmi:id="12063" head="12066" tail="12087"/><cas:NonEmptyFSList xmi:id="12495" head="12362" tail="12498"/><cas:NonEmptyFSList xmi:id="12553" head="12556" tail="12577"/><cas:NonEmptyFSList xmi:id="13079" head="13058" tail="13082"/><cas:NonEmptyFSList xmi:id="13110" head="13089" tail="13113"/><cas:NonEmptyFSList xmi:id="13127" head="13120" tail="13130"/><cas:NonEmptyFSList xmi:id="13152" head="13131" tail="13155"/><cas:NonEmptyFSList xmi:id="13190" head="13162" tail="13193"/><cas:NonEmptyFSList xmi:id="13231" head="13203" tail="13234"/><cas:NonEmptyFSList xmi:id="13272" head="13244" tail="13275"/><cas:NonEmptyFSList xmi:id="13313" head="13285" tail="13316"/><cas:NonEmptyFSList xmi:id="13354" head="13326" tail="13357"/><cas:NonEmptyFSList xmi:id="13402" head="13367" tail="13405"/><cas:NonEmptyFSList xmi:id="13425" head="13418" tail="13428"/><cas:NonEmptyFSList xmi:id="13436" head="13429" tail="13439"/><cas:NonEmptyFSList xmi:id="13447" head="13440" tail="13450"/><cas:NonEmptyFSList xmi:id="13458" head="13451" tail="13461"/><cas:NonEmptyFSList xmi:id="13469" head="13462" tail="13472"/><cas:NonEmptyFSList xmi:id="13481" head="13474" tail="13484"/><cas:NonEmptyFSList xmi:id="13492" head="13485" tail="13495"/><cas:NonEmptyFSList xmi:id="13505" head="13498" tail="13508"/><cas:NonEmptyFSList xmi:id="13516" head="13509" tail="13519"/><cas:NonEmptyFSList xmi:id="13527" head="13520" tail="13530"/><cas:NonEmptyFSList xmi:id="13538" head="13531" tail="13541"/><cas:NonEmptyFSList xmi:id="13549" head="13542" tail="13552"/><cas:NonEmptyFSList xmi:id="13560" head="13553" tail="13563"/><cas:NonEmptyFSList xmi:id="13571" head="13564" tail="13574"/><cas:NonEmptyFSList xmi:id="13582" head="13575" tail="13585"/><cas:NonEmptyFSList xmi:id="13593" head="13586" tail="13596"/><cas:NonEmptyFSList xmi:id="13604" head="13597" tail="13607"/><cas:NonEmptyFSList xmi:id="13615" head="13608" tail="13618"/><cas:NonEmptyFSList xmi:id="13626" head="13619" tail="13629"/><cas:NonEmptyFSList xmi:id="13637" head="13630" tail="13640"/><cas:NonEmptyFSList xmi:id="13648" head="13641" tail="13651"/><cas:NonEmptyFSList xmi:id="13659" head="13652" tail="13662"/><cas:NonEmptyFSList xmi:id="13670" head="13663" tail="13673"/><cas:NonEmptyFSList xmi:id="13681" head="13674" tail="13684"/><cas:NonEmptyFSList xmi:id="13692" head="13685" tail="13695"/><cas:NonEmptyFSList xmi:id="13703" head="13696" tail="13706"/><cas:NonEmptyFSList xmi:id="13714" head="13707" tail="13717"/><cas:NonEmptyFSList xmi:id="13725" head="13718" tail="13728"/><cas:NonEmptyFSList xmi:id="13736" head="13729" tail="13739"/><cas:NonEmptyFSList xmi:id="13747" head="13740" tail="13750"/><cas:NonEmptyFSList xmi:id="13758" head="13751" tail="13761"/><cas:NonEmptyFSList xmi:id="13769" head="13762" tail="13772"/><cas:NonEmptyFSList xmi:id="13780" head="13773" tail="13783"/><cas:NonEmptyFSList xmi:id="13791" head="13784" tail="13794"/><cas:NonEmptyFSList xmi:id="13802" head="13795" tail="13805"/><cas:NonEmptyFSList xmi:id="13813" head="13806" tail="13816"/><cas:NonEmptyFSList xmi:id="13824" head="13817" tail="13827"/><cas:NonEmptyFSList xmi:id="13835" head="13828" tail="13838"/><cas:NonEmptyFSList xmi:id="13846" head="13839" tail="13849"/><cas:NonEmptyFSList xmi:id="13857" head="13850" tail="13860"/><cas:NonEmptyFSList xmi:id="13868" head="13861" tail="13871"/><cas:NonEmptyFSList xmi:id="13879" head="13872" tail="13882"/><cas:NonEmptyFSList xmi:id="13890" head="13883" tail="13893"/><cas:NonEmptyFSList xmi:id="13901" head="13894" tail="13904"/><cas:NonEmptyFSList xmi:id="13912" head="13905" tail="13915"/><cas:NonEmptyFSList xmi:id="13923" head="13916" tail="13926"/><cas:NonEmptyFSList xmi:id="13934" head="13927" tail="13937"/><cas:EmptyFSList xmi:id="7731"/><cas:EmptyFSList xmi:id="9781"/><cas:EmptyFSList xmi:id="13473"/><cas:EmptyFSList xmi:id="13496"/><cas:EmptyFSList xmi:id="13497"/><types:Token xmi:id="7732" sofa="11" begin="0" end="7" text="APP-CTF" pos="NN" ner="O"/><types:Token xmi:id="7739" sofa="11" begin="8" end="20" text="accumulation" pos="NN" ner="O"/><types:Token xmi:id="7753" sofa="11" begin="0" end="5" text="PSEN1" pos="NN" ner="O"/><types:Token xmi:id="7760" sofa="11" begin="6" end="15" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="7774" sofa="11" begin="0" end="10" text="cell-based" pos="JJ" ner="O"/><types:Token xmi:id="7781" sofa="11" begin="11" end="15" text="data" pos="NNS" ner="O"/><types:Token xmi:id="7795" sofa="11" begin="0" end="4" text="APH1" pos="NN" ner="O"/><types:Token xmi:id="7802" sofa="11" begin="5" end="13" text="variants" pos="NNS" ner="O"/><types:Token xmi:id="7816" sofa="11" begin="0" end="16" text="transition-state" pos="JJ" ner="O"/><types:Token xmi:id="7823" sofa="11" begin="17" end="25" text="analogue" pos="NN" ner="O"/><types:Token xmi:id="7837" sofa="11" begin="0" end="4" text="They" pos="PRP" ner="O"/><types:Token xmi:id="7844" sofa="11" begin="5" end="8" text="are" pos="VBP" ner="O"/><types:Token xmi:id="7851" sofa="11" begin="9" end="17" text="purified" pos="VBN" ner="O"/><types:Token xmi:id="7868" sofa="11" begin="0" end="4" text="They" pos="PRP" ner="O"/><types:Token xmi:id="7875" sofa="11" begin="5" end="8" text="are" pos="VBP" ner="O"/><types:Token xmi:id="7882" sofa="11" begin="9" end="17" text="anterior" pos="JJ" ner="O"/><types:Token xmi:id="7899" sofa="11" begin="0" end="4" text="They" pos="PRP" ner="O"/><types:Token xmi:id="7906" sofa="11" begin="5" end="8" text="are" pos="VBP" ner="O"/><types:Token xmi:id="7913" sofa="11" begin="9" end="16" text="shorter" pos="JJR" ner="O"/><types:Token xmi:id="7930" sofa="11" begin="0" end="4" text="They" pos="PRP" ner="O"/><types:Token xmi:id="7937" sofa="11" begin="5" end="8" text="are" pos="VBP" ner="O"/><types:Token xmi:id="7944" sofa="11" begin="9" end="15" text="longer" pos="RBR" ner="O"/><types:Token xmi:id="7961" sofa="11" begin="0" end="4" text="They" pos="PRP" ner="O"/><types:Token xmi:id="7968" sofa="11" begin="5" end="8" text="are" pos="VBP" ner="O"/><types:Token xmi:id="7975" sofa="11" begin="9" end="18" text="supported" pos="VBN" ner="O"/><types:Token xmi:id="7992" sofa="11" begin="0" end="3" text="FAD" pos="NN" ner="O"/><types:Token xmi:id="8003" sofa="11" begin="0" end="7" text="I-CLiPs" pos="NNS" ner="O"/><types:Token xmi:id="8014" sofa="11" begin="0" end="3" text="NCT" pos="NN" ner="O"/><types:Token xmi:id="8025" sofa="11" begin="0" end="5" text="PSEN1" pos="NN" ner="O"/><types:Token xmi:id="8036" sofa="11" begin="0" end="5" text="D257A" pos="NN" ner="O"/><types:Token xmi:id="8047" sofa="11" begin="0" end="8" text="plasmids" pos="NNS" ner="O"/><types:Token xmi:id="8058" sofa="11" begin="0" end="8" text="affinity" pos="NN" ner="O"/><types:Token xmi:id="8065" sofa="11" begin="9" end="23" text="chromatography" pos="NN" ner="O"/><types:Token xmi:id="8079" sofa="11" begin="0" end="6" text="lysate" pos="NN" ner="O"/><types:Token xmi:id="8090" sofa="11" begin="0" end="4" text="cell" pos="NN" ner="O"/><types:Token xmi:id="8097" sofa="11" begin="5" end="10" text="lines" pos="NNS" ner="O"/><types:Token xmi:id="8111" sofa="11" begin="0" end="8" text="knockout" pos="NN" ner="O"/><types:Token xmi:id="8118" sofa="11" begin="9" end="20" text="experiments" pos="NNS" ner="O"/><types:Token xmi:id="8132" sofa="11" begin="0" end="2" text="AD" pos="NN" ner="O"/><types:Token xmi:id="8143" sofa="11" begin="0" end="8" text="APP-CTFs" pos="NNS" ner="O"/><types:Token xmi:id="8154" sofa="11" begin="0" end="11" text="c-secretase" pos="NN" ner="O"/><types:Token xmi:id="8165" sofa="11" begin="0" end="11" text="cholesterol" pos="NN" ner="O"/><types:Token xmi:id="8176" sofa="11" begin="0" end="4" text="AICD" pos="NN" ner="ORGANIZATION"/><types:Token xmi:id="8187" sofa="11" begin="0" end="9" text="aspartate" pos="NN" ner="O"/><types:Token xmi:id="8198" sofa="11" begin="0" end="10" text="C-terminal" pos="JJ" ner="O"/><types:Token xmi:id="8209" sofa="11" begin="0" end="10" text="42-residue" pos="JJ" ner="O"/><types:Token xmi:id="8220" sofa="11" begin="0" end="2" text="99" pos="CD" ner="NUMBER"/><types:Token xmi:id="8231" sofa="11" begin="0" end="4" text="DDAA" pos="NN" ner="ORGANIZATION"/><types:Token xmi:id="8242" sofa="11" begin="0" end="12" text="densitometry" pos="NN" ner="O"/><types:Token xmi:id="8253" sofa="11" begin="0" end="2" text="EM" pos="NN" ner="O"/><types:Token xmi:id="8264" sofa="11" begin="0" end="5" text="ELISA" pos="NN" ner="PERSON"/><types:Token xmi:id="8275" sofa="11" begin="0" end="14" text="immunostaining" pos="NN" ner="O"/><types:Token xmi:id="8286" sofa="11" begin="0" end="12" text="purification" pos="NN" ner="O"/><types:Token xmi:id="8297" sofa="11" begin="0" end="4" text="LRP1" pos="NN" ner="O"/><types:Token xmi:id="8308" sofa="11" begin="0" end="11" text="biochemical" pos="JJ" ner="O"/><types:Token xmi:id="8319" sofa="11" begin="0" end="5" text="PSEN1" pos="NN" ner="O"/><types:Token xmi:id="8330" sofa="11" begin="0" end="2" text="AD" pos="NN" ner="O"/><types:Token xmi:id="8341" sofa="11" begin="0" end="12" text="Semagacestat" pos="NN" ner="O"/><types:Token xmi:id="8352" sofa="11" begin="0" end="5" text="P436Q" pos="NN" ner="O"/><types:Token xmi:id="8363" sofa="11" begin="0" end="5" text="L166P" pos="NN" ner="O"/><types:Token xmi:id="8374" sofa="11" begin="0" end="9" text="wild-type" pos="JJ" ner="O"/><types:Token xmi:id="8385" sofa="11" begin="0" end="4" text="AICD" pos="NN" ner="ORGANIZATION"/><types:Token xmi:id="8396" sofa="11" begin="0" end="8" text="C100-His" pos="NN" ner="O"/><types:Token xmi:id="8407" sofa="11" begin="0" end="2" text="13" pos="CD" ner="NUMBER"/><types:Token xmi:id="8418" sofa="11" begin="0" end="2" text="42" pos="CD" ner="NUMBER"/><types:Token xmi:id="8429" sofa="11" begin="0" end="5" text="P436Q" pos="NN" ner="O"/><types:Token xmi:id="8440" sofa="11" begin="0" end="3" text="185" pos="CD" ner="NUMBER"/><types:Token xmi:id="8451" sofa="11" begin="0" end="5" text="PSEN2" pos="NN" ner="O"/><types:Token xmi:id="8472" sofa="11" begin="0" end="4" text="What" pos="WDT" ner="O"/><types:Token xmi:id="8479" sofa="11" begin="5" end="11" text="effect" pos="NN" ner="O"/><types:Token xmi:id="8486" sofa="11" begin="12" end="15" text="can" pos="MD" ner="O"/><types:Token xmi:id="8493" sofa="11" begin="16" end="18" text="be" pos="VB" ner="O"/><types:Token xmi:id="8500" sofa="11" begin="19" end="27" text="observed" pos="VBN" ner="O"/><types:Token xmi:id="8507" sofa="11" begin="28" end="32" text="when" pos="WRB" ner="O"/><types:Token xmi:id="8514" sofa="11" begin="33" end="37" text="when" pos="WRB" ner="O"/><types:Token xmi:id="8521" sofa="11" begin="38" end="39" text="Œ" pos="NNP" ner="O"/><types:Token xmi:id="8528" sofa="11" begin="39" end="40" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="8535" sofa="11" begin="40" end="41" text="-" pos=":" ner="O"/><types:Token xmi:id="8542" sofa="11" begin="41" end="50" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="8549" sofa="11" begin="51" end="53" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="8556" sofa="11" begin="54" end="61" text="blocked" pos="VBN" ner="O"/><types:Token xmi:id="8563" sofa="11" begin="61" end="62" text="?" pos="." ner="O"/><types:Token xmi:id="8623" sofa="11" begin="0" end="0" text="effect" pos="NN" ner="O"/><types:Token xmi:id="8630" sofa="11" begin="0" end="0" text="What" pos="WDT" ner="O"/><types:Token xmi:id="8647" sofa="11" begin="0" end="0" text="observed" pos="VBN" ner="O"/><types:Token xmi:id="8654" sofa="11" begin="0" end="0" text="effect" pos="NN" ner="O"/><types:Token xmi:id="8671" sofa="11" begin="0" end="0" text="observed" pos="VBN" ner="O"/><types:Token xmi:id="8678" sofa="11" begin="0" end="0" text="can" pos="MD" ner="O"/><types:Token xmi:id="8695" sofa="11" begin="0" end="0" text="observed" pos="VBN" ner="O"/><types:Token xmi:id="8702" sofa="11" begin="0" end="0" text="be" pos="VB" ner="O"/><types:Token xmi:id="8719" sofa="11" begin="0" end="0" text="observed" pos="VBN" ner="O"/><types:Token xmi:id="8726" sofa="11" begin="0" end="0" text="when" pos="WRB" ner="O"/><types:Token xmi:id="8743" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="8750" sofa="11" begin="0" end="0" text="when" pos="WRB" ner="O"/><types:Token xmi:id="8767" sofa="11" begin="0" end="0" text="when" pos="WRB" ner="O"/><types:Token xmi:id="8774" sofa="11" begin="0" end="0" text="Œ" pos="NNP" ner="O"/><types:Token xmi:id="8791" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="8798" sofa="11" begin="0" end="0" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="8815" sofa="11" begin="0" end="0" text="observed" pos="VBN" ner="O"/><types:Token xmi:id="8822" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="8839" sofa="11" begin="0" end="0" text="blocked" pos="VBN" ner="O"/><types:Token xmi:id="8846" sofa="11" begin="0" end="0" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="8863" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="8870" sofa="11" begin="0" end="0" text="blocked" pos="VBN" ner="O"/><types:Token xmi:id="8888" sofa="11" begin="0" end="4" text="When" pos="WRB" ner="O"/><types:Token xmi:id="8895" sofa="11" begin="5" end="9" text="APH1" pos="NN" ner="O"/><types:Token xmi:id="8902" sofa="11" begin="10" end="15" text="genes" pos="NNS" ner="O"/><types:Token xmi:id="8909" sofa="11" begin="16" end="19" text="are" pos="VBP" ner="O"/><types:Token xmi:id="8916" sofa="11" begin="20" end="33" text="overexpressed" pos="VBN" ner="O"/><types:Token xmi:id="8923" sofa="11" begin="34" end="36" text="in" pos="IN" ner="O"/><types:Token xmi:id="8930" sofa="11" begin="37" end="40" text="MEF" pos="NN" ner="O"/><types:Token xmi:id="8937" sofa="11" begin="41" end="43" text="KO" pos="NN" ner="O"/><types:Token xmi:id="8944" sofa="11" begin="44" end="48" text="what" pos="WDT" ner="O"/><types:Token xmi:id="8951" sofa="11" begin="49" end="56" text="happens" pos="VBZ" ner="O"/><types:Token xmi:id="8958" sofa="11" begin="57" end="61" text="with" pos="IN" ner="O"/><types:Token xmi:id="8965" sofa="11" begin="62" end="65" text="the" pos="DT" ner="O"/><types:Token xmi:id="8972" sofa="11" begin="66" end="68" text="AŒ" pos="NN" ner="O"/><types:Token xmi:id="8979" sofa="11" begin="68" end="69" text="≤" pos="NN" ner="O"/><types:Token xmi:id="8986" sofa="11" begin="69" end="70" text="?" pos="." ner="O"/><types:Token xmi:id="9049" sofa="11" begin="0" end="0" text="overexpressed" pos="VBN" ner="O"/><types:Token xmi:id="9056" sofa="11" begin="0" end="0" text="When" pos="WRB" ner="O"/><types:Token xmi:id="9073" sofa="11" begin="0" end="0" text="genes" pos="NNS" ner="O"/><types:Token xmi:id="9080" sofa="11" begin="0" end="0" text="APH1" pos="NN" ner="O"/><types:Token xmi:id="9097" sofa="11" begin="0" end="0" text="overexpressed" pos="VBN" ner="O"/><types:Token xmi:id="9104" sofa="11" begin="0" end="0" text="genes" pos="NNS" ner="O"/><types:Token xmi:id="9121" sofa="11" begin="0" end="0" text="overexpressed" pos="VBN" ner="O"/><types:Token xmi:id="9128" sofa="11" begin="0" end="0" text="are" pos="VBP" ner="O"/><types:Token xmi:id="9145" sofa="11" begin="0" end="0" text="KO" pos="NN" ner="O"/><types:Token xmi:id="9152" sofa="11" begin="0" end="0" text="MEF" pos="NN" ner="O"/><types:Token xmi:id="9169" sofa="11" begin="0" end="0" text="overexpressed" pos="VBN" ner="O"/><types:Token xmi:id="9176" sofa="11" begin="0" end="0" text="KO" pos="NN" ner="O"/><types:Token xmi:id="9193" sofa="11" begin="0" end="0" text="happens" pos="VBZ" ner="O"/><types:Token xmi:id="9200" sofa="11" begin="0" end="0" text="what" pos="WDT" ner="O"/><types:Token xmi:id="9217" sofa="11" begin="0" end="0" text="KO" pos="NN" ner="O"/><types:Token xmi:id="9224" sofa="11" begin="0" end="0" text="happens" pos="VBZ" ner="O"/><types:Token xmi:id="9241" sofa="11" begin="0" end="0" text="≤" pos="NN" ner="O"/><types:Token xmi:id="9248" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="9265" sofa="11" begin="0" end="0" text="≤" pos="NN" ner="O"/><types:Token xmi:id="9272" sofa="11" begin="0" end="0" text="AŒ" pos="NN" ner="O"/><types:Token xmi:id="9289" sofa="11" begin="0" end="0" text="happens" pos="VBZ" ner="O"/><types:Token xmi:id="9296" sofa="11" begin="0" end="0" text="≤" pos="NN" ner="O"/><types:Token xmi:id="9314" sofa="11" begin="0" end="2" text="In" pos="IN" ner="O"/><types:Token xmi:id="9321" sofa="11" begin="3" end="8" text="which" pos="WDT" ner="O"/><types:Token xmi:id="9328" sofa="11" begin="9" end="13" text="gene" pos="NN" ner="O"/><types:Token xmi:id="9335" sofa="11" begin="14" end="17" text="are" pos="VBP" ner="O"/><types:Token xmi:id="9342" sofa="11" begin="18" end="27" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="9349" sofa="11" begin="28" end="38" text="associated" pos="VBN" ner="O"/><types:Token xmi:id="9356" sofa="11" begin="39" end="41" text="to" pos="TO" ner="O"/><types:Token xmi:id="9363" sofa="11" begin="42" end="46" text="many" pos="JJ" ner="O"/><types:Token xmi:id="9370" sofa="11" begin="47" end="52" text="cases" pos="NNS" ner="O"/><types:Token xmi:id="9377" sofa="11" begin="53" end="55" text="of" pos="IN" ner="O"/><types:Token xmi:id="9384" sofa="11" begin="56" end="67" text="early-onset" pos="JJ" ner="O"/><types:Token xmi:id="9391" sofa="11" begin="68" end="76" text="familial" pos="JJ" ner="O"/><types:Token xmi:id="9398" sofa="11" begin="77" end="82" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="9405" sofa="11" begin="83" end="85" text="of" pos="IN" ner="O"/><types:Token xmi:id="9412" sofa="11" begin="86" end="95" text="Alzheimer" pos="NN" ner="O"/><types:Token xmi:id="9419" sofa="11" begin="95" end="97" text="'s" pos="POS" ner="O"/><types:Token xmi:id="9426" sofa="11" begin="98" end="105" text="disease" pos="NN" ner="O"/><types:Token xmi:id="9433" sofa="11" begin="105" end="106" text="?" pos="." ner="O"/><types:Token xmi:id="9505" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="9512" sofa="11" begin="0" end="0" text="which" pos="WDT" ner="O"/><types:Token xmi:id="9529" sofa="11" begin="0" end="0" text="associated" pos="VBN" ner="O"/><types:Token xmi:id="9536" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="9553" sofa="11" begin="0" end="0" text="associated" pos="VBN" ner="O"/><types:Token xmi:id="9560" sofa="11" begin="0" end="0" text="are" pos="VBP" ner="O"/><types:Token xmi:id="9577" sofa="11" begin="0" end="0" text="associated" pos="VBN" ner="O"/><types:Token xmi:id="9584" sofa="11" begin="0" end="0" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="9601" sofa="11" begin="0" end="0" text="cases" pos="NNS" ner="O"/><types:Token xmi:id="9608" sofa="11" begin="0" end="0" text="many" pos="JJ" ner="O"/><types:Token xmi:id="9625" sofa="11" begin="0" end="0" text="associated" pos="VBN" ner="O"/><types:Token xmi:id="9632" sofa="11" begin="0" end="0" text="cases" pos="NNS" ner="O"/><types:Token xmi:id="9649" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="9656" sofa="11" begin="0" end="0" text="early-onset" pos="JJ" ner="O"/><types:Token xmi:id="9673" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="9680" sofa="11" begin="0" end="0" text="familial" pos="JJ" ner="O"/><types:Token xmi:id="9697" sofa="11" begin="0" end="0" text="cases" pos="NNS" ner="O"/><types:Token xmi:id="9704" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="9721" sofa="11" begin="0" end="0" text="disease" pos="NN" ner="O"/><types:Token xmi:id="9728" sofa="11" begin="0" end="0" text="Alzheimer" pos="NN" ner="O"/><types:Token xmi:id="9745" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="9752" sofa="11" begin="0" end="0" text="disease" pos="NN" ner="O"/><types:Token xmi:id="9770" sofa="11" begin="106" end="107" text="G" pos="NN" ner="O"/><types:Token xmi:id="9792" sofa="11" begin="0" end="4" text="What" pos="WDT" ner="O"/><types:Token xmi:id="9799" sofa="11" begin="5" end="17" text="experimental" pos="JJ" ner="O"/><types:Token xmi:id="9806" sofa="11" begin="18" end="27" text="technique" pos="NN" ner="O"/><types:Token xmi:id="9813" sofa="11" begin="28" end="31" text="was" pos="VBD" ner="O"/><types:Token xmi:id="9820" sofa="11" begin="32" end="36" text="used" pos="VBN" ner="O"/><types:Token xmi:id="9827" sofa="11" begin="37" end="49" text="specifically" pos="RB" ner="O"/><types:Token xmi:id="9834" sofa="11" begin="50" end="52" text="to" pos="TO" ner="O"/><types:Token xmi:id="9841" sofa="11" begin="53" end="59" text="purify" pos="VB" ner="O"/><types:Token xmi:id="9848" sofa="11" begin="60" end="63" text="the" pos="DT" ner="O"/><types:Token xmi:id="9855" sofa="11" begin="64" end="65" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="9862" sofa="11" begin="65" end="66" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="9869" sofa="11" begin="66" end="67" text="-" pos=":" ner="O"/><types:Token xmi:id="9876" sofa="11" begin="67" end="76" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="9883" sofa="11" begin="77" end="84" text="complex" pos="NN" ner="O"/><types:Token xmi:id="9890" sofa="11" begin="84" end="85" text="?" pos="." ner="O"/><types:Token xmi:id="9953" sofa="11" begin="0" end="0" text="technique" pos="NN" ner="O"/><types:Token xmi:id="9960" sofa="11" begin="0" end="0" text="What" pos="WDT" ner="O"/><types:Token xmi:id="9977" sofa="11" begin="0" end="0" text="technique" pos="NN" ner="O"/><types:Token xmi:id="9984" sofa="11" begin="0" end="0" text="experimental" pos="JJ" ner="O"/><types:Token xmi:id="10001" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="10008" sofa="11" begin="0" end="0" text="technique" pos="NN" ner="O"/><types:Token xmi:id="10025" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="10032" sofa="11" begin="0" end="0" text="was" pos="VBD" ner="O"/><types:Token xmi:id="10049" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="10056" sofa="11" begin="0" end="0" text="specifically" pos="RB" ner="O"/><types:Token xmi:id="10073" sofa="11" begin="0" end="0" text="purify" pos="VB" ner="O"/><types:Token xmi:id="10080" sofa="11" begin="0" end="0" text="to" pos="TO" ner="O"/><types:Token xmi:id="10097" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="10104" sofa="11" begin="0" end="0" text="purify" pos="VB" ner="O"/><types:Token xmi:id="10121" sofa="11" begin="0" end="0" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="10128" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="10145" sofa="11" begin="0" end="0" text="purify" pos="VB" ner="O"/><types:Token xmi:id="10152" sofa="11" begin="0" end="0" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="10169" sofa="11" begin="0" end="0" text="complex" pos="NN" ner="O"/><types:Token xmi:id="10176" sofa="11" begin="0" end="0" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="10193" sofa="11" begin="0" end="0" text="complex" pos="NN" ner="O"/><types:Token xmi:id="10200" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="10217" sofa="11" begin="0" end="0" text="purify" pos="VB" ner="O"/><types:Token xmi:id="10224" sofa="11" begin="0" end="0" text="complex" pos="NN" ner="O"/><types:Token xmi:id="10242" sofa="11" begin="0" end="4" text="What" pos="WDT" ner="O"/><types:Token xmi:id="10249" sofa="11" begin="5" end="12" text="peptide" pos="NN" ner="O"/><types:Token xmi:id="10256" sofa="11" begin="13" end="15" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="10263" sofa="11" begin="16" end="20" text="able" pos="JJ" ner="O"/><types:Token xmi:id="10270" sofa="11" begin="21" end="23" text="to" pos="TO" ner="O"/><types:Token xmi:id="10277" sofa="11" begin="24" end="31" text="control" pos="VB" ner="O"/><types:Token xmi:id="10284" sofa="11" begin="32" end="35" text="the" pos="DT" ner="O"/><types:Token xmi:id="10291" sofa="11" begin="36" end="46" text="expression" pos="NN" ner="O"/><types:Token xmi:id="10298" sofa="11" begin="47" end="49" text="of" pos="IN" ner="O"/><types:Token xmi:id="10305" sofa="11" begin="50" end="53" text="the" pos="DT" ner="O"/><types:Token xmi:id="10312" sofa="11" begin="54" end="58" text="ApoE" pos="NN" ner="O"/><types:Token xmi:id="10319" sofa="11" begin="59" end="63" text="gene" pos="NN" ner="O"/><types:Token xmi:id="10326" sofa="11" begin="63" end="64" text="?" pos="." ner="O"/><types:Token xmi:id="10383" sofa="11" begin="0" end="0" text="peptide" pos="NN" ner="O"/><types:Token xmi:id="10390" sofa="11" begin="0" end="0" text="What" pos="WDT" ner="O"/><types:Token xmi:id="10407" sofa="11" begin="0" end="0" text="able" pos="JJ" ner="O"/><types:Token xmi:id="10414" sofa="11" begin="0" end="0" text="peptide" pos="NN" ner="O"/><types:Token xmi:id="10431" sofa="11" begin="0" end="0" text="able" pos="JJ" ner="O"/><types:Token xmi:id="10438" sofa="11" begin="0" end="0" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="10455" sofa="11" begin="0" end="0" text="control" pos="VB" ner="O"/><types:Token xmi:id="10462" sofa="11" begin="0" end="0" text="to" pos="TO" ner="O"/><types:Token xmi:id="10479" sofa="11" begin="0" end="0" text="able" pos="JJ" ner="O"/><types:Token xmi:id="10486" sofa="11" begin="0" end="0" text="control" pos="VB" ner="O"/><types:Token xmi:id="10503" sofa="11" begin="0" end="0" text="expression" pos="NN" ner="O"/><types:Token xmi:id="10510" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="10527" sofa="11" begin="0" end="0" text="control" pos="VB" ner="O"/><types:Token xmi:id="10534" sofa="11" begin="0" end="0" text="expression" pos="NN" ner="O"/><types:Token xmi:id="10551" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="10558" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="10575" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="10582" sofa="11" begin="0" end="0" text="ApoE" pos="NN" ner="O"/><types:Token xmi:id="10599" sofa="11" begin="0" end="0" text="expression" pos="NN" ner="O"/><types:Token xmi:id="10606" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="10624" sofa="11" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types:Token xmi:id="10631" sofa="11" begin="6" end="11" text="amino" pos="NN" ner="O"/><types:Token xmi:id="10638" sofa="11" begin="12" end="16" text="acid" pos="NN" ner="O"/><types:Token xmi:id="10645" sofa="11" begin="17" end="19" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="10652" sofa="11" begin="20" end="28" text="critical" pos="JJ" ner="O"/><types:Token xmi:id="10659" sofa="11" begin="29" end="32" text="for" pos="IN" ner="O"/><types:Token xmi:id="10666" sofa="11" begin="33" end="36" text="the" pos="DT" ner="O"/><types:Token xmi:id="10673" sofa="11" begin="37" end="45" text="activity" pos="NN" ner="O"/><types:Token xmi:id="10680" sofa="11" begin="46" end="48" text="of" pos="IN" ner="O"/><types:Token xmi:id="10687" sofa="11" begin="49" end="52" text="the" pos="DT" ner="O"/><types:Token xmi:id="10694" sofa="11" begin="53" end="56" text="PS1" pos="NN" ner="O"/><types:Token xmi:id="10701" sofa="11" begin="57" end="64" text="protein" pos="NN" ner="O"/><types:Token xmi:id="10708" sofa="11" begin="64" end="65" text="?" pos="." ner="O"/><types:Token xmi:id="10765" sofa="11" begin="0" end="0" text="acid" pos="NN" ner="O"/><types:Token xmi:id="10772" sofa="11" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types:Token xmi:id="10789" sofa="11" begin="0" end="0" text="acid" pos="NN" ner="O"/><types:Token xmi:id="10796" sofa="11" begin="0" end="0" text="amino" pos="NN" ner="O"/><types:Token xmi:id="10813" sofa="11" begin="0" end="0" text="critical" pos="JJ" ner="O"/><types:Token xmi:id="10820" sofa="11" begin="0" end="0" text="acid" pos="NN" ner="O"/><types:Token xmi:id="10837" sofa="11" begin="0" end="0" text="critical" pos="JJ" ner="O"/><types:Token xmi:id="10844" sofa="11" begin="0" end="0" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="10861" sofa="11" begin="0" end="0" text="activity" pos="NN" ner="O"/><types:Token xmi:id="10868" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="10885" sofa="11" begin="0" end="0" text="critical" pos="JJ" ner="O"/><types:Token xmi:id="10892" sofa="11" begin="0" end="0" text="activity" pos="NN" ner="O"/><types:Token xmi:id="10909" sofa="11" begin="0" end="0" text="protein" pos="NN" ner="O"/><types:Token xmi:id="10916" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="10933" sofa="11" begin="0" end="0" text="protein" pos="NN" ner="O"/><types:Token xmi:id="10940" sofa="11" begin="0" end="0" text="PS1" pos="NN" ner="O"/><types:Token xmi:id="10957" sofa="11" begin="0" end="0" text="activity" pos="NN" ner="O"/><types:Token xmi:id="10964" sofa="11" begin="0" end="0" text="protein" pos="NN" ner="O"/><types:Token xmi:id="10982" sofa="11" begin="0" end="4" text="What" pos="WDT" ner="O"/><types:Token xmi:id="10989" sofa="11" begin="5" end="17" text="experimental" pos="JJ" ner="O"/><types:Token xmi:id="10996" sofa="11" begin="18" end="27" text="technique" pos="NN" ner="O"/><types:Token xmi:id="11003" sofa="11" begin="28" end="31" text="was" pos="VBD" ner="O"/><types:Token xmi:id="11010" sofa="11" begin="32" end="36" text="used" pos="VBN" ner="O"/><types:Token xmi:id="11017" sofa="11" begin="37" end="39" text="to" pos="TO" ner="O"/><types:Token xmi:id="11024" sofa="11" begin="40" end="49" text="determine" pos="VB" ner="O"/><types:Token xmi:id="11031" sofa="11" begin="50" end="53" text="the" pos="DT" ner="O"/><types:Token xmi:id="11038" sofa="11" begin="54" end="63" text="structure" pos="NN" ner="O"/><types:Token xmi:id="11045" sofa="11" begin="64" end="66" text="of" pos="IN" ner="O"/><types:Token xmi:id="11052" sofa="11" begin="67" end="68" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="11059" sofa="11" begin="68" end="69" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="11066" sofa="11" begin="69" end="70" text="-" pos=":" ner="O"/><types:Token xmi:id="11073" sofa="11" begin="70" end="79" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11080" sofa="11" begin="79" end="80" text="?" pos="." ner="O"/><types:Token xmi:id="11143" sofa="11" begin="0" end="0" text="technique" pos="NN" ner="O"/><types:Token xmi:id="11150" sofa="11" begin="0" end="0" text="What" pos="WDT" ner="O"/><types:Token xmi:id="11167" sofa="11" begin="0" end="0" text="technique" pos="NN" ner="O"/><types:Token xmi:id="11174" sofa="11" begin="0" end="0" text="experimental" pos="JJ" ner="O"/><types:Token xmi:id="11191" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="11198" sofa="11" begin="0" end="0" text="technique" pos="NN" ner="O"/><types:Token xmi:id="11215" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="11222" sofa="11" begin="0" end="0" text="was" pos="VBD" ner="O"/><types:Token xmi:id="11239" sofa="11" begin="0" end="0" text="determine" pos="VB" ner="O"/><types:Token xmi:id="11246" sofa="11" begin="0" end="0" text="to" pos="TO" ner="O"/><types:Token xmi:id="11263" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="11270" sofa="11" begin="0" end="0" text="determine" pos="VB" ner="O"/><types:Token xmi:id="11287" sofa="11" begin="0" end="0" text="structure" pos="NN" ner="O"/><types:Token xmi:id="11294" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="11311" sofa="11" begin="0" end="0" text="determine" pos="VB" ner="O"/><types:Token xmi:id="11318" sofa="11" begin="0" end="0" text="structure" pos="NN" ner="O"/><types:Token xmi:id="11335" sofa="11" begin="0" end="0" text="structure" pos="NN" ner="O"/><types:Token xmi:id="11342" sofa="11" begin="0" end="0" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="11359" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11366" sofa="11" begin="0" end="0" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="11383" sofa="11" begin="0" end="0" text="used" pos="VBN" ner="O"/><types:Token xmi:id="11390" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11408" sofa="11" begin="0" end="4" text="What" pos="WDT" ner="O"/><types:Token xmi:id="11415" sofa="11" begin="5" end="14" text="candidate" pos="NN" ner="O"/><types:Token xmi:id="11422" sofa="11" begin="15" end="19" text="drug" pos="NN" ner="O"/><types:Token xmi:id="11429" sofa="11" begin="20" end="24" text="that" pos="WDT" ner="O"/><types:Token xmi:id="11436" sofa="11" begin="25" end="31" text="blocks" pos="VBZ" ner="O"/><types:Token xmi:id="11443" sofa="11" begin="32" end="35" text="the" pos="DT" ner="O"/><types:Token xmi:id="11450" sofa="11" begin="36" end="37" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="11457" sofa="11" begin="37" end="38" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="11464" sofa="11" begin="38" end="39" text="-" pos=":" ner="O"/><types:Token xmi:id="11471" sofa="11" begin="39" end="48" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11478" sofa="11" begin="49" end="51" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="11485" sofa="11" begin="52" end="55" text="now" pos="RB" ner="DATE"/><types:Token xmi:id="11492" sofa="11" begin="56" end="62" text="tested" pos="VBN" ner="O"/><types:Token xmi:id="11499" sofa="11" begin="63" end="65" text="in" pos="IN" ner="O"/><types:Token xmi:id="11506" sofa="11" begin="66" end="74" text="clinical" pos="JJ" ner="O"/><types:Token xmi:id="11513" sofa="11" begin="75" end="81" text="trials" pos="NNS" ner="O"/><types:Token xmi:id="11520" sofa="11" begin="81" end="82" text="?" pos="." ner="O"/><types:Token xmi:id="11589" sofa="11" begin="0" end="0" text="drug" pos="NN" ner="O"/><types:Token xmi:id="11596" sofa="11" begin="0" end="0" text="What" pos="WDT" ner="O"/><types:Token xmi:id="11613" sofa="11" begin="0" end="0" text="drug" pos="NN" ner="O"/><types:Token xmi:id="11620" sofa="11" begin="0" end="0" text="candidate" pos="NN" ner="O"/><types:Token xmi:id="11637" sofa="11" begin="0" end="0" text="tested" pos="VBN" ner="O"/><types:Token xmi:id="11644" sofa="11" begin="0" end="0" text="drug" pos="NN" ner="O"/><types:Token xmi:id="11661" sofa="11" begin="0" end="0" text="blocks" pos="VBZ" ner="O"/><types:Token xmi:id="11668" sofa="11" begin="0" end="0" text="that" pos="WDT" ner="O"/><types:Token xmi:id="11685" sofa="11" begin="0" end="0" text="drug" pos="NN" ner="O"/><types:Token xmi:id="11692" sofa="11" begin="0" end="0" text="blocks" pos="VBZ" ner="O"/><types:Token xmi:id="11709" sofa="11" begin="0" end="0" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="11716" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="11733" sofa="11" begin="0" end="0" text="blocks" pos="VBZ" ner="O"/><types:Token xmi:id="11740" sofa="11" begin="0" end="0" text="Œ" pos="NN" ner="O"/><types:Token xmi:id="11757" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11764" sofa="11" begin="0" end="0" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="11781" sofa="11" begin="0" end="0" text="blocks" pos="VBZ" ner="O"/><types:Token xmi:id="11788" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11805" sofa="11" begin="0" end="0" text="tested" pos="VBN" ner="O"/><types:Token xmi:id="11812" sofa="11" begin="0" end="0" text="is" pos="VBZ" ner="O"/><types:Token xmi:id="11829" sofa="11" begin="0" end="0" text="tested" pos="VBN" ner="O"/><types:Token xmi:id="11836" sofa="11" begin="0" end="0" text="now" pos="RB" ner="DATE"/><types:Token xmi:id="11853" sofa="11" begin="0" end="0" text="trials" pos="NNS" ner="O"/><types:Token xmi:id="11860" sofa="11" begin="0" end="0" text="clinical" pos="JJ" ner="O"/><types:Token xmi:id="11877" sofa="11" begin="0" end="0" text="tested" pos="VBN" ner="O"/><types:Token xmi:id="11884" sofa="11" begin="0" end="0" text="trials" pos="NNS" ner="O"/><types:Token xmi:id="11902" sofa="11" begin="0" end="4" text="What" pos="WDT" ner="O"/><types:Token xmi:id="11909" sofa="11" begin="5" end="13" text="mutation" pos="NN" ner="O"/><types:Token xmi:id="11916" sofa="11" begin="14" end="16" text="of" pos="IN" ner="O"/><types:Token xmi:id="11923" sofa="11" begin="17" end="20" text="the" pos="DT" ner="O"/><types:Token xmi:id="11930" sofa="11" begin="21" end="24" text="PS1" pos="NN" ner="O"/><types:Token xmi:id="11937" sofa="11" begin="25" end="32" text="protein" pos="NN" ner="O"/><types:Token xmi:id="11944" sofa="11" begin="33" end="39" text="causes" pos="VBZ" ner="O"/><types:Token xmi:id="11951" sofa="11" begin="40" end="41" text="Œ" pos="NNP" ner="O"/><types:Token xmi:id="11958" sofa="11" begin="41" end="42" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="11965" sofa="11" begin="42" end="43" text="-" pos=":" ner="O"/><types:Token xmi:id="11972" sofa="11" begin="43" end="52" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="11979" sofa="11" begin="53" end="61" text="activity" pos="NN" ner="O"/><types:Token xmi:id="11986" sofa="11" begin="62" end="68" text="almost" pos="RB" ner="O"/><types:Token xmi:id="11993" sofa="11" begin="69" end="71" text="to" pos="TO" ner="O"/><types:Token xmi:id="12000" sofa="11" begin="72" end="81" text="disappear" pos="VB" ner="O"/><types:Token xmi:id="12007" sofa="11" begin="81" end="82" text="?" pos="." ner="O"/><types:Token xmi:id="12073" sofa="11" begin="0" end="0" text="causes" pos="VBZ" ner="O"/><types:Token xmi:id="12080" sofa="11" begin="0" end="0" text="What" pos="WDT" ner="O"/><types:Token xmi:id="12097" sofa="11" begin="0" end="0" text="causes" pos="VBZ" ner="O"/><types:Token xmi:id="12104" sofa="11" begin="0" end="0" text="mutation" pos="NN" ner="O"/><types:Token xmi:id="12121" sofa="11" begin="0" end="0" text="protein" pos="NN" ner="O"/><types:Token xmi:id="12128" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="12145" sofa="11" begin="0" end="0" text="protein" pos="NN" ner="O"/><types:Token xmi:id="12152" sofa="11" begin="0" end="0" text="PS1" pos="NN" ner="O"/><types:Token xmi:id="12169" sofa="11" begin="0" end="0" text="mutation" pos="NN" ner="O"/><types:Token xmi:id="12176" sofa="11" begin="0" end="0" text="protein" pos="NN" ner="O"/><types:Token xmi:id="12193" sofa="11" begin="0" end="0" text="causes" pos="VBZ" ner="O"/><types:Token xmi:id="12200" sofa="11" begin="0" end="0" text="Œ" pos="NNP" ner="O"/><types:Token xmi:id="12217" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="12224" sofa="11" begin="0" end="0" text="≥" pos="SYM" ner="O"/><types:Token xmi:id="12241" sofa="11" begin="0" end="0" text="Œ" pos="NNP" ner="O"/><types:Token xmi:id="12248" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="12265" sofa="11" begin="0" end="0" text="disappear" pos="VB" ner="O"/><types:Token xmi:id="12272" sofa="11" begin="0" end="0" text="activity" pos="NN" ner="O"/><types:Token xmi:id="12289" sofa="11" begin="0" end="0" text="activity" pos="NN" ner="O"/><types:Token xmi:id="12296" sofa="11" begin="0" end="0" text="almost" pos="RB" ner="O"/><types:Token xmi:id="12313" sofa="11" begin="0" end="0" text="disappear" pos="VB" ner="O"/><types:Token xmi:id="12320" sofa="11" begin="0" end="0" text="to" pos="TO" ner="O"/><types:Token xmi:id="12337" sofa="11" begin="0" end="0" text="secretase" pos="NN" ner="O"/><types:Token xmi:id="12344" sofa="11" begin="0" end="0" text="disappear" pos="VB" ner="O"/><types:Token xmi:id="12362" sofa="11" begin="0" end="3" text="How" pos="WRB" ner="O"/><types:Token xmi:id="12369" sofa="11" begin="4" end="8" text="many" pos="JJ" ner="O"/><types:Token xmi:id="12376" sofa="11" begin="9" end="18" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="12383" sofa="11" begin="19" end="27" text="relevant" pos="JJ" ner="O"/><types:Token xmi:id="12390" sofa="11" begin="28" end="31" text="for" pos="IN" ner="O"/><types:Token xmi:id="12397" sofa="11" begin="32" end="40" text="familial" pos="JJ" ner="O"/><types:Token xmi:id="12404" sofa="11" begin="41" end="46" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="12411" sofa="11" begin="47" end="49" text="of" pos="IN" ner="O"/><types:Token xmi:id="12418" sofa="11" begin="50" end="59" text="Alzheimer" pos="NN" ner="O"/><types:Token xmi:id="12425" sofa="11" begin="59" end="61" text="'s" pos="POS" ner="O"/><types:Token xmi:id="12432" sofa="11" begin="62" end="69" text="disease" pos="NN" ner="O"/><types:Token xmi:id="12439" sofa="11" begin="70" end="74" text="have" pos="VBP" ner="O"/><types:Token xmi:id="12446" sofa="11" begin="75" end="79" text="been" pos="VBN" ner="O"/><types:Token xmi:id="12453" sofa="11" begin="80" end="88" text="detected" pos="VBN" ner="O"/><types:Token xmi:id="12460" sofa="11" begin="89" end="92" text="for" pos="IN" ner="O"/><types:Token xmi:id="12467" sofa="11" begin="93" end="96" text="the" pos="DT" ner="O"/><types:Token xmi:id="12474" sofa="11" begin="97" end="102" text="PSEN1" pos="NN" ner="O"/><types:Token xmi:id="12481" sofa="11" begin="103" end="107" text="gene" pos="NN" ner="O"/><types:Token xmi:id="12488" sofa="11" begin="107" end="108" text="?" pos="." ner="O"/><types:Token xmi:id="12563" sofa="11" begin="0" end="0" text="many" pos="JJ" ner="O"/><types:Token xmi:id="12570" sofa="11" begin="0" end="0" text="How" pos="WRB" ner="O"/><types:Token xmi:id="12587" sofa="11" begin="0" end="0" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="12594" sofa="11" begin="0" end="0" text="many" pos="JJ" ner="O"/><types:Token xmi:id="12611" sofa="11" begin="0" end="0" text="detected" pos="VBN" ner="O"/><types:Token xmi:id="12618" sofa="11" begin="0" end="0" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="12635" sofa="11" begin="0" end="0" text="mutations" pos="NNS" ner="O"/><types:Token xmi:id="12642" sofa="11" begin="0" end="0" text="relevant" pos="JJ" ner="O"/><types:Token xmi:id="12659" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="12666" sofa="11" begin="0" end="0" text="familial" pos="JJ" ner="O"/><types:Token xmi:id="12683" sofa="11" begin="0" end="0" text="relevant" pos="JJ" ner="O"/><types:Token xmi:id="12690" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="12707" sofa="11" begin="0" end="0" text="disease" pos="NN" ner="O"/><types:Token xmi:id="12714" sofa="11" begin="0" end="0" text="Alzheimer" pos="NN" ner="O"/><types:Token xmi:id="12731" sofa="11" begin="0" end="0" text="forms" pos="NNS" ner="O"/><types:Token xmi:id="12738" sofa="11" begin="0" end="0" text="disease" pos="NN" ner="O"/><types:Token xmi:id="12755" sofa="11" begin="0" end="0" text="detected" pos="VBN" ner="O"/><types:Token xmi:id="12762" sofa="11" begin="0" end="0" text="have" pos="VBP" ner="O"/><types:Token xmi:id="12779" sofa="11" begin="0" end="0" text="detected" pos="VBN" ner="O"/><types:Token xmi:id="12786" sofa="11" begin="0" end="0" text="been" pos="VBN" ner="O"/><types:Token xmi:id="12803" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="12810" sofa="11" begin="0" end="0" text="the" pos="DT" ner="O"/><types:Token xmi:id="12827" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Token xmi:id="12834" sofa="11" begin="0" end="0" text="PSEN1" pos="NN" ner="O"/><types:Token xmi:id="12851" sofa="11" begin="0" end="0" text="detected" pos="VBN" ner="O"/><types:Token xmi:id="12858" sofa="11" begin="0" end="0" text="gene" pos="NN" ner="O"/><types:Answer xmi:id="18" sofa="11" begin="0" end="20" text="APP-CTF accumulation" id="0" isCorrect="true" isSelected="false" nounPhraseList="13418" nerList="14087" tokenList="7732 7739"/><types:Answer xmi:id="33" sofa="11" begin="0" end="15" text="PSEN1 mutations" id="1" isCorrect="false" isSelected="false" nounPhraseList="13429" nerList="14100" tokenList="7753 7760"/><types:Answer xmi:id="48" sofa="11" begin="0" end="15" text="cell-based data" id="2" isCorrect="false" isSelected="false" nounPhraseList="13440" nerList="" tokenList="7774 7781"/><types:Answer xmi:id="63" sofa="11" begin="0" end="13" text="APH1 variants" id="3" isCorrect="false" isSelected="false" nounPhraseList="13451" nerList="14114" tokenList="7795 7802"/><types:Answer xmi:id="78" sofa="11" begin="0" end="25" text="transition-state analogue" id="4" isCorrect="false" isSelected="false" nounPhraseList="13462" nerList="" tokenList="7816 7823"/><types:Answer xmi:id="126" sofa="11" begin="0" end="17" text="They are purified" id="0" isCorrect="false" isSelected="false" nounPhraseList="" nerList="" tokenList="7837 7844 7851"/><types:Answer xmi:id="141" sofa="11" begin="0" end="17" text="They are anterior" id="1" isCorrect="false" isSelected="false" nounPhraseList="13474" nerList="" tokenList="7868 7875 7882"/><types:Answer xmi:id="156" sofa="11" begin="0" end="16" text="They are shorter" id="2" isCorrect="false" isSelected="false" nounPhraseList="13485" nerList="" tokenList="7899 7906 7913"/><types:Answer xmi:id="171" sofa="11" begin="0" end="15" text="They are longer" id="3" isCorrect="true" isSelected="false" nounPhraseList="" nerList="" tokenList="7930 7937 7944"/><types:Answer xmi:id="186" sofa="11" begin="0" end="18" text="They are supported" id="4" isCorrect="false" isSelected="false" nounPhraseList="" nerList="" tokenList="7961 7968 7975"/><types:Answer xmi:id="234" sofa="11" begin="0" end="3" text="FAD" id="0" isCorrect="false" isSelected="false" nounPhraseList="13498" nerList="" tokenList="7992"/><types:Answer xmi:id="249" sofa="11" begin="0" end="7" text="I-CLiPs" id="1" isCorrect="false" isSelected="false" nounPhraseList="13509" nerList="" tokenList="8003"/><types:Answer xmi:id="264" sofa="11" begin="0" end="3" text="NCT" id="2" isCorrect="false" isSelected="false" nounPhraseList="13520" nerList="" tokenList="8014"/><types:Answer xmi:id="279" sofa="11" begin="0" end="5" text="PSEN1" id="3" isCorrect="true" isSelected="false" nounPhraseList="13531" nerList="" tokenList="8025"/><types:Answer xmi:id="294" sofa="11" begin="0" end="5" text="D257A" id="4" isCorrect="false" isSelected="false" nounPhraseList="13542" nerList="" tokenList="8036"/><types:Answer xmi:id="342" sofa="11" begin="0" end="8" text="plasmids" id="0" isCorrect="false" isSelected="false" nounPhraseList="13553" nerList="" tokenList="8047"/><types:Answer xmi:id="357" sofa="11" begin="0" end="23" text="affinity chromatography" id="1" isCorrect="true" isSelected="false" nounPhraseList="13564" nerList="" tokenList="8058 8065"/><types:Answer xmi:id="372" sofa="11" begin="0" end="6" text="lysate" id="2" isCorrect="false" isSelected="false" nounPhraseList="13575" nerList="" tokenList="8079"/><types:Answer xmi:id="387" sofa="11" begin="0" end="10" text="cell lines" id="3" isCorrect="false" isSelected="false" nounPhraseList="13586" nerList="" tokenList="8090 8097"/><types:Answer xmi:id="402" sofa="11" begin="0" end="20" text="knockout experiments" id="4" isCorrect="false" isSelected="false" nounPhraseList="13597" nerList="" tokenList="8111 8118"/><types:Answer xmi:id="450" sofa="11" begin="0" end="2" text="AD" id="0" isCorrect="false" isSelected="false" nounPhraseList="13608" nerList="" tokenList="8132"/><types:Answer xmi:id="465" sofa="11" begin="0" end="8" text="APP-CTFs" id="1" isCorrect="false" isSelected="false" nounPhraseList="13619" nerList="" tokenList="8143"/><types:Answer xmi:id="480" sofa="11" begin="0" end="11" text="c-secretase" id="2" isCorrect="false" isSelected="false" nounPhraseList="13630" nerList="" tokenList="8154"/><types:Answer xmi:id="495" sofa="11" begin="0" end="11" text="cholesterol" id="3" isCorrect="false" isSelected="false" nounPhraseList="13641" nerList="" tokenList="8165"/><types:Answer xmi:id="510" sofa="11" begin="0" end="4" text="AICD" id="4" isCorrect="true" isSelected="false" nounPhraseList="13652" nerList="" tokenList="8176"/><types:Answer xmi:id="558" sofa="11" begin="0" end="9" text="aspartate" id="0" isCorrect="true" isSelected="false" nounPhraseList="13663" nerList="" tokenList="8187"/><types:Answer xmi:id="573" sofa="11" begin="0" end="10" text="C-terminal" id="1" isCorrect="false" isSelected="false" nounPhraseList="13674" nerList="" tokenList="8198"/><types:Answer xmi:id="588" sofa="11" begin="0" end="10" text="42-residue" id="2" isCorrect="false" isSelected="false" nounPhraseList="13685" nerList="" tokenList="8209"/><types:Answer xmi:id="603" sofa="11" begin="0" end="2" text="99" id="3" isCorrect="false" isSelected="false" nounPhraseList="13696" nerList="" tokenList="8220"/><types:Answer xmi:id="618" sofa="11" begin="0" end="4" text="DDAA" id="4" isCorrect="false" isSelected="false" nounPhraseList="13707" nerList="" tokenList="8231"/><types:Answer xmi:id="666" sofa="11" begin="0" end="12" text="densitometry" id="0" isCorrect="false" isSelected="false" nounPhraseList="13718" nerList="" tokenList="8242"/><types:Answer xmi:id="681" sofa="11" begin="0" end="2" text="EM" id="1" isCorrect="true" isSelected="false" nounPhraseList="13729" nerList="" tokenList="8253"/><types:Answer xmi:id="696" sofa="11" begin="0" end="5" text="ELISA" id="2" isCorrect="false" isSelected="false" nounPhraseList="13740" nerList="" tokenList="8264"/><types:Answer xmi:id="711" sofa="11" begin="0" end="14" text="immunostaining" id="3" isCorrect="false" isSelected="false" nounPhraseList="13751" nerList="" tokenList="8275"/><types:Answer xmi:id="726" sofa="11" begin="0" end="12" text="purification" id="4" isCorrect="false" isSelected="false" nounPhraseList="13762" nerList="" tokenList="8286"/><types:Answer xmi:id="774" sofa="11" begin="0" end="4" text="LRP1" id="0" isCorrect="false" isSelected="false" nounPhraseList="13773" nerList="" tokenList="8297"/><types:Answer xmi:id="789" sofa="11" begin="0" end="11" text="biochemical" id="1" isCorrect="false" isSelected="false" nounPhraseList="13784" nerList="" tokenList="8308"/><types:Answer xmi:id="804" sofa="11" begin="0" end="5" text="PSEN1" id="2" isCorrect="false" isSelected="false" nounPhraseList="13795" nerList="" tokenList="8319"/><types:Answer xmi:id="819" sofa="11" begin="0" end="2" text="AD" id="3" isCorrect="false" isSelected="false" nounPhraseList="13806" nerList="" tokenList="8330"/><types:Answer xmi:id="834" sofa="11" begin="0" end="12" text="Semagacestat" id="4" isCorrect="true" isSelected="false" nounPhraseList="13817" nerList="" tokenList="8341"/><types:Answer xmi:id="882" sofa="11" begin="0" end="5" text="P436Q" id="0" isCorrect="true" isSelected="false" nounPhraseList="13828" nerList="" tokenList="8352"/><types:Answer xmi:id="897" sofa="11" begin="0" end="5" text="L166P" id="1" isCorrect="false" isSelected="false" nounPhraseList="13839" nerList="" tokenList="8363"/><types:Answer xmi:id="912" sofa="11" begin="0" end="9" text="wild-type" id="2" isCorrect="false" isSelected="false" nounPhraseList="13850" nerList="" tokenList="8374"/><types:Answer xmi:id="927" sofa="11" begin="0" end="4" text="AICD" id="3" isCorrect="false" isSelected="false" nounPhraseList="13861" nerList="" tokenList="8385"/><types:Answer xmi:id="942" sofa="11" begin="0" end="8" text="C100-His" id="4" isCorrect="false" isSelected="false" nounPhraseList="13872" nerList="14167" tokenList="8396"/><types:Answer xmi:id="990" sofa="11" begin="0" end="2" text="13" id="0" isCorrect="false" isSelected="false" nounPhraseList="13883" nerList="" tokenList="8407"/><types:Answer xmi:id="1005" sofa="11" begin="0" end="2" text="42" id="1" isCorrect="false" isSelected="false" nounPhraseList="13894" nerList="" tokenList="8418"/><types:Answer xmi:id="1020" sofa="11" begin="0" end="5" text="P436Q" id="2" isCorrect="false" isSelected="false" nounPhraseList="13905" nerList="" tokenList="8429"/><types:Answer xmi:id="1035" sofa="11" begin="0" end="3" text="185" id="3" isCorrect="true" isSelected="false" nounPhraseList="13916" nerList="" tokenList="8440"/><types:Answer xmi:id="1050" sofa="11" begin="0" end="5" text="PSEN2" id="4" isCorrect="false" isSelected="false" nounPhraseList="13927" nerList="" tokenList="8451"/><types:Dependency xmi:id="8616" sofa="11" begin="0" end="0" governor="8623" dependent="8630" relation="det"/><types:Dependency xmi:id="8640" sofa="11" begin="0" end="0" governor="8647" dependent="8654" relation="nsubjpass"/><types:Dependency xmi:id="8664" sofa="11" begin="0" end="0" governor="8671" dependent="8678" relation="aux"/><types:Dependency xmi:id="8688" sofa="11" begin="0" end="0" governor="8695" dependent="8702" relation="auxpass"/><types:Dependency xmi:id="8712" sofa="11" begin="0" end="0" governor="8719" dependent="8726" relation="dobj"/><types:Dependency xmi:id="8736" sofa="11" begin="0" end="0" governor="8743" dependent="8750" relation="advmod"/><types:Dependency xmi:id="8760" sofa="11" begin="0" end="0" governor="8767" dependent="8774" relation="dep"/><types:Dependency xmi:id="8784" sofa="11" begin="0" end="0" governor="8791" dependent="8798" relation="dep"/><types:Dependency xmi:id="8808" sofa="11" begin="0" end="0" governor="8815" dependent="8822" relation="advcl"/><types:Dependency xmi:id="8832" sofa="11" begin="0" end="0" governor="8839" dependent="8846" relation="auxpass"/><types:Dependency xmi:id="8856" sofa="11" begin="0" end="0" governor="8863" dependent="8870" relation="rcmod"/><types:Dependency xmi:id="9042" sofa="11" begin="0" end="0" governor="9049" dependent="9056" relation="advmod"/><types:Dependency xmi:id="9066" sofa="11" begin="0" end="0" governor="9073" dependent="9080" relation="nn"/><types:Dependency xmi:id="9090" sofa="11" begin="0" end="0" governor="9097" dependent="9104" relation="nsubjpass"/><types:Dependency xmi:id="9114" sofa="11" begin="0" end="0" governor="9121" dependent="9128" relation="auxpass"/><types:Dependency xmi:id="9138" sofa="11" begin="0" end="0" governor="9145" dependent="9152" relation="nn"/><types:Dependency xmi:id="9162" sofa="11" begin="0" end="0" governor="9169" dependent="9176" relation="prep_in"/><types:Dependency xmi:id="9186" sofa="11" begin="0" end="0" governor="9193" dependent="9200" relation="nsubj"/><types:Dependency xmi:id="9210" sofa="11" begin="0" end="0" governor="9217" dependent="9224" relation="rcmod"/><types:Dependency xmi:id="9234" sofa="11" begin="0" end="0" governor="9241" dependent="9248" relation="det"/><types:Dependency xmi:id="9258" sofa="11" begin="0" end="0" governor="9265" dependent="9272" relation="nn"/><types:Dependency xmi:id="9282" sofa="11" begin="0" end="0" governor="9289" dependent="9296" relation="prep_with"/><types:Dependency xmi:id="9498" sofa="11" begin="0" end="0" governor="9505" dependent="9512" relation="det"/><types:Dependency xmi:id="9522" sofa="11" begin="0" end="0" governor="9529" dependent="9536" relation="prep_in"/><types:Dependency xmi:id="9546" sofa="11" begin="0" end="0" governor="9553" dependent="9560" relation="auxpass"/><types:Dependency xmi:id="9570" sofa="11" begin="0" end="0" governor="9577" dependent="9584" relation="nsubjpass"/><types:Dependency xmi:id="9594" sofa="11" begin="0" end="0" governor="9601" dependent="9608" relation="amod"/><types:Dependency xmi:id="9618" sofa="11" begin="0" end="0" governor="9625" dependent="9632" relation="prep_to"/><types:Dependency xmi:id="9642" sofa="11" begin="0" end="0" governor="9649" dependent="9656" relation="amod"/><types:Dependency xmi:id="9666" sofa="11" begin="0" end="0" governor="9673" dependent="9680" relation="amod"/><types:Dependency xmi:id="9690" sofa="11" begin="0" end="0" governor="9697" dependent="9704" relation="prep_of"/><types:Dependency xmi:id="9714" sofa="11" begin="0" end="0" governor="9721" dependent="9728" relation="poss"/><types:Dependency xmi:id="9738" sofa="11" begin="0" end="0" governor="9745" dependent="9752" relation="prep_of"/><types:Dependency xmi:id="9946" sofa="11" begin="0" end="0" governor="9953" dependent="9960" relation="det"/><types:Dependency xmi:id="9970" sofa="11" begin="0" end="0" governor="9977" dependent="9984" relation="amod"/><types:Dependency xmi:id="9994" sofa="11" begin="0" end="0" governor="10001" dependent="10008" relation="nsubjpass"/><types:Dependency xmi:id="10018" sofa="11" begin="0" end="0" governor="10025" dependent="10032" relation="auxpass"/><types:Dependency xmi:id="10042" sofa="11" begin="0" end="0" governor="10049" dependent="10056" relation="advmod"/><types:Dependency xmi:id="10066" sofa="11" begin="0" end="0" governor="10073" dependent="10080" relation="aux"/><types:Dependency xmi:id="10090" sofa="11" begin="0" end="0" governor="10097" dependent="10104" relation="xcomp"/><types:Dependency xmi:id="10114" sofa="11" begin="0" end="0" governor="10121" dependent="10128" relation="det"/><types:Dependency xmi:id="10138" sofa="11" begin="0" end="0" governor="10145" dependent="10152" relation="dobj"/><types:Dependency xmi:id="10162" sofa="11" begin="0" end="0" governor="10169" dependent="10176" relation="dep"/><types:Dependency xmi:id="10186" sofa="11" begin="0" end="0" governor="10193" dependent="10200" relation="nn"/><types:Dependency xmi:id="10210" sofa="11" begin="0" end="0" governor="10217" dependent="10224" relation="dep"/><types:Dependency xmi:id="10376" sofa="11" begin="0" end="0" governor="10383" dependent="10390" relation="det"/><types:Dependency xmi:id="10400" sofa="11" begin="0" end="0" governor="10407" dependent="10414" relation="attr"/><types:Dependency xmi:id="10424" sofa="11" begin="0" end="0" governor="10431" dependent="10438" relation="cop"/><types:Dependency xmi:id="10448" sofa="11" begin="0" end="0" governor="10455" dependent="10462" relation="aux"/><types:Dependency xmi:id="10472" sofa="11" begin="0" end="0" governor="10479" dependent="10486" relation="xcomp"/><types:Dependency xmi:id="10496" sofa="11" begin="0" end="0" governor="10503" dependent="10510" relation="det"/><types:Dependency xmi:id="10520" sofa="11" begin="0" end="0" governor="10527" dependent="10534" relation="dobj"/><types:Dependency xmi:id="10544" sofa="11" begin="0" end="0" governor="10551" dependent="10558" relation="det"/><types:Dependency xmi:id="10568" sofa="11" begin="0" end="0" governor="10575" dependent="10582" relation="nn"/><types:Dependency xmi:id="10592" sofa="11" begin="0" end="0" governor="10599" dependent="10606" relation="prep_of"/><types:Dependency xmi:id="10758" sofa="11" begin="0" end="0" governor="10765" dependent="10772" relation="det"/><types:Dependency xmi:id="10782" sofa="11" begin="0" end="0" governor="10789" dependent="10796" relation="nn"/><types:Dependency xmi:id="10806" sofa="11" begin="0" end="0" governor="10813" dependent="10820" relation="attr"/><types:Dependency xmi:id="10830" sofa="11" begin="0" end="0" governor="10837" dependent="10844" relation="cop"/><types:Dependency xmi:id="10854" sofa="11" begin="0" end="0" governor="10861" dependent="10868" relation="det"/><types:Dependency xmi:id="10878" sofa="11" begin="0" end="0" governor="10885" dependent="10892" relation="prep_for"/><types:Dependency xmi:id="10902" sofa="11" begin="0" end="0" governor="10909" dependent="10916" relation="det"/><types:Dependency xmi:id="10926" sofa="11" begin="0" end="0" governor="10933" dependent="10940" relation="nn"/><types:Dependency xmi:id="10950" sofa="11" begin="0" end="0" governor="10957" dependent="10964" relation="prep_of"/><types:Dependency xmi:id="11136" sofa="11" begin="0" end="0" governor="11143" dependent="11150" relation="det"/><types:Dependency xmi:id="11160" sofa="11" begin="0" end="0" governor="11167" dependent="11174" relation="amod"/><types:Dependency xmi:id="11184" sofa="11" begin="0" end="0" governor="11191" dependent="11198" relation="nsubjpass"/><types:Dependency xmi:id="11208" sofa="11" begin="0" end="0" governor="11215" dependent="11222" relation="auxpass"/><types:Dependency xmi:id="11232" sofa="11" begin="0" end="0" governor="11239" dependent="11246" relation="aux"/><types:Dependency xmi:id="11256" sofa="11" begin="0" end="0" governor="11263" dependent="11270" relation="xcomp"/><types:Dependency xmi:id="11280" sofa="11" begin="0" end="0" governor="11287" dependent="11294" relation="det"/><types:Dependency xmi:id="11304" sofa="11" begin="0" end="0" governor="11311" dependent="11318" relation="dobj"/><types:Dependency xmi:id="11328" sofa="11" begin="0" end="0" governor="11335" dependent="11342" relation="prep_of"/><types:Dependency xmi:id="11352" sofa="11" begin="0" end="0" governor="11359" dependent="11366" relation="dep"/><types:Dependency xmi:id="11376" sofa="11" begin="0" end="0" governor="11383" dependent="11390" relation="dep"/><types:Dependency xmi:id="11582" sofa="11" begin="0" end="0" governor="11589" dependent="11596" relation="det"/><types:Dependency xmi:id="11606" sofa="11" begin="0" end="0" governor="11613" dependent="11620" relation="nn"/><types:Dependency xmi:id="11630" sofa="11" begin="0" end="0" governor="11637" dependent="11644" relation="nsubjpass"/><types:Dependency xmi:id="11654" sofa="11" begin="0" end="0" governor="11661" dependent="11668" relation="nsubj"/><types:Dependency xmi:id="11678" sofa="11" begin="0" end="0" governor="11685" dependent="11692" relation="rcmod"/><types:Dependency xmi:id="11702" sofa="11" begin="0" end="0" governor="11709" dependent="11716" relation="det"/><types:Dependency xmi:id="11726" sofa="11" begin="0" end="0" governor="11733" dependent="11740" relation="dobj"/><types:Dependency xmi:id="11750" sofa="11" begin="0" end="0" governor="11757" dependent="11764" relation="dep"/><types:Dependency xmi:id="11774" sofa="11" begin="0" end="0" governor="11781" dependent="11788" relation="dep"/><types:Dependency xmi:id="11798" sofa="11" begin="0" end="0" governor="11805" dependent="11812" relation="auxpass"/><types:Dependency xmi:id="11822" sofa="11" begin="0" end="0" governor="11829" dependent="11836" relation="advmod"/><types:Dependency xmi:id="11846" sofa="11" begin="0" end="0" governor="11853" dependent="11860" relation="amod"/><types:Dependency xmi:id="11870" sofa="11" begin="0" end="0" governor="11877" dependent="11884" relation="prep_in"/><types:Dependency xmi:id="12066" sofa="11" begin="0" end="0" governor="12073" dependent="12080" relation="dobj"/><types:Dependency xmi:id="12090" sofa="11" begin="0" end="0" governor="12097" dependent="12104" relation="nsubj"/><types:Dependency xmi:id="12114" sofa="11" begin="0" end="0" governor="12121" dependent="12128" relation="det"/><types:Dependency xmi:id="12138" sofa="11" begin="0" end="0" governor="12145" dependent="12152" relation="nn"/><types:Dependency xmi:id="12162" sofa="11" begin="0" end="0" governor="12169" dependent="12176" relation="prep_of"/><types:Dependency xmi:id="12186" sofa="11" begin="0" end="0" governor="12193" dependent="12200" relation="dobj"/><types:Dependency xmi:id="12210" sofa="11" begin="0" end="0" governor="12217" dependent="12224" relation="dep"/><types:Dependency xmi:id="12234" sofa="11" begin="0" end="0" governor="12241" dependent="12248" relation="dep"/><types:Dependency xmi:id="12258" sofa="11" begin="0" end="0" governor="12265" dependent="12272" relation="nsubj"/><types:Dependency xmi:id="12282" sofa="11" begin="0" end="0" governor="12289" dependent="12296" relation="advmod"/><types:Dependency xmi:id="12306" sofa="11" begin="0" end="0" governor="12313" dependent="12320" relation="aux"/><types:Dependency xmi:id="12330" sofa="11" begin="0" end="0" governor="12337" dependent="12344" relation="infmod"/><types:Dependency xmi:id="12556" sofa="11" begin="0" end="0" governor="12563" dependent="12570" relation="advmod"/><types:Dependency xmi:id="12580" sofa="11" begin="0" end="0" governor="12587" dependent="12594" relation="amod"/><types:Dependency xmi:id="12604" sofa="11" begin="0" end="0" governor="12611" dependent="12618" relation="nsubjpass"/><types:Dependency xmi:id="12628" sofa="11" begin="0" end="0" governor="12635" dependent="12642" relation="amod"/><types:Dependency xmi:id="12652" sofa="11" begin="0" end="0" governor="12659" dependent="12666" relation="amod"/><types:Dependency xmi:id="12676" sofa="11" begin="0" end="0" governor="12683" dependent="12690" relation="prep_for"/><types:Dependency xmi:id="12700" sofa="11" begin="0" end="0" governor="12707" dependent="12714" relation="poss"/><types:Dependency xmi:id="12724" sofa="11" begin="0" end="0" governor="12731" dependent="12738" relation="prep_of"/><types:Dependency xmi:id="12748" sofa="11" begin="0" end="0" governor="12755" dependent="12762" relation="aux"/><types:Dependency xmi:id="12772" sofa="11" begin="0" end="0" governor="12779" dependent="12786" relation="auxpass"/><types:Dependency xmi:id="12796" sofa="11" begin="0" end="0" governor="12803" dependent="12810" relation="det"/><types:Dependency xmi:id="12820" sofa="11" begin="0" end="0" governor="12827" dependent="12834" relation="nn"/><types:Dependency xmi:id="12844" sofa="11" begin="0" end="0" governor="12851" dependent="12858" relation="prep_for"/><types:Question xmi:id="8462" sofa="11" begin="0" end="62" id="0" text="What effect can be observed when when Œ≥-secretase is blocked? " dependencies="8616 8640 8664 8688 8712 8736 8760 8784 8808 8832 8856" nerList="13969" nounList="13058 13065 13072" tokenList="8472 8479 8486 8493 8500 8507 8514 8521 8528 8535 8542 8549 8556 8563"/><types:Question xmi:id="8878" sofa="11" begin="0" end="70" id="1" text="When APH1 genes are overexpressed in MEF KO what happens with the AŒ≤?" dependencies="9042 9066 9090 9114 9138 9162 9186 9210 9234 9258 9282" nerList="13982" nounList="13089 13096 13103" tokenList="8888 8895 8902 8909 8916 8923 8930 8937 8944 8951 8958 8965 8972 8979 8986"/><types:Question xmi:id="9304" sofa="11" begin="0" end="106" id="2" text="In which gene are mutations associated to many cases of early-onset familial forms of Alzheimer's disease?G" dependencies="9498 9522 9546 9570 9594 9618 9642 9666 9690 9714 9738" tokenList="9314 9321 9328 9335 9342 9349 9356 9363 9370 9377 9384 9391 9398 9405 9412 9419 9426 9433"/><types:Question xmi:id="9760" sofa="11" begin="106" end="107" id="3" text="In which gene are mutations associated to many cases of early-onset familial forms of Alzheimer's disease?G" dependencies="" nerList="" nounList="13120" tokenList="9770"/><types:Question xmi:id="9782" sofa="11" begin="0" end="85" id="4" text="What experimental technique was used specifically to purify the Œ≥-secretase complex?" dependencies="9946 9970 9994 10018 10042 10066 10090 10114 10138 10162 10186 10210" nerList="13996" nounList="13131 13138 13145" tokenList="9792 9799 9806 9813 9820 9827 9834 9841 9848 9855 9862 9869 9876 9883 9890"/><types:Question xmi:id="10232" sofa="11" begin="0" end="64" id="5" text="What peptide is able to control the expression of the ApoE gene?" dependencies="10376 10400 10424 10448 10472 10496 10520 10544 10568 10592" nerList="14009" nounList="13162 13169 13176 13183" tokenList="10242 10249 10256 10263 10270 10277 10284 10291 10298 10305 10312 10319 10326"/><types:Question xmi:id="10614" sofa="11" begin="0" end="65" id="6" text="Which amino acid is critical for the activity of the PS1 protein?" dependencies="10758 10782 10806 10830 10854 10878 10902 10926 10950" nerList="14022" nounList="13203 13210 13217 13224" tokenList="10624 10631 10638 10645 10652 10659 10666 10673 10680 10687 10694 10701 10708"/><types:Question xmi:id="10972" sofa="11" begin="0" end="80" id="7" text="What experimental technique was used to determine the structure of Œ≥-secretase?" dependencies="11136 11160 11184 11208 11232 11256 11280 11304 11328 11352 11376" nerList="14035" nounList="13244 13251 13258 13265" tokenList="10982 10989 10996 11003 11010 11017 11024 11031 11038 11045 11052 11059 11066 11073 11080"/><types:Question xmi:id="11398" sofa="11" begin="0" end="82" id="8" text="What candidate drug that blocks the Œ≥-secretase is now tested in clinical trials?" dependencies="11582 11606 11630 11654 11678 11702 11726 11750 11774 11798 11822 11846 11870" nerList="14048" nounList="13285 13292 13299 13306" tokenList="11408 11415 11422 11429 11436 11443 11450 11457 11464 11471 11478 11485 11492 11499 11506 11513 11520"/><types:Question xmi:id="11892" sofa="11" begin="0" end="82" id="9" text="What mutation of the PS1 protein causes Œ≥-secretase activity almost to disappear?" dependencies="12066 12090 12114 12138 12162 12186 12210 12234 12258 12282 12306 12330" nerList="14061" nounList="13326 13333 13340 13347" tokenList="11902 11909 11916 11923 11930 11937 11944 11951 11958 11965 11972 11979 11986 11993 12000 12007"/><types:Question xmi:id="12352" sofa="11" begin="0" end="108" id="10" text="How many mutations relevant for familial forms of Alzheimer's disease have been detected for the PSEN1 gene?" dependencies="12556 12580 12604 12628 12652 12676 12700 12724 12748 12772 12796 12820 12844" nerList="14074" nounList="13367 13374 13381 13388 13395" tokenList="12362 12369 12376 12383 12390 12397 12404 12411 12418 12425 12432 12439 12446 12453 12460 12467 12474 12481 12488"/><types:Synonym xmi:id="14245" sofa="11" begin="0" end="0" text="endogenous peptide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14252" sofa="11" begin="0" end="0" text="exogenous peptide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14259" sofa="11" begin="0" end="0" text="glycylpeptide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14266" sofa="11" begin="0" end="0" text="acetyl-CoA:peptide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14273" sofa="11" begin="0" end="0" text="polypeptide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14317" sofa="11" begin="0" end="0" text="cellular amino acid" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14324" sofa="11" begin="0" end="0" text="amino acid/choline" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14331" sofa="11" begin="0" end="0" text="glycine" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14505" sofa="11" begin="0" end="0" text="secondary" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14512" sofa="11" begin="0" end="0" text="rostral" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14541" sofa="11" begin="0" end="0" text="flavin adenine dinucleotide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14548" sofa="11" begin="0" end="0" text="flavin-adenine dinucleotide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14555" sofa="11" begin="0" end="0" text="oxidized flavin adenine dinucleotide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14562" sofa="11" begin="0" end="0" text="oxidized flavin-adenine dinucleotide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14569" sofa="11" begin="0" end="0" text="oxidized flavine-adenine dinucleotide" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14669" sofa="11" begin="0" end="0" text="sterol" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14676" sofa="11" begin="0" end="0" text="acyl-CoA:cholesterol" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14683" sofa="11" begin="0" end="0" text="acylcoenzyme A:cholesterol" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14711" sofa="11" begin="0" end="0" text="carbamoyl-phosphate:L-aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14718" sofa="11" begin="0" end="0" text="aspartic" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14725" sofa="11" begin="0" end="0" text="glutamyl" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14732" sofa="11" begin="0" end="0" text="L-aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14739" sofa="11" begin="0" end="0" text="acetyl-CoA:L-aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14746" sofa="11" begin="0" end="0" text="NAD-dependent aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14753" sofa="11" begin="0" end="0" text="NADH2-dependent aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14760" sofa="11" begin="0" end="0" text="NADP+-dependent aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14767" sofa="11" begin="0" end="0" text="D-aspartate" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14774" sofa="11" begin="0" end="0" text="aspartic acid" source="gigaword-pubmed" weight="1.0"/><types:Synonym xmi:id="14817" sofa="11" begin="0" end="0" text="protein C-terminus" source="gigaword-pubmed" weight="1.0"/><types:NER xmi:id="14074" sofa="11" begin="0" end="0" text="PSEN1 gene" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14061" sofa="11" begin="0" end="0" text="PS1 protein causes Œ ≥ -secretase" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14048" sofa="11" begin="0" end="0" text="Œ ≥ -secretase" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14035" sofa="11" begin="0" end="0" text="Œ ≥ -secretase" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14022" sofa="11" begin="0" end="0" text="PS1 protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14009" sofa="11" begin="0" end="0" text="ApoE gene" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="13996" sofa="11" begin="0" end="0" text="Œ ≥ -secretase complex" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="13982" sofa="11" begin="0" end="0" text="APH1 genes" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="13969" sofa="11" begin="0" end="0" text="-secretase" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14167" sofa="11" begin="0" end="0" text="C100" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14114" sofa="11" begin="0" end="0" text="APH1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14100" sofa="11" begin="0" end="0" text="PSEN1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types:NER xmi:id="14087" sofa="11" begin="0" end="0" text="APP-CTF" tag="B-PROTEIN" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13937"/><types:NounPhrase xmi:id="13927" sofa="11" begin="0" end="0" text="PSEN2" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13926"/><types:NounPhrase xmi:id="13916" sofa="11" begin="0" end="0" text="185" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13915"/><types:NounPhrase xmi:id="13905" sofa="11" begin="0" end="0" text="P436Q" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13904"/><types:NounPhrase xmi:id="13894" sofa="11" begin="0" end="0" text="42" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13893"/><types:NounPhrase xmi:id="13883" sofa="11" begin="0" end="0" text="13" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13882"/><types:NounPhrase xmi:id="13872" sofa="11" begin="0" end="0" text="C100-His" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13871"/><types:NounPhrase xmi:id="13861" sofa="11" begin="0" end="0" text="AICD" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13860"/><types:NounPhrase xmi:id="13850" sofa="11" begin="0" end="0" text="wild-type" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13849"/><types:NounPhrase xmi:id="13839" sofa="11" begin="0" end="0" text="L166P" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13838"/><types:NounPhrase xmi:id="13828" sofa="11" begin="0" end="0" text="P436Q" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13827"/><types:NounPhrase xmi:id="13817" sofa="11" begin="0" end="0" text="Semagacestat" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13816"/><types:NounPhrase xmi:id="13806" sofa="11" begin="0" end="0" text="AD" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13805"/><types:NounPhrase xmi:id="13795" sofa="11" begin="0" end="0" text="PSEN1" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13794"/><types:NounPhrase xmi:id="13784" sofa="11" begin="0" end="0" text="biochemical" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13783"/><types:NounPhrase xmi:id="13773" sofa="11" begin="0" end="0" text="LRP1" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13772"/><types:NounPhrase xmi:id="13762" sofa="11" begin="0" end="0" text="purification" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13761"/><types:NounPhrase xmi:id="13751" sofa="11" begin="0" end="0" text="immunostaining" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13750"/><types:NounPhrase xmi:id="13740" sofa="11" begin="0" end="0" text="ELISA" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13739"/><types:NounPhrase xmi:id="13729" sofa="11" begin="0" end="0" text="EM" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13728"/><types:NounPhrase xmi:id="13718" sofa="11" begin="0" end="0" text="densitometry" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13717"/><types:NounPhrase xmi:id="13707" sofa="11" begin="0" end="0" text="DDAA" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13706"/><types:NounPhrase xmi:id="13696" sofa="11" begin="0" end="0" text="99" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13695"/><types:NounPhrase xmi:id="13685" sofa="11" begin="0" end="0" text="42-residue" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13684"/><types:NounPhrase xmi:id="13674" sofa="11" begin="0" end="0" text="C-terminal" weight="0.0" synonyms="14817"/><cas:EmptyFSList xmi:id="13673"/><types:NounPhrase xmi:id="13663" sofa="11" begin="0" end="0" text="aspartate" weight="0.0" synonyms="14711 14718 14725 14732 14739 14746 14753 14760 14767 14774"/><cas:EmptyFSList xmi:id="13662"/><types:NounPhrase xmi:id="13652" sofa="11" begin="0" end="0" text="AICD" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13651"/><types:NounPhrase xmi:id="13641" sofa="11" begin="0" end="0" text="cholesterol" weight="0.0" synonyms="14669 14676 14683"/><cas:EmptyFSList xmi:id="13640"/><types:NounPhrase xmi:id="13630" sofa="11" begin="0" end="0" text="c-secretase" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13629"/><types:NounPhrase xmi:id="13619" sofa="11" begin="0" end="0" text="APP-CTFs" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13618"/><types:NounPhrase xmi:id="13608" sofa="11" begin="0" end="0" text="AD" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13607"/><types:NounPhrase xmi:id="13597" sofa="11" begin="0" end="0" text="knockout experiments" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13596"/><types:NounPhrase xmi:id="13586" sofa="11" begin="0" end="0" text="cell lines" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13585"/><types:NounPhrase xmi:id="13575" sofa="11" begin="0" end="0" text="lysate" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13574"/><types:NounPhrase xmi:id="13564" sofa="11" begin="0" end="0" text="affinity chromatography" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13563"/><types:NounPhrase xmi:id="13553" sofa="11" begin="0" end="0" text="plasmids" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13552"/><types:NounPhrase xmi:id="13542" sofa="11" begin="0" end="0" text="D257A" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13541"/><types:NounPhrase xmi:id="13531" sofa="11" begin="0" end="0" text="PSEN1" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13530"/><types:NounPhrase xmi:id="13520" sofa="11" begin="0" end="0" text="NCT" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13519"/><types:NounPhrase xmi:id="13509" sofa="11" begin="0" end="0" text="I-CLiPs" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13508"/><types:NounPhrase xmi:id="13498" sofa="11" begin="0" end="0" text="FAD" weight="0.0" synonyms="14541 14548 14555 14562 14569"/><cas:EmptyFSList xmi:id="13495"/><types:NounPhrase xmi:id="13485" sofa="11" begin="0" end="0" text="shorter" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13484"/><types:NounPhrase xmi:id="13474" sofa="11" begin="0" end="0" text="anterior" weight="0.0" synonyms="14505 14512"/><cas:EmptyFSList xmi:id="13472"/><types:NounPhrase xmi:id="13462" sofa="11" begin="0" end="0" text="transition-state analogue" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13461"/><types:NounPhrase xmi:id="13451" sofa="11" begin="0" end="0" text="APH1 variants" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13450"/><types:NounPhrase xmi:id="13440" sofa="11" begin="0" end="0" text="cell-based data" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13439"/><types:NounPhrase xmi:id="13429" sofa="11" begin="0" end="0" text="PSEN1 mutations" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13428"/><types:NounPhrase xmi:id="13418" sofa="11" begin="0" end="0" text="APP-CTF accumulation" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13417"/><types:NounPhrase xmi:id="13395" sofa="11" begin="0" end="0" text="PSEN1 gene" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13414" head="13395" tail="13417"/><types:NounPhrase xmi:id="13388" sofa="11" begin="0" end="0" text="disease" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13411" head="13388" tail="13414"/><types:NounPhrase xmi:id="13381" sofa="11" begin="0" end="0" text="Alzheimer" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13408" head="13381" tail="13411"/><types:NounPhrase xmi:id="13374" sofa="11" begin="0" end="0" text="familial forms" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13405" head="13374" tail="13408"/><types:NounPhrase xmi:id="13367" sofa="11" begin="0" end="0" text="many mutations relevant" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13366"/><types:NounPhrase xmi:id="13347" sofa="11" begin="0" end="0" text="secretase activity" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13363" head="13347" tail="13366"/><types:NounPhrase xmi:id="13340" sofa="11" begin="0" end="0" text="Œ" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13360" head="13340" tail="13363"/><types:NounPhrase xmi:id="13333" sofa="11" begin="0" end="0" text="PS1 protein" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13357" head="13333" tail="13360"/><types:NounPhrase xmi:id="13326" sofa="11" begin="0" end="0" text="mutation" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13325"/><types:NounPhrase xmi:id="13306" sofa="11" begin="0" end="0" text="clinical trials" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13322" head="13306" tail="13325"/><types:NounPhrase xmi:id="13299" sofa="11" begin="0" end="0" text="secretase" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13319" head="13299" tail="13322"/><types:NounPhrase xmi:id="13292" sofa="11" begin="0" end="0" text="Œ" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13316" head="13292" tail="13319"/><types:NounPhrase xmi:id="13285" sofa="11" begin="0" end="0" text="candidate drug" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13284"/><types:NounPhrase xmi:id="13265" sofa="11" begin="0" end="0" text="secretase" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13281" head="13265" tail="13284"/><types:NounPhrase xmi:id="13258" sofa="11" begin="0" end="0" text="Œ" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13278" head="13258" tail="13281"/><types:NounPhrase xmi:id="13251" sofa="11" begin="0" end="0" text="structure" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13275" head="13251" tail="13278"/><types:NounPhrase xmi:id="13244" sofa="11" begin="0" end="0" text="experimental technique" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13243"/><types:NounPhrase xmi:id="13224" sofa="11" begin="0" end="0" text="PS1 protein" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13240" head="13224" tail="13243"/><types:NounPhrase xmi:id="13217" sofa="11" begin="0" end="0" text="activity" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13237" head="13217" tail="13240"/><types:NounPhrase xmi:id="13210" sofa="11" begin="0" end="0" text="critical" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13234" head="13210" tail="13237"/><types:NounPhrase xmi:id="13203" sofa="11" begin="0" end="0" text="amino acid" weight="0.0" synonyms="14317 14324 14331"/><cas:EmptyFSList xmi:id="13202"/><types:NounPhrase xmi:id="13183" sofa="11" begin="0" end="0" text="ApoE gene" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13199" head="13183" tail="13202"/><types:NounPhrase xmi:id="13176" sofa="11" begin="0" end="0" text="expression" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13196" head="13176" tail="13199"/><types:NounPhrase xmi:id="13169" sofa="11" begin="0" end="0" text="able" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13193" head="13169" tail="13196"/><types:NounPhrase xmi:id="13162" sofa="11" begin="0" end="0" text="peptide" weight="0.0" synonyms="14245 14252 14259 14266 14273"/><cas:EmptyFSList xmi:id="13161"/><types:NounPhrase xmi:id="13145" sofa="11" begin="0" end="0" text="secretase complex" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13158" head="13145" tail="13161"/><types:NounPhrase xmi:id="13138" sofa="11" begin="0" end="0" text="Œ" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13155" head="13138" tail="13158"/><types:NounPhrase xmi:id="13131" sofa="11" begin="0" end="0" text="experimental technique" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13130"/><types:NounPhrase xmi:id="13120" sofa="11" begin="0" end="0" text="G" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13119"/><types:NounPhrase xmi:id="13103" sofa="11" begin="0" end="0" text="AŒ ≤" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13116" head="13103" tail="13119"/><types:NounPhrase xmi:id="13096" sofa="11" begin="0" end="0" text="MEF KO" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13113" head="13096" tail="13116"/><types:NounPhrase xmi:id="13089" sofa="11" begin="0" end="0" text="APH1 genes" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="13088"/><types:NounPhrase xmi:id="13072" sofa="11" begin="0" end="0" text="secretase" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13085" head="13072" tail="13088"/><types:NounPhrase xmi:id="13065" sofa="11" begin="0" end="0" text="Œ" weight="0.0" synonyms=""/><cas:NonEmptyFSList xmi:id="13082" head="13065" tail="13085"/><types:NounPhrase xmi:id="13058" sofa="11" begin="0" end="0" text="effect" weight="0.0" synonyms=""/><cas:EmptyFSList xmi:id="12865"/><cas:NonEmptyFSList xmi:id="12841" head="12844" tail="12865"/><cas:NonEmptyFSList xmi:id="12817" head="12820" tail="12841"/><cas:NonEmptyFSList xmi:id="12793" head="12796" tail="12817"/><cas:NonEmptyFSList xmi:id="12769" head="12772" tail="12793"/><cas:NonEmptyFSList xmi:id="12745" head="12748" tail="12769"/><cas:NonEmptyFSList xmi:id="12721" head="12724" tail="12745"/><cas:NonEmptyFSList xmi:id="12697" head="12700" tail="12721"/><cas:NonEmptyFSList xmi:id="12673" head="12676" tail="12697"/><cas:NonEmptyFSList xmi:id="12649" head="12652" tail="12673"/><cas:NonEmptyFSList xmi:id="12625" head="12628" tail="12649"/><cas:NonEmptyFSList xmi:id="12601" head="12604" tail="12625"/><cas:NonEmptyFSList xmi:id="12577" head="12580" tail="12601"/><cas:EmptyFSList xmi:id="12552"/><cas:NonEmptyFSList xmi:id="12549" head="12488" tail="12552"/><cas:NonEmptyFSList xmi:id="12546" head="12481" tail="12549"/><cas:NonEmptyFSList xmi:id="12543" head="12474" tail="12546"/><cas:NonEmptyFSList xmi:id="12540" head="12467" tail="12543"/><cas:NonEmptyFSList xmi:id="12537" head="12460" tail="12540"/><cas:NonEmptyFSList xmi:id="12534" head="12453" tail="12537"/><cas:NonEmptyFSList xmi:id="12531" head="12446" tail="12534"/><cas:NonEmptyFSList xmi:id="12528" head="12439" tail="12531"/><cas:NonEmptyFSList xmi:id="12525" head="12432" tail="12528"/><cas:NonEmptyFSList xmi:id="12522" head="12425" tail="12525"/><cas:NonEmptyFSList xmi:id="12519" head="12418" tail="12522"/><cas:NonEmptyFSList xmi:id="12516" head="12411" tail="12519"/><cas:NonEmptyFSList xmi:id="12513" head="12404" tail="12516"/><cas:NonEmptyFSList xmi:id="12510" head="12397" tail="12513"/><cas:NonEmptyFSList xmi:id="12507" head="12390" tail="12510"/><cas:NonEmptyFSList xmi:id="12504" head="12383" tail="12507"/><cas:NonEmptyFSList xmi:id="12501" head="12376" tail="12504"/><cas:NonEmptyFSList xmi:id="12498" head="12369" tail="12501"/><cas:EmptyFSList xmi:id="12351"/><cas:NonEmptyFSList xmi:id="12327" head="12330" tail="12351"/><cas:NonEmptyFSList xmi:id="12303" head="12306" tail="12327"/><cas:NonEmptyFSList xmi:id="12279" head="12282" tail="12303"/><cas:NonEmptyFSList xmi:id="12255" head="12258" tail="12279"/><cas:NonEmptyFSList xmi:id="12231" head="12234" tail="12255"/><cas:NonEmptyFSList xmi:id="12207" head="12210" tail="12231"/><cas:NonEmptyFSList xmi:id="12183" head="12186" tail="12207"/><cas:NonEmptyFSList xmi:id="12159" head="12162" tail="12183"/><cas:NonEmptyFSList xmi:id="12135" head="12138" tail="12159"/><cas:NonEmptyFSList xmi:id="12111" head="12114" tail="12135"/><cas:NonEmptyFSList xmi:id="12087" head="12090" tail="12111"/><cas:EmptyFSList xmi:id="12062"/><cas:NonEmptyFSList xmi:id="12059" head="12007" tail="12062"/><cas:NonEmptyFSList xmi:id="12056" head="12000" tail="12059"/><cas:NonEmptyFSList xmi:id="12053" head="11993" tail="12056"/><cas:NonEmptyFSList xmi:id="12050" head="11986" tail="12053"/><cas:NonEmptyFSList xmi:id="12047" head="11979" tail="12050"/><cas:NonEmptyFSList xmi:id="12044" head="11972" tail="12047"/><cas:NonEmptyFSList xmi:id="12041" head="11965" tail="12044"/><cas:NonEmptyFSList xmi:id="12038" head="11958" tail="12041"/><cas:NonEmptyFSList xmi:id="12035" head="11951" tail="12038"/><cas:NonEmptyFSList xmi:id="12032" head="11944" tail="12035"/><cas:NonEmptyFSList xmi:id="12029" head="11937" tail="12032"/><cas:NonEmptyFSList xmi:id="12026" head="11930" tail="12029"/><cas:NonEmptyFSList xmi:id="12023" head="11923" tail="12026"/><cas:NonEmptyFSList xmi:id="12020" head="11916" tail="12023"/><cas:NonEmptyFSList xmi:id="12017" head="11909" tail="12020"/><cas:EmptyFSList xmi:id="11891"/><cas:NonEmptyFSList xmi:id="11867" head="11870" tail="11891"/><cas:NonEmptyFSList xmi:id="11843" head="11846" tail="11867"/><cas:NonEmptyFSList xmi:id="11819" head="11822" tail="11843"/><cas:NonEmptyFSList xmi:id="11795" head="11798" tail="11819"/><cas:NonEmptyFSList xmi:id="11771" head="11774" tail="11795"/><cas:NonEmptyFSList xmi:id="11747" head="11750" tail="11771"/><cas:NonEmptyFSList xmi:id="11723" head="11726" tail="11747"/><cas:NonEmptyFSList xmi:id="11699" head="11702" tail="11723"/><cas:NonEmptyFSList xmi:id="11675" head="11678" tail="11699"/><cas:NonEmptyFSList xmi:id="11651" head="11654" tail="11675"/><cas:NonEmptyFSList xmi:id="11627" head="11630" tail="11651"/><cas:NonEmptyFSList xmi:id="11603" head="11606" tail="11627"/><cas:EmptyFSList xmi:id="11578"/><cas:NonEmptyFSList xmi:id="11575" head="11520" tail="11578"/><cas:NonEmptyFSList xmi:id="11572" head="11513" tail="11575"/><cas:NonEmptyFSList xmi:id="11569" head="11506" tail="11572"/><cas:NonEmptyFSList xmi:id="11566" head="11499" tail="11569"/><cas:NonEmptyFSList xmi:id="11563" head="11492" tail="11566"/><cas:NonEmptyFSList xmi:id="11560" head="11485" tail="11563"/><cas:NonEmptyFSList xmi:id="11557" head="11478" tail="11560"/><cas:NonEmptyFSList xmi:id="11554" head="11471" tail="11557"/><cas:NonEmptyFSList xmi:id="11551" head="11464" tail="11554"/><cas:NonEmptyFSList xmi:id="11548" head="11457" tail="11551"/><cas:NonEmptyFSList xmi:id="11545" head="11450" tail="11548"/><cas:NonEmptyFSList xmi:id="11542" head="11443" tail="11545"/><cas:NonEmptyFSList xmi:id="11539" head="11436" tail="11542"/><cas:NonEmptyFSList xmi:id="11536" head="11429" tail="11539"/><cas:NonEmptyFSList xmi:id="11533" head="11422" tail="11536"/><cas:NonEmptyFSList xmi:id="11530" head="11415" tail="11533"/><cas:EmptyFSList xmi:id="11397"/><cas:NonEmptyFSList xmi:id="11373" head="11376" tail="11397"/><cas:NonEmptyFSList xmi:id="11349" head="11352" tail="11373"/><cas:NonEmptyFSList xmi:id="11325" head="11328" tail="11349"/><cas:NonEmptyFSList xmi:id="11301" head="11304" tail="11325"/><cas:NonEmptyFSList xmi:id="11277" head="11280" tail="11301"/><cas:NonEmptyFSList xmi:id="11253" head="11256" tail="11277"/><cas:NonEmptyFSList xmi:id="11229" head="11232" tail="11253"/><cas:NonEmptyFSList xmi:id="11205" head="11208" tail="11229"/><cas:NonEmptyFSList xmi:id="11181" head="11184" tail="11205"/><cas:NonEmptyFSList xmi:id="11157" head="11160" tail="11181"/><cas:EmptyFSList xmi:id="11132"/><cas:NonEmptyFSList xmi:id="11129" head="11080" tail="11132"/><cas:NonEmptyFSList xmi:id="11126" head="11073" tail="11129"/><cas:NonEmptyFSList xmi:id="11123" head="11066" tail="11126"/><cas:NonEmptyFSList xmi:id="11120" head="11059" tail="11123"/><cas:NonEmptyFSList xmi:id="11117" head="11052" tail="11120"/><cas:NonEmptyFSList xmi:id="11114" head="11045" tail="11117"/><cas:NonEmptyFSList xmi:id="11111" head="11038" tail="11114"/><cas:NonEmptyFSList xmi:id="11108" head="11031" tail="11111"/><cas:NonEmptyFSList xmi:id="11105" head="11024" tail="11108"/><cas:NonEmptyFSList xmi:id="11102" head="11017" tail="11105"/><cas:NonEmptyFSList xmi:id="11099" head="11010" tail="11102"/><cas:NonEmptyFSList xmi:id="11096" head="11003" tail="11099"/><cas:NonEmptyFSList xmi:id="11093" head="10996" tail="11096"/><cas:NonEmptyFSList xmi:id="11090" head="10989" tail="11093"/><cas:EmptyFSList xmi:id="10971"/><cas:NonEmptyFSList xmi:id="10947" head="10950" tail="10971"/><cas:NonEmptyFSList xmi:id="10923" head="10926" tail="10947"/><cas:NonEmptyFSList xmi:id="10899" head="10902" tail="10923"/><cas:NonEmptyFSList xmi:id="10875" head="10878" tail="10899"/><cas:NonEmptyFSList xmi:id="10851" head="10854" tail="10875"/><cas:NonEmptyFSList xmi:id="10827" head="10830" tail="10851"/><cas:NonEmptyFSList xmi:id="10803" head="10806" tail="10827"/><cas:NonEmptyFSList xmi:id="10779" head="10782" tail="10803"/><cas:EmptyFSList xmi:id="10754"/><cas:NonEmptyFSList xmi:id="10751" head="10708" tail="10754"/><cas:NonEmptyFSList xmi:id="10748" head="10701" tail="10751"/><cas:NonEmptyFSList xmi:id="10745" head="10694" tail="10748"/><cas:NonEmptyFSList xmi:id="10742" head="10687" tail="10745"/><cas:NonEmptyFSList xmi:id="10739" head="10680" tail="10742"/><cas:NonEmptyFSList xmi:id="10736" head="10673" tail="10739"/><cas:NonEmptyFSList xmi:id="10733" head="10666" tail="10736"/><cas:NonEmptyFSList xmi:id="10730" head="10659" tail="10733"/><cas:NonEmptyFSList xmi:id="10727" head="10652" tail="10730"/><cas:NonEmptyFSList xmi:id="10724" head="10645" tail="10727"/><cas:NonEmptyFSList xmi:id="10721" head="10638" tail="10724"/><cas:NonEmptyFSList xmi:id="10718" head="10631" tail="10721"/><cas:EmptyFSList xmi:id="10613"/><cas:NonEmptyFSList xmi:id="10589" head="10592" tail="10613"/><cas:NonEmptyFSList xmi:id="10565" head="10568" tail="10589"/><cas:NonEmptyFSList xmi:id="10541" head="10544" tail="10565"/><cas:NonEmptyFSList xmi:id="10517" head="10520" tail="10541"/><cas:NonEmptyFSList xmi:id="10493" head="10496" tail="10517"/><cas:NonEmptyFSList xmi:id="10469" head="10472" tail="10493"/><cas:NonEmptyFSList xmi:id="10445" head="10448" tail="10469"/><cas:NonEmptyFSList xmi:id="10421" head="10424" tail="10445"/><cas:NonEmptyFSList xmi:id="10397" head="10400" tail="10421"/><cas:EmptyFSList xmi:id="10372"/><cas:NonEmptyFSList xmi:id="10369" head="10326" tail="10372"/><cas:NonEmptyFSList xmi:id="10366" head="10319" tail="10369"/><cas:NonEmptyFSList xmi:id="10363" head="10312" tail="10366"/><cas:NonEmptyFSList xmi:id="10360" head="10305" tail="10363"/><cas:NonEmptyFSList xmi:id="10357" head="10298" tail="10360"/><cas:NonEmptyFSList xmi:id="10354" head="10291" tail="10357"/><cas:NonEmptyFSList xmi:id="10351" head="10284" tail="10354"/><cas:NonEmptyFSList xmi:id="10348" head="10277" tail="10351"/><cas:NonEmptyFSList xmi:id="10345" head="10270" tail="10348"/><cas:NonEmptyFSList xmi:id="10342" head="10263" tail="10345"/><cas:NonEmptyFSList xmi:id="10339" head="10256" tail="10342"/><cas:NonEmptyFSList xmi:id="10336" head="10249" tail="10339"/><cas:EmptyFSList xmi:id="10231"/><cas:NonEmptyFSList xmi:id="10207" head="10210" tail="10231"/><cas:NonEmptyFSList xmi:id="10183" head="10186" tail="10207"/><cas:NonEmptyFSList xmi:id="10159" head="10162" tail="10183"/><cas:NonEmptyFSList xmi:id="10135" head="10138" tail="10159"/><cas:NonEmptyFSList xmi:id="10111" head="10114" tail="10135"/><cas:NonEmptyFSList xmi:id="10087" head="10090" tail="10111"/><cas:NonEmptyFSList xmi:id="10063" head="10066" tail="10087"/><cas:NonEmptyFSList xmi:id="10039" head="10042" tail="10063"/><cas:NonEmptyFSList xmi:id="10015" head="10018" tail="10039"/><cas:NonEmptyFSList xmi:id="9991" head="9994" tail="10015"/><cas:NonEmptyFSList xmi:id="9967" head="9970" tail="9991"/><cas:EmptyFSList xmi:id="9942"/><cas:NonEmptyFSList xmi:id="9939" head="9890" tail="9942"/><cas:NonEmptyFSList xmi:id="9936" head="9883" tail="9939"/><cas:NonEmptyFSList xmi:id="9933" head="9876" tail="9936"/><cas:NonEmptyFSList xmi:id="9930" head="9869" tail="9933"/><cas:NonEmptyFSList xmi:id="9927" head="9862" tail="9930"/><cas:NonEmptyFSList xmi:id="9924" head="9855" tail="9927"/><cas:NonEmptyFSList xmi:id="9921" head="9848" tail="9924"/><cas:NonEmptyFSList xmi:id="9918" head="9841" tail="9921"/><cas:NonEmptyFSList xmi:id="9915" head="9834" tail="9918"/><cas:NonEmptyFSList xmi:id="9912" head="9827" tail="9915"/><cas:NonEmptyFSList xmi:id="9909" head="9820" tail="9912"/><cas:NonEmptyFSList xmi:id="9906" head="9813" tail="9909"/><cas:NonEmptyFSList xmi:id="9903" head="9806" tail="9906"/><cas:NonEmptyFSList xmi:id="9900" head="9799" tail="9903"/><cas:EmptyFSList xmi:id="9780"/><cas:EmptyFSList xmi:id="9759"/><cas:NonEmptyFSList xmi:id="9735" head="9738" tail="9759"/><cas:NonEmptyFSList xmi:id="9711" head="9714" tail="9735"/><cas:NonEmptyFSList xmi:id="9687" head="9690" tail="9711"/><cas:NonEmptyFSList xmi:id="9663" head="9666" tail="9687"/><cas:NonEmptyFSList xmi:id="9639" head="9642" tail="9663"/><cas:NonEmptyFSList xmi:id="9615" head="9618" tail="9639"/><cas:NonEmptyFSList xmi:id="9591" head="9594" tail="9615"/><cas:NonEmptyFSList xmi:id="9567" head="9570" tail="9591"/><cas:NonEmptyFSList xmi:id="9543" head="9546" tail="9567"/><cas:NonEmptyFSList xmi:id="9519" head="9522" tail="9543"/><cas:EmptyFSList xmi:id="9494"/><cas:NonEmptyFSList xmi:id="9491" head="9433" tail="9494"/><cas:NonEmptyFSList xmi:id="9488" head="9426" tail="9491"/><cas:NonEmptyFSList xmi:id="9485" head="9419" tail="9488"/><cas:NonEmptyFSList xmi:id="9482" head="9412" tail="9485"/><cas:NonEmptyFSList xmi:id="9479" head="9405" tail="9482"/><cas:NonEmptyFSList xmi:id="9476" head="9398" tail="9479"/><cas:NonEmptyFSList xmi:id="9473" head="9391" tail="9476"/><cas:NonEmptyFSList xmi:id="9470" head="9384" tail="9473"/><cas:NonEmptyFSList xmi:id="9467" head="9377" tail="9470"/><cas:NonEmptyFSList xmi:id="9464" head="9370" tail="9467"/><cas:NonEmptyFSList xmi:id="9461" head="9363" tail="9464"/><cas:NonEmptyFSList xmi:id="9458" head="9356" tail="9461"/><cas:NonEmptyFSList xmi:id="9455" head="9349" tail="9458"/><cas:NonEmptyFSList xmi:id="9452" head="9342" tail="9455"/><cas:NonEmptyFSList xmi:id="9449" head="9335" tail="9452"/><cas:NonEmptyFSList xmi:id="9446" head="9328" tail="9449"/><cas:NonEmptyFSList xmi:id="9443" head="9321" tail="9446"/><cas:EmptyFSList xmi:id="9303"/><cas:NonEmptyFSList xmi:id="9279" head="9282" tail="9303"/><cas:NonEmptyFSList xmi:id="9255" head="9258" tail="9279"/><cas:NonEmptyFSList xmi:id="9231" head="9234" tail="9255"/><cas:NonEmptyFSList xmi:id="9207" head="9210" tail="9231"/><cas:NonEmptyFSList xmi:id="9183" head="9186" tail="9207"/><cas:NonEmptyFSList xmi:id="9159" head="9162" tail="9183"/><cas:NonEmptyFSList xmi:id="9135" head="9138" tail="9159"/><cas:NonEmptyFSList xmi:id="9111" head="9114" tail="9135"/><cas:NonEmptyFSList xmi:id="9087" head="9090" tail="9111"/><cas:NonEmptyFSList xmi:id="9063" head="9066" tail="9087"/><cas:EmptyFSList xmi:id="9038"/><cas:NonEmptyFSList xmi:id="9035" head="8986" tail="9038"/><cas:NonEmptyFSList xmi:id="9032" head="8979" tail="9035"/><cas:NonEmptyFSList xmi:id="9029" head="8972" tail="9032"/><cas:NonEmptyFSList xmi:id="9026" head="8965" tail="9029"/><cas:NonEmptyFSList xmi:id="9023" head="8958" tail="9026"/><cas:NonEmptyFSList xmi:id="9020" head="8951" tail="9023"/><cas:NonEmptyFSList xmi:id="9017" head="8944" tail="9020"/><cas:NonEmptyFSList xmi:id="9014" head="8937" tail="9017"/><cas:NonEmptyFSList xmi:id="9011" head="8930" tail="9014"/><cas:NonEmptyFSList xmi:id="9008" head="8923" tail="9011"/><cas:NonEmptyFSList xmi:id="9005" head="8916" tail="9008"/><cas:NonEmptyFSList xmi:id="9002" head="8909" tail="9005"/><cas:NonEmptyFSList xmi:id="8999" head="8902" tail="9002"/><cas:NonEmptyFSList xmi:id="8996" head="8895" tail="8999"/><cas:EmptyFSList xmi:id="8877"/><cas:NonEmptyFSList xmi:id="8853" head="8856" tail="8877"/><cas:NonEmptyFSList xmi:id="8829" head="8832" tail="8853"/><cas:NonEmptyFSList xmi:id="8805" head="8808" tail="8829"/><cas:NonEmptyFSList xmi:id="8781" head="8784" tail="8805"/><cas:NonEmptyFSList xmi:id="8757" head="8760" tail="8781"/><cas:NonEmptyFSList xmi:id="8733" head="8736" tail="8757"/><cas:NonEmptyFSList xmi:id="8709" head="8712" tail="8733"/><cas:NonEmptyFSList xmi:id="8685" head="8688" tail="8709"/><cas:NonEmptyFSList xmi:id="8661" head="8664" tail="8685"/><cas:NonEmptyFSList xmi:id="8637" head="8640" tail="8661"/><cas:EmptyFSList xmi:id="8612"/><cas:NonEmptyFSList xmi:id="8609" head="8563" tail="8612"/><cas:NonEmptyFSList xmi:id="8606" head="8556" tail="8609"/><cas:NonEmptyFSList xmi:id="8603" head="8549" tail="8606"/><cas:NonEmptyFSList xmi:id="8600" head="8542" tail="8603"/><cas:NonEmptyFSList xmi:id="8597" head="8535" tail="8600"/><cas:NonEmptyFSList xmi:id="8594" head="8528" tail="8597"/><cas:NonEmptyFSList xmi:id="8591" head="8521" tail="8594"/><cas:NonEmptyFSList xmi:id="8588" head="8514" tail="8591"/><cas:NonEmptyFSList xmi:id="8585" head="8507" tail="8588"/><cas:NonEmptyFSList xmi:id="8582" head="8500" tail="8585"/><cas:NonEmptyFSList xmi:id="8579" head="8493" tail="8582"/><cas:NonEmptyFSList xmi:id="8576" head="8486" tail="8579"/><cas:NonEmptyFSList xmi:id="8573" head="8479" tail="8576"/><cas:EmptyFSList xmi:id="8461"/><cas:EmptyFSList xmi:id="8450"/><cas:EmptyFSList xmi:id="8439"/><cas:EmptyFSList xmi:id="8428"/><cas:EmptyFSList xmi:id="8417"/><cas:EmptyFSList xmi:id="8406"/><cas:EmptyFSList xmi:id="8395"/><cas:EmptyFSList xmi:id="8384"/><cas:EmptyFSList xmi:id="8373"/><cas:EmptyFSList xmi:id="8362"/><cas:EmptyFSList xmi:id="8351"/><cas:EmptyFSList xmi:id="8340"/><cas:EmptyFSList xmi:id="8329"/><cas:EmptyFSList xmi:id="8318"/><cas:EmptyFSList xmi:id="8307"/><cas:EmptyFSList xmi:id="8296"/><cas:EmptyFSList xmi:id="8285"/><cas:EmptyFSList xmi:id="8274"/><cas:EmptyFSList xmi:id="8263"/><cas:EmptyFSList xmi:id="8252"/><cas:EmptyFSList xmi:id="8241"/><cas:EmptyFSList xmi:id="8230"/><cas:EmptyFSList xmi:id="8219"/><cas:EmptyFSList xmi:id="8208"/><cas:EmptyFSList xmi:id="8197"/><cas:EmptyFSList xmi:id="8186"/><cas:EmptyFSList xmi:id="8175"/><cas:EmptyFSList xmi:id="8164"/><cas:EmptyFSList xmi:id="8153"/><cas:EmptyFSList xmi:id="8142"/><cas:EmptyFSList xmi:id="8131"/><cas:NonEmptyFSList xmi:id="8128" head="8118" tail="8131"/><cas:EmptyFSList xmi:id="8110"/><cas:NonEmptyFSList xmi:id="8107" head="8097" tail="8110"/><cas:EmptyFSList xmi:id="8089"/><cas:EmptyFSList xmi:id="8078"/><cas:NonEmptyFSList xmi:id="8075" head="8065" tail="8078"/><cas:EmptyFSList xmi:id="8057"/><cas:EmptyFSList xmi:id="8046"/><cas:EmptyFSList xmi:id="8035"/><cas:EmptyFSList xmi:id="8024"/><cas:EmptyFSList xmi:id="8013"/><cas:EmptyFSList xmi:id="8002"/><cas:EmptyFSList xmi:id="7991"/><cas:NonEmptyFSList xmi:id="7988" head="7975" tail="7991"/><cas:NonEmptyFSList xmi:id="7985" head="7968" tail="7988"/><cas:EmptyFSList xmi:id="7960"/><cas:NonEmptyFSList xmi:id="7957" head="7944" tail="7960"/><cas:NonEmptyFSList xmi:id="7954" head="7937" tail="7957"/><cas:EmptyFSList xmi:id="7929"/><cas:NonEmptyFSList xmi:id="7926" head="7913" tail="7929"/><cas:NonEmptyFSList xmi:id="7923" head="7906" tail="7926"/><cas:EmptyFSList xmi:id="7898"/><cas:NonEmptyFSList xmi:id="7895" head="7882" tail="7898"/><cas:NonEmptyFSList xmi:id="7892" head="7875" tail="7895"/><cas:EmptyFSList xmi:id="7867"/><cas:NonEmptyFSList xmi:id="7864" head="7851" tail="7867"/><cas:NonEmptyFSList xmi:id="7861" head="7844" tail="7864"/><cas:EmptyFSList xmi:id="7836"/><cas:NonEmptyFSList xmi:id="7833" head="7823" tail="7836"/><cas:EmptyFSList xmi:id="7815"/><cas:NonEmptyFSList xmi:id="7812" head="7802" tail="7815"/><cas:EmptyFSList xmi:id="7794"/><cas:NonEmptyFSList xmi:id="7791" head="7781" tail="7794"/><cas:EmptyFSList xmi:id="7773"/><cas:NonEmptyFSList xmi:id="7770" head="7760" tail="7773"/><cas:EmptyFSList xmi:id="7752"/><cas:NonEmptyFSList xmi:id="7749" head="7739" tail="7752"/><cas:EmptyFSList xmi:id="7730"/><cas:NonEmptyFSList xmi:id="7727" head="6404" tail="7730"/><cas:NonEmptyFSList xmi:id="7724" head="6392" tail="7727"/><cas:NonEmptyFSList xmi:id="7721" head="6380" tail="7724"/><cas:NonEmptyFSList xmi:id="7718" head="6368" tail="7721"/><cas:NonEmptyFSList xmi:id="7715" head="6356" tail="7718"/><cas:NonEmptyFSList xmi:id="7712" head="6344" tail="7715"/><cas:NonEmptyFSList xmi:id="7709" head="6332" tail="7712"/><cas:NonEmptyFSList xmi:id="7706" head="6320" tail="7709"/><cas:NonEmptyFSList xmi:id="7703" head="6308" tail="7706"/><cas:NonEmptyFSList xmi:id="7700" head="6296" tail="7703"/><cas:NonEmptyFSList xmi:id="7697" head="6284" tail="7700"/><cas:NonEmptyFSList xmi:id="7694" head="6272" tail="7697"/><cas:NonEmptyFSList xmi:id="7691" head="6260" tail="7694"/><cas:NonEmptyFSList xmi:id="7688" head="6248" tail="7691"/><cas:NonEmptyFSList xmi:id="7685" head="6236" tail="7688"/><cas:NonEmptyFSList xmi:id="7682" head="6224" tail="7685"/><cas:NonEmptyFSList xmi:id="7679" head="6212" tail="7682"/><cas:NonEmptyFSList xmi:id="7676" head="6200" tail="7679"/><cas:NonEmptyFSList xmi:id="7673" head="6188" tail="7676"/><cas:NonEmptyFSList xmi:id="7670" head="6176" tail="7673"/><cas:NonEmptyFSList xmi:id="7667" head="6164" tail="7670"/><cas:NonEmptyFSList xmi:id="7664" head="6152" tail="7667"/><cas:NonEmptyFSList xmi:id="7661" head="6140" tail="7664"/><cas:NonEmptyFSList xmi:id="7658" head="6128" tail="7661"/><cas:NonEmptyFSList xmi:id="7655" head="6116" tail="7658"/><cas:NonEmptyFSList xmi:id="7652" head="6104" tail="7655"/><cas:NonEmptyFSList xmi:id="7649" head="6092" tail="7652"/><cas:NonEmptyFSList xmi:id="7646" head="6080" tail="7649"/><cas:NonEmptyFSList xmi:id="7643" head="6068" tail="7646"/><cas:NonEmptyFSList xmi:id="7640" head="6056" tail="7643"/><cas:NonEmptyFSList xmi:id="7637" head="6044" tail="7640"/><cas:NonEmptyFSList xmi:id="7634" head="6032" tail="7637"/><cas:NonEmptyFSList xmi:id="7631" head="6020" tail="7634"/><cas:NonEmptyFSList xmi:id="7628" head="6008" tail="7631"/><cas:NonEmptyFSList xmi:id="7625" head="5996" tail="7628"/><cas:NonEmptyFSList xmi:id="7622" head="5984" tail="7625"/><cas:NonEmptyFSList xmi:id="7619" head="5972" tail="7622"/><cas:NonEmptyFSList xmi:id="7616" head="5960" tail="7619"/><cas:NonEmptyFSList xmi:id="7613" head="5948" tail="7616"/><cas:NonEmptyFSList xmi:id="7610" head="5936" tail="7613"/><cas:NonEmptyFSList xmi:id="7607" head="5924" tail="7610"/><cas:NonEmptyFSList xmi:id="7604" head="5912" tail="7607"/><cas:NonEmptyFSList xmi:id="7601" head="5900" tail="7604"/><cas:NonEmptyFSList xmi:id="7598" head="5888" tail="7601"/><cas:NonEmptyFSList xmi:id="7595" head="5876" tail="7598"/><cas:NonEmptyFSList xmi:id="7592" head="5864" tail="7595"/><cas:NonEmptyFSList xmi:id="7589" head="5852" tail="7592"/><cas:NonEmptyFSList xmi:id="7586" head="5840" tail="7589"/><cas:NonEmptyFSList xmi:id="7583" head="5828" tail="7586"/><cas:NonEmptyFSList xmi:id="7580" head="5816" tail="7583"/><cas:NonEmptyFSList xmi:id="7577" head="5804" tail="7580"/><cas:NonEmptyFSList xmi:id="7574" head="5792" tail="7577"/><cas:NonEmptyFSList xmi:id="7571" head="5780" tail="7574"/><cas:NonEmptyFSList xmi:id="7568" head="5768" tail="7571"/><cas:NonEmptyFSList xmi:id="7565" head="5756" tail="7568"/><cas:NonEmptyFSList xmi:id="7562" head="5744" tail="7565"/><cas:NonEmptyFSList xmi:id="7559" head="5732" tail="7562"/><cas:NonEmptyFSList xmi:id="7556" head="5720" tail="7559"/><cas:NonEmptyFSList xmi:id="7553" head="5708" tail="7556"/><cas:NonEmptyFSList xmi:id="7550" head="5696" tail="7553"/><cas:NonEmptyFSList xmi:id="7547" head="5684" tail="7550"/><cas:NonEmptyFSList xmi:id="7544" head="5672" tail="7547"/><cas:NonEmptyFSList xmi:id="7541" head="5660" tail="7544"/><cas:NonEmptyFSList xmi:id="7538" head="5648" tail="7541"/><cas:NonEmptyFSList xmi:id="7535" head="5636" tail="7538"/><cas:NonEmptyFSList xmi:id="7532" head="5624" tail="7535"/><cas:NonEmptyFSList xmi:id="7529" head="5612" tail="7532"/><cas:NonEmptyFSList xmi:id="7526" head="5600" tail="7529"/><cas:NonEmptyFSList xmi:id="7523" head="5588" tail="7526"/><cas:NonEmptyFSList xmi:id="7520" head="5576" tail="7523"/><cas:NonEmptyFSList xmi:id="7517" head="5564" tail="7520"/><cas:NonEmptyFSList xmi:id="7514" head="5552" tail="7517"/><cas:NonEmptyFSList xmi:id="7511" head="5540" tail="7514"/><cas:NonEmptyFSList xmi:id="7508" head="5528" tail="7511"/><cas:NonEmptyFSList xmi:id="7505" head="5516" tail="7508"/><cas:NonEmptyFSList xmi:id="7502" head="5504" tail="7505"/><cas:NonEmptyFSList xmi:id="7499" head="5492" tail="7502"/><cas:NonEmptyFSList xmi:id="7496" head="5480" tail="7499"/><cas:NonEmptyFSList xmi:id="7493" head="5468" tail="7496"/><cas:NonEmptyFSList xmi:id="7490" head="5456" tail="7493"/><cas:NonEmptyFSList xmi:id="7487" head="5444" tail="7490"/><cas:NonEmptyFSList xmi:id="7484" head="5432" tail="7487"/><cas:NonEmptyFSList xmi:id="7481" head="5420" tail="7484"/><cas:NonEmptyFSList xmi:id="7478" head="5408" tail="7481"/><cas:NonEmptyFSList xmi:id="7475" head="5396" tail="7478"/><cas:NonEmptyFSList xmi:id="7472" head="5384" tail="7475"/><cas:NonEmptyFSList xmi:id="7469" head="5372" tail="7472"/><cas:NonEmptyFSList xmi:id="7466" head="5360" tail="7469"/><cas:NonEmptyFSList xmi:id="7463" head="5348" tail="7466"/><cas:NonEmptyFSList xmi:id="7460" head="5336" tail="7463"/><cas:NonEmptyFSList xmi:id="7457" head="5324" tail="7460"/><cas:NonEmptyFSList xmi:id="7454" head="5312" tail="7457"/><cas:NonEmptyFSList xmi:id="7451" head="5300" tail="7454"/><cas:NonEmptyFSList xmi:id="7448" head="5288" tail="7451"/><cas:NonEmptyFSList xmi:id="7445" head="5276" tail="7448"/><cas:NonEmptyFSList xmi:id="7442" head="5264" tail="7445"/><cas:NonEmptyFSList xmi:id="7439" head="5252" tail="7442"/><cas:NonEmptyFSList xmi:id="7436" head="5240" tail="7439"/><cas:NonEmptyFSList xmi:id="7433" head="5216" tail="7436"/><cas:NonEmptyFSList xmi:id="7430" head="5204" tail="7433"/><cas:NonEmptyFSList xmi:id="7427" head="5180" tail="7430"/><cas:NonEmptyFSList xmi:id="7424" head="5168" tail="7427"/><cas:NonEmptyFSList xmi:id="7421" head="5156" tail="7424"/><cas:NonEmptyFSList xmi:id="7418" head="5144" tail="7421"/><cas:NonEmptyFSList xmi:id="7415" head="5132" tail="7418"/><cas:NonEmptyFSList xmi:id="7412" head="5120" tail="7415"/><cas:NonEmptyFSList xmi:id="7409" head="5096" tail="7412"/><cas:NonEmptyFSList xmi:id="7406" head="5084" tail="7409"/><cas:NonEmptyFSList xmi:id="7403" head="5072" tail="7406"/><cas:NonEmptyFSList xmi:id="7400" head="5048" tail="7403"/><cas:NonEmptyFSList xmi:id="7397" head="5036" tail="7400"/><cas:NonEmptyFSList xmi:id="7394" head="5024" tail="7397"/><cas:NonEmptyFSList xmi:id="7391" head="5012" tail="7394"/><cas:NonEmptyFSList xmi:id="7388" head="5000" tail="7391"/><cas:NonEmptyFSList xmi:id="7385" head="4988" tail="7388"/><cas:NonEmptyFSList xmi:id="7382" head="4976" tail="7385"/><cas:NonEmptyFSList xmi:id="7379" head="4964" tail="7382"/><cas:NonEmptyFSList xmi:id="7376" head="4952" tail="7379"/><cas:NonEmptyFSList xmi:id="7373" head="4940" tail="7376"/><cas:NonEmptyFSList xmi:id="7370" head="4928" tail="7373"/><cas:NonEmptyFSList xmi:id="7367" head="4916" tail="7370"/><cas:NonEmptyFSList xmi:id="7364" head="4904" tail="7367"/><cas:NonEmptyFSList xmi:id="7361" head="4892" tail="7364"/><cas:NonEmptyFSList xmi:id="7358" head="4880" tail="7361"/><cas:NonEmptyFSList xmi:id="7355" head="4868" tail="7358"/><cas:NonEmptyFSList xmi:id="7352" head="4856" tail="7355"/><cas:NonEmptyFSList xmi:id="7349" head="4844" tail="7352"/><cas:NonEmptyFSList xmi:id="7346" head="4832" tail="7349"/><cas:NonEmptyFSList xmi:id="7343" head="4820" tail="7346"/><cas:NonEmptyFSList xmi:id="7340" head="4808" tail="7343"/><cas:NonEmptyFSList xmi:id="7337" head="4796" tail="7340"/><cas:NonEmptyFSList xmi:id="7334" head="4784" tail="7337"/><cas:NonEmptyFSList xmi:id="7331" head="4772" tail="7334"/><cas:NonEmptyFSList xmi:id="7328" head="4760" tail="7331"/><cas:NonEmptyFSList xmi:id="7325" head="4748" tail="7328"/><cas:NonEmptyFSList xmi:id="7322" head="4736" tail="7325"/><cas:NonEmptyFSList xmi:id="7319" head="4724" tail="7322"/><cas:NonEmptyFSList xmi:id="7316" head="4712" tail="7319"/><cas:NonEmptyFSList xmi:id="7313" head="4700" tail="7316"/><cas:NonEmptyFSList xmi:id="7310" head="4688" tail="7313"/><cas:NonEmptyFSList xmi:id="7307" head="4676" tail="7310"/><cas:NonEmptyFSList xmi:id="7304" head="4664" tail="7307"/><cas:NonEmptyFSList xmi:id="7301" head="4652" tail="7304"/><cas:NonEmptyFSList xmi:id="7298" head="4640" tail="7301"/><cas:NonEmptyFSList xmi:id="7295" head="4628" tail="7298"/><cas:NonEmptyFSList xmi:id="7292" head="4616" tail="7295"/><cas:NonEmptyFSList xmi:id="7289" head="4604" tail="7292"/><cas:NonEmptyFSList xmi:id="7286" head="4592" tail="7289"/><cas:NonEmptyFSList xmi:id="7283" head="4580" tail="7286"/><cas:NonEmptyFSList xmi:id="7280" head="4568" tail="7283"/><cas:NonEmptyFSList xmi:id="7277" head="4556" tail="7280"/><cas:NonEmptyFSList xmi:id="7274" head="4544" tail="7277"/><cas:NonEmptyFSList xmi:id="7271" head="4532" tail="7274"/><cas:NonEmptyFSList xmi:id="7268" head="4520" tail="7271"/><cas:NonEmptyFSList xmi:id="7265" head="4508" tail="7268"/><cas:NonEmptyFSList xmi:id="7262" head="4496" tail="7265"/><cas:NonEmptyFSList xmi:id="7259" head="4484" tail="7262"/><cas:NonEmptyFSList xmi:id="7256" head="4472" tail="7259"/><cas:NonEmptyFSList xmi:id="7253" head="4460" tail="7256"/><cas:NonEmptyFSList xmi:id="7250" head="4448" tail="7253"/><cas:NonEmptyFSList xmi:id="7247" head="4436" tail="7250"/><cas:NonEmptyFSList xmi:id="7244" head="4424" tail="7247"/><cas:NonEmptyFSList xmi:id="7241" head="4412" tail="7244"/><cas:NonEmptyFSList xmi:id="7238" head="4400" tail="7241"/><cas:NonEmptyFSList xmi:id="7235" head="4388" tail="7238"/><cas:NonEmptyFSList xmi:id="7232" head="4376" tail="7235"/><cas:NonEmptyFSList xmi:id="7229" head="4364" tail="7232"/><cas:NonEmptyFSList xmi:id="7226" head="4352" tail="7229"/><cas:NonEmptyFSList xmi:id="7223" head="4340" tail="7226"/><cas:NonEmptyFSList xmi:id="7220" head="4328" tail="7223"/><cas:NonEmptyFSList xmi:id="7217" head="4316" tail="7220"/><cas:NonEmptyFSList xmi:id="7214" head="4304" tail="7217"/><cas:NonEmptyFSList xmi:id="7211" head="4292" tail="7214"/><cas:NonEmptyFSList xmi:id="7208" head="4280" tail="7211"/><cas:NonEmptyFSList xmi:id="7205" head="4268" tail="7208"/><cas:NonEmptyFSList xmi:id="7202" head="4256" tail="7205"/><cas:NonEmptyFSList xmi:id="7199" head="4244" tail="7202"/><cas:NonEmptyFSList xmi:id="7196" head="4232" tail="7199"/><cas:NonEmptyFSList xmi:id="7193" head="4220" tail="7196"/><cas:NonEmptyFSList xmi:id="7190" head="4208" tail="7193"/><cas:NonEmptyFSList xmi:id="7187" head="4196" tail="7190"/><cas:NonEmptyFSList xmi:id="7184" head="4184" tail="7187"/><cas:NonEmptyFSList xmi:id="7181" head="4172" tail="7184"/><cas:NonEmptyFSList xmi:id="7178" head="4160" tail="7181"/><cas:NonEmptyFSList xmi:id="7175" head="4148" tail="7178"/><cas:NonEmptyFSList xmi:id="7172" head="4136" tail="7175"/><cas:NonEmptyFSList xmi:id="7169" head="4124" tail="7172"/><cas:NonEmptyFSList xmi:id="7166" head="4112" tail="7169"/><cas:NonEmptyFSList xmi:id="7163" head="4100" tail="7166"/><cas:NonEmptyFSList xmi:id="7160" head="4088" tail="7163"/><cas:NonEmptyFSList xmi:id="7157" head="4076" tail="7160"/><cas:NonEmptyFSList xmi:id="7154" head="4064" tail="7157"/><cas:NonEmptyFSList xmi:id="7151" head="4052" tail="7154"/><cas:NonEmptyFSList xmi:id="7148" head="4040" tail="7151"/><cas:NonEmptyFSList xmi:id="7145" head="4028" tail="7148"/><cas:NonEmptyFSList xmi:id="7142" head="4016" tail="7145"/><cas:NonEmptyFSList xmi:id="7139" head="4004" tail="7142"/><cas:NonEmptyFSList xmi:id="7136" head="3992" tail="7139"/><cas:NonEmptyFSList xmi:id="7133" head="3980" tail="7136"/><cas:NonEmptyFSList xmi:id="7130" head="3968" tail="7133"/><cas:NonEmptyFSList xmi:id="7127" head="3956" tail="7130"/><cas:NonEmptyFSList xmi:id="7124" head="3944" tail="7127"/><cas:NonEmptyFSList xmi:id="7121" head="3932" tail="7124"/><cas:NonEmptyFSList xmi:id="7118" head="3920" tail="7121"/><cas:NonEmptyFSList xmi:id="7115" head="3908" tail="7118"/><cas:NonEmptyFSList xmi:id="7112" head="3896" tail="7115"/><cas:NonEmptyFSList xmi:id="7109" head="3884" tail="7112"/><cas:NonEmptyFSList xmi:id="7106" head="3872" tail="7109"/><cas:NonEmptyFSList xmi:id="7103" head="3860" tail="7106"/><cas:NonEmptyFSList xmi:id="7100" head="3848" tail="7103"/><cas:NonEmptyFSList xmi:id="7097" head="3836" tail="7100"/><cas:NonEmptyFSList xmi:id="7094" head="3824" tail="7097"/><cas:NonEmptyFSList xmi:id="7091" head="3812" tail="7094"/><cas:NonEmptyFSList xmi:id="7088" head="3800" tail="7091"/><cas:NonEmptyFSList xmi:id="7085" head="3788" tail="7088"/><cas:NonEmptyFSList xmi:id="7082" head="3776" tail="7085"/><cas:NonEmptyFSList xmi:id="7079" head="3764" tail="7082"/><cas:NonEmptyFSList xmi:id="7076" head="3752" tail="7079"/><cas:NonEmptyFSList xmi:id="7073" head="3740" tail="7076"/><cas:NonEmptyFSList xmi:id="7070" head="3728" tail="7073"/><cas:NonEmptyFSList xmi:id="7067" head="3716" tail="7070"/><cas:NonEmptyFSList xmi:id="7064" head="3704" tail="7067"/><cas:NonEmptyFSList xmi:id="7061" head="3692" tail="7064"/><cas:NonEmptyFSList xmi:id="7058" head="3680" tail="7061"/><cas:NonEmptyFSList xmi:id="7055" head="3668" tail="7058"/><cas:NonEmptyFSList xmi:id="7052" head="3656" tail="7055"/><cas:NonEmptyFSList xmi:id="7049" head="3644" tail="7052"/><cas:NonEmptyFSList xmi:id="7046" head="3632" tail="7049"/><cas:NonEmptyFSList xmi:id="7043" head="3620" tail="7046"/><cas:NonEmptyFSList xmi:id="7040" head="3608" tail="7043"/><cas:NonEmptyFSList xmi:id="7037" head="3596" tail="7040"/><cas:NonEmptyFSList xmi:id="7034" head="3584" tail="7037"/><cas:NonEmptyFSList xmi:id="7031" head="3572" tail="7034"/><cas:NonEmptyFSList xmi:id="7028" head="3560" tail="7031"/><cas:NonEmptyFSList xmi:id="7025" head="3548" tail="7028"/><cas:NonEmptyFSList xmi:id="7022" head="3536" tail="7025"/><cas:NonEmptyFSList xmi:id="7019" head="3524" tail="7022"/><cas:NonEmptyFSList xmi:id="7016" head="3512" tail="7019"/><cas:NonEmptyFSList xmi:id="7013" head="3500" tail="7016"/><cas:NonEmptyFSList xmi:id="7010" head="3488" tail="7013"/><cas:NonEmptyFSList xmi:id="7007" head="3476" tail="7010"/><cas:NonEmptyFSList xmi:id="7004" head="3464" tail="7007"/><cas:NonEmptyFSList xmi:id="7001" head="3452" tail="7004"/><cas:NonEmptyFSList xmi:id="6998" head="3440" tail="7001"/><cas:NonEmptyFSList xmi:id="6995" head="3428" tail="6998"/><cas:NonEmptyFSList xmi:id="6992" head="3416" tail="6995"/><cas:NonEmptyFSList xmi:id="6989" head="3404" tail="6992"/><cas:NonEmptyFSList xmi:id="6986" head="3392" tail="6989"/><cas:NonEmptyFSList xmi:id="6983" head="3380" tail="6986"/><cas:NonEmptyFSList xmi:id="6980" head="3368" tail="6983"/><cas:NonEmptyFSList xmi:id="6977" head="3356" tail="6980"/><cas:NonEmptyFSList xmi:id="6974" head="3344" tail="6977"/><cas:NonEmptyFSList xmi:id="6971" head="3332" tail="6974"/><cas:NonEmptyFSList xmi:id="6968" head="3320" tail="6971"/><cas:NonEmptyFSList xmi:id="6965" head="3308" tail="6968"/><cas:NonEmptyFSList xmi:id="6962" head="3296" tail="6965"/><cas:NonEmptyFSList xmi:id="6959" head="3284" tail="6962"/><cas:NonEmptyFSList xmi:id="6956" head="3272" tail="6959"/><cas:NonEmptyFSList xmi:id="6953" head="3260" tail="6956"/><cas:NonEmptyFSList xmi:id="6950" head="3248" tail="6953"/><cas:NonEmptyFSList xmi:id="6947" head="3236" tail="6950"/><cas:NonEmptyFSList xmi:id="6944" head="3224" tail="6947"/><cas:NonEmptyFSList xmi:id="6941" head="3212" tail="6944"/><cas:NonEmptyFSList xmi:id="6938" head="3200" tail="6941"/><cas:NonEmptyFSList xmi:id="6935" head="3188" tail="6938"/><cas:NonEmptyFSList xmi:id="6932" head="3176" tail="6935"/><cas:NonEmptyFSList xmi:id="6929" head="3164" tail="6932"/><cas:NonEmptyFSList xmi:id="6926" head="3152" tail="6929"/><cas:NonEmptyFSList xmi:id="6923" head="3140" tail="6926"/><cas:NonEmptyFSList xmi:id="6920" head="3128" tail="6923"/><cas:NonEmptyFSList xmi:id="6917" head="3116" tail="6920"/><cas:NonEmptyFSList xmi:id="6914" head="3104" tail="6917"/><cas:NonEmptyFSList xmi:id="6911" head="3080" tail="6914"/><cas:NonEmptyFSList xmi:id="6908" head="3068" tail="6911"/><cas:NonEmptyFSList xmi:id="6905" head="3056" tail="6908"/><cas:NonEmptyFSList xmi:id="6902" head="3044" tail="6905"/><cas:NonEmptyFSList xmi:id="6899" head="3032" tail="6902"/><cas:NonEmptyFSList xmi:id="6896" head="3020" tail="6899"/><cas:NonEmptyFSList xmi:id="6893" head="3008" tail="6896"/><cas:NonEmptyFSList xmi:id="6890" head="2996" tail="6893"/><cas:NonEmptyFSList xmi:id="6887" head="2984" tail="6890"/><cas:NonEmptyFSList xmi:id="6884" head="2972" tail="6887"/><cas:NonEmptyFSList xmi:id="6881" head="2960" tail="6884"/><cas:NonEmptyFSList xmi:id="6878" head="2948" tail="6881"/><cas:NonEmptyFSList xmi:id="6875" head="2936" tail="6878"/><cas:NonEmptyFSList xmi:id="6872" head="2924" tail="6875"/><cas:NonEmptyFSList xmi:id="6869" head="2912" tail="6872"/><cas:NonEmptyFSList xmi:id="6866" head="2900" tail="6869"/><cas:NonEmptyFSList xmi:id="6863" head="2888" tail="6866"/><cas:NonEmptyFSList xmi:id="6860" head="2876" tail="6863"/><cas:NonEmptyFSList xmi:id="6857" head="2864" tail="6860"/><cas:NonEmptyFSList xmi:id="6854" head="2852" tail="6857"/><cas:NonEmptyFSList xmi:id="6851" head="2840" tail="6854"/><cas:NonEmptyFSList xmi:id="6848" head="2828" tail="6851"/><cas:NonEmptyFSList xmi:id="6845" head="2816" tail="6848"/><cas:NonEmptyFSList xmi:id="6842" head="2804" tail="6845"/><cas:NonEmptyFSList xmi:id="6839" head="2792" tail="6842"/><cas:NonEmptyFSList xmi:id="6836" head="2780" tail="6839"/><cas:NonEmptyFSList xmi:id="6833" head="2768" tail="6836"/><cas:NonEmptyFSList xmi:id="6830" head="2756" tail="6833"/><cas:NonEmptyFSList xmi:id="6827" head="2744" tail="6830"/><cas:NonEmptyFSList xmi:id="6824" head="2732" tail="6827"/><cas:NonEmptyFSList xmi:id="6821" head="2720" tail="6824"/><cas:NonEmptyFSList xmi:id="6818" head="2708" tail="6821"/><cas:NonEmptyFSList xmi:id="6815" head="2696" tail="6818"/><cas:NonEmptyFSList xmi:id="6812" head="2684" tail="6815"/><cas:NonEmptyFSList xmi:id="6809" head="2672" tail="6812"/><cas:NonEmptyFSList xmi:id="6806" head="2660" tail="6809"/><cas:NonEmptyFSList xmi:id="6803" head="2648" tail="6806"/><cas:NonEmptyFSList xmi:id="6800" head="2636" tail="6803"/><cas:NonEmptyFSList xmi:id="6797" head="2624" tail="6800"/><cas:NonEmptyFSList xmi:id="6794" head="2612" tail="6797"/><cas:NonEmptyFSList xmi:id="6791" head="2600" tail="6794"/><cas:NonEmptyFSList xmi:id="6788" head="2588" tail="6791"/><cas:NonEmptyFSList xmi:id="6785" head="2576" tail="6788"/><cas:NonEmptyFSList xmi:id="6782" head="2552" tail="6785"/><cas:NonEmptyFSList xmi:id="6779" head="2540" tail="6782"/><cas:NonEmptyFSList xmi:id="6776" head="2528" tail="6779"/><cas:NonEmptyFSList xmi:id="6773" head="2516" tail="6776"/><cas:NonEmptyFSList xmi:id="6770" head="2504" tail="6773"/><cas:NonEmptyFSList xmi:id="6767" head="2492" tail="6770"/><cas:NonEmptyFSList xmi:id="6764" head="2480" tail="6767"/><cas:NonEmptyFSList xmi:id="6761" head="2468" tail="6764"/><cas:NonEmptyFSList xmi:id="6758" head="2456" tail="6761"/><cas:NonEmptyFSList xmi:id="6755" head="2444" tail="6758"/><cas:NonEmptyFSList xmi:id="6752" head="2432" tail="6755"/><cas:NonEmptyFSList xmi:id="6749" head="2420" tail="6752"/><cas:NonEmptyFSList xmi:id="6746" head="2408" tail="6749"/><cas:NonEmptyFSList xmi:id="6743" head="2396" tail="6746"/><cas:NonEmptyFSList xmi:id="6740" head="2384" tail="6743"/><cas:NonEmptyFSList xmi:id="6737" head="2372" tail="6740"/><cas:NonEmptyFSList xmi:id="6734" head="2360" tail="6737"/><cas:NonEmptyFSList xmi:id="6731" head="2348" tail="6734"/><cas:NonEmptyFSList xmi:id="6728" head="2336" tail="6731"/><cas:NonEmptyFSList xmi:id="6725" head="2324" tail="6728"/><cas:NonEmptyFSList xmi:id="6722" head="2312" tail="6725"/><cas:NonEmptyFSList xmi:id="6719" head="2300" tail="6722"/><cas:NonEmptyFSList xmi:id="6716" head="2288" tail="6719"/><cas:NonEmptyFSList xmi:id="6713" head="2276" tail="6716"/><cas:NonEmptyFSList xmi:id="6710" head="2264" tail="6713"/><cas:NonEmptyFSList xmi:id="6707" head="2252" tail="6710"/><cas:NonEmptyFSList xmi:id="6704" head="2240" tail="6707"/><cas:NonEmptyFSList xmi:id="6701" head="2228" tail="6704"/><cas:NonEmptyFSList xmi:id="6698" head="2216" tail="6701"/><cas:NonEmptyFSList xmi:id="6695" head="2204" tail="6698"/><cas:NonEmptyFSList xmi:id="6692" head="2192" tail="6695"/><cas:NonEmptyFSList xmi:id="6689" head="2180" tail="6692"/><cas:NonEmptyFSList xmi:id="6686" head="2168" tail="6689"/><cas:NonEmptyFSList xmi:id="6683" head="2156" tail="6686"/><cas:NonEmptyFSList xmi:id="6680" head="2144" tail="6683"/><cas:NonEmptyFSList xmi:id="6677" head="2132" tail="6680"/><cas:NonEmptyFSList xmi:id="6674" head="2120" tail="6677"/><cas:NonEmptyFSList xmi:id="6671" head="2108" tail="6674"/><cas:NonEmptyFSList xmi:id="6668" head="2096" tail="6671"/><cas:NonEmptyFSList xmi:id="6665" head="2084" tail="6668"/><cas:NonEmptyFSList xmi:id="6662" head="2072" tail="6665"/><cas:NonEmptyFSList xmi:id="6659" head="2060" tail="6662"/><cas:NonEmptyFSList xmi:id="6656" head="2048" tail="6659"/><cas:NonEmptyFSList xmi:id="6653" head="2036" tail="6656"/><cas:NonEmptyFSList xmi:id="6650" head="2024" tail="6653"/><cas:NonEmptyFSList xmi:id="6647" head="2012" tail="6650"/><cas:NonEmptyFSList xmi:id="6644" head="2000" tail="6647"/><cas:NonEmptyFSList xmi:id="6641" head="1988" tail="6644"/><cas:NonEmptyFSList xmi:id="6638" head="1976" tail="6641"/><cas:NonEmptyFSList xmi:id="6635" head="1964" tail="6638"/><cas:NonEmptyFSList xmi:id="6632" head="1952" tail="6635"/><cas:NonEmptyFSList xmi:id="6629" head="1940" tail="6632"/><cas:NonEmptyFSList xmi:id="6626" head="1928" tail="6629"/><cas:NonEmptyFSList xmi:id="6623" head="1916" tail="6626"/><cas:NonEmptyFSList xmi:id="6620" head="1904" tail="6623"/><cas:NonEmptyFSList xmi:id="6617" head="1892" tail="6620"/><cas:NonEmptyFSList xmi:id="6614" head="1880" tail="6617"/><cas:NonEmptyFSList xmi:id="6611" head="1868" tail="6614"/><cas:NonEmptyFSList xmi:id="6608" head="1856" tail="6611"/><cas:NonEmptyFSList xmi:id="6605" head="1844" tail="6608"/><cas:NonEmptyFSList xmi:id="6602" head="1832" tail="6605"/><cas:NonEmptyFSList xmi:id="6599" head="1820" tail="6602"/><cas:NonEmptyFSList xmi:id="6596" head="1808" tail="6599"/><cas:NonEmptyFSList xmi:id="6593" head="1796" tail="6596"/><cas:NonEmptyFSList xmi:id="6590" head="1784" tail="6593"/><cas:NonEmptyFSList xmi:id="6587" head="1772" tail="6590"/><cas:NonEmptyFSList xmi:id="6584" head="1760" tail="6587"/><cas:NonEmptyFSList xmi:id="6581" head="1748" tail="6584"/><cas:NonEmptyFSList xmi:id="6578" head="1736" tail="6581"/><cas:NonEmptyFSList xmi:id="6575" head="1724" tail="6578"/><cas:NonEmptyFSList xmi:id="6572" head="1712" tail="6575"/><cas:NonEmptyFSList xmi:id="6569" head="1700" tail="6572"/><cas:NonEmptyFSList xmi:id="6566" head="1688" tail="6569"/><cas:NonEmptyFSList xmi:id="6563" head="1676" tail="6566"/><cas:NonEmptyFSList xmi:id="6560" head="1664" tail="6563"/><cas:NonEmptyFSList xmi:id="6557" head="1652" tail="6560"/><cas:NonEmptyFSList xmi:id="6554" head="1640" tail="6557"/><cas:NonEmptyFSList xmi:id="6551" head="1628" tail="6554"/><cas:NonEmptyFSList xmi:id="6548" head="1616" tail="6551"/><cas:NonEmptyFSList xmi:id="6545" head="1604" tail="6548"/><cas:NonEmptyFSList xmi:id="6542" head="1592" tail="6545"/><cas:NonEmptyFSList xmi:id="6539" head="1580" tail="6542"/><cas:NonEmptyFSList xmi:id="6536" head="1568" tail="6539"/><cas:NonEmptyFSList xmi:id="6533" head="1556" tail="6536"/><cas:NonEmptyFSList xmi:id="6530" head="1544" tail="6533"/><cas:NonEmptyFSList xmi:id="6527" head="1532" tail="6530"/><cas:NonEmptyFSList xmi:id="6524" head="1520" tail="6527"/><cas:NonEmptyFSList xmi:id="6521" head="1508" tail="6524"/><cas:NonEmptyFSList xmi:id="6518" head="1496" tail="6521"/><cas:NonEmptyFSList xmi:id="6515" head="1484" tail="6518"/><cas:NonEmptyFSList xmi:id="6512" head="1472" tail="6515"/><cas:NonEmptyFSList xmi:id="6509" head="1460" tail="6512"/><cas:NonEmptyFSList xmi:id="6506" head="1448" tail="6509"/><cas:NonEmptyFSList xmi:id="6503" head="1436" tail="6506"/><cas:NonEmptyFSList xmi:id="6500" head="1424" tail="6503"/><cas:NonEmptyFSList xmi:id="6497" head="1412" tail="6500"/><cas:NonEmptyFSList xmi:id="6494" head="1400" tail="6497"/><cas:NonEmptyFSList xmi:id="6491" head="1388" tail="6494"/><cas:NonEmptyFSList xmi:id="6488" head="1376" tail="6491"/><cas:NonEmptyFSList xmi:id="6485" head="1364" tail="6488"/><cas:NonEmptyFSList xmi:id="6482" head="1352" tail="6485"/><cas:NonEmptyFSList xmi:id="6479" head="1340" tail="6482"/><cas:NonEmptyFSList xmi:id="6476" head="1328" tail="6479"/><cas:NonEmptyFSList xmi:id="6473" head="1316" tail="6476"/><cas:NonEmptyFSList xmi:id="6470" head="1304" tail="6473"/><cas:NonEmptyFSList xmi:id="6467" head="1292" tail="6470"/><cas:NonEmptyFSList xmi:id="6464" head="1280" tail="6467"/><cas:NonEmptyFSList xmi:id="6461" head="1268" tail="6464"/><cas:NonEmptyFSList xmi:id="6458" head="1256" tail="6461"/><cas:NonEmptyFSList xmi:id="6455" head="1244" tail="6458"/><cas:NonEmptyFSList xmi:id="6452" head="1232" tail="6455"/><cas:NonEmptyFSList xmi:id="6449" head="1220" tail="6452"/><cas:NonEmptyFSList xmi:id="6446" head="1208" tail="6449"/><cas:NonEmptyFSList xmi:id="6443" head="1196" tail="6446"/><cas:NonEmptyFSList xmi:id="6440" head="1184" tail="6443"/><cas:NonEmptyFSList xmi:id="6437" head="1172" tail="6440"/><cas:NonEmptyFSList xmi:id="6434" head="1160" tail="6437"/><cas:NonEmptyFSList xmi:id="6431" head="1148" tail="6434"/><types:QuestionAnswerSet xmi:id="15182" sofa="11" begin="0" end="0" question="12352" answerList="990 1005 1020 1035 1050"/><types:QuestionAnswerSet xmi:id="15159" sofa="11" begin="0" end="0" question="11892" answerList="882 897 912 927 942"/><types:QuestionAnswerSet xmi:id="15136" sofa="11" begin="0" end="0" question="11398" answerList="774 789 804 819 834"/><types:QuestionAnswerSet xmi:id="15113" sofa="11" begin="0" end="0" question="10972" answerList="666 681 696 711 726"/><types:QuestionAnswerSet xmi:id="15090" sofa="11" begin="0" end="0" question="10614" answerList="558 573 588 603 618"/><types:QuestionAnswerSet xmi:id="15067" sofa="11" begin="0" end="0" question="10232" answerList="450 465 480 495 510"/><types:QuestionAnswerSet xmi:id="15044" sofa="11" begin="0" end="0" question="9782" answerList="342 357 372 387 402"/><types:QuestionAnswerSet xmi:id="15021" sofa="11" begin="0" end="0" question="9760" answerList="234 249 264 279 294"/><types:QuestionAnswerSet xmi:id="14998" sofa="11" begin="0" end="0" question="8878" answerList="126 141 156 171 186"/><types:QuestionAnswerSet xmi:id="14975" sofa="11" begin="0" end="0" question="8462" answerList="18 33 48 63 78"/><cas:View sofa="11" members="1119 1124 1136 1148 1160 1172 1184 1196 1208 1220 1232 1244 1256 1268 1280 1292 1304 1316 1328 1340 1352 1364 1376 1388 1400 1412 1424 1436 1448 1460 1472 1484 1496 1508 1520 1532 1544 1556 1568 1580 1592 1604 1616 1628 1640 1652 1664 1676 1688 1700 1712 1724 1736 1748 1760 1772 1784 1796 1808 1820 1832 1844 1856 1868 1880 1892 1904 1916 1928 1940 1952 1964 1976 1988 2000 2012 2024 2036 2048 2060 2072 2084 2096 2108 2120 2132 2144 2156 2168 2180 2192 2204 2216 2228 2240 2252 2264 2276 2288 2300 2312 2324 2336 2348 2360 2372 2384 2396 2408 2420 2432 2444 2456 2468 2480 2492 2504 2516 2528 2540 2552 2576 2588 2600 2612 2624 2636 2648 2660 2672 2684 2696 2708 2720 2732 2744 2756 2768 2780 2792 2804 2816 2828 2840 2852 2864 2876 2888 2900 2912 2924 2936 2948 2960 2972 2984 2996 3008 3020 3032 3044 3056 3068 3080 3104 3116 3128 3140 3152 3164 3176 3188 3200 3212 3224 3236 3248 3260 3272 3284 3296 3308 3320 3332 3344 3356 3368 3380 3392 3404 3416 3428 3440 3452 3464 3476 3488 3500 3512 3524 3536 3548 3560 3572 3584 3596 3608 3620 3632 3644 3656 3668 3680 3692 3704 3716 3728 3740 3752 3764 3776 3788 3800 3812 3824 3836 3848 3860 3872 3884 3896 3908 3920 3932 3944 3956 3968 3980 3992 4004 4016 4028 4040 4052 4064 4076 4088 4100 4112 4124 4136 4148 4160 4172 4184 4196 4208 4220 4232 4244 4256 4268 4280 4292 4304 4316 4328 4340 4352 4364 4376 4388 4400 4412 4424 4436 4448 4460 4472 4484 4496 4508 4520 4532 4544 4556 4568 4580 4592 4604 4616 4628 4640 4652 4664 4676 4688 4700 4712 4724 4736 4748 4760 4772 4784 4796 4808 4820 4832 4844 4856 4868 4880 4892 4904 4916 4928 4940 4952 4964 4976 4988 5000 5012 5024 5036 5048 5072 5084 5096 5120 5132 5144 5156 5168 5180 5204 5216 5240 5252 5264 5276 5288 5300 5312 5324 5336 5348 5360 5372 5384 5396 5408 5420 5432 5444 5456 5468 5480 5492 5504 5516 5528 5540 5552 5564 5576 5588 5600 5612 5624 5636 5648 5660 5672 5684 5696 5708 5720 5732 5744 5756 5768 5780 5792 5804 5816 5828 5840 5852 5864 5876 5888 5900 5912 5924 5936 5948 5960 5972 5984 5996 6008 6020 6032 6044 6056 6068 6080 6092 6104 6116 6128 6140 6152 6164 6176 6188 6200 6212 6224 6236 6248 6260 6272 6284 6296 6308 6320 6332 6344 6356 6368 6380 6392 6404 6428 7746 7767 7788 7809 7830 7858 7889 7920 7951 7982 7999 8010 8021 8032 8043 8054 8072 8086 8104 8125 8139 8150 8161 8172 8183 8194 8205 8216 8227 8238 8249 8260 8271 8282 8293 8304 8315 8326 8337 8348 8359 8370 8381 8392 8403 8414 8425 8436 8447 8458 8570 8613 8993 9039 9440 9495 9777 9897 9943 10333 10373 10715 10755 11087 11133 11527 11579 12014 12063 12495 12553 13079 13110 13127 13152 13190 13231 13272 13313 13354 13402 13425 13436 13447 13458 13469 13481 13492 13505 13516 13527 13538 13549 13560 13571 13582 13593 13604 13615 13626 13637 13648 13659 13670 13681 13692 13703 13714 13725 13736 13747 13758 13769 13780 13791 13802 13813 13824 13835 13846 13857 13868 13879 13890 13901 13912 13923 13934 7731 9781 13473 13496 13497 7732 7739 7753 7760 7774 7781 7795 7802 7816 7823 7837 7844 7851 7868 7875 7882 7899 7906 7913 7930 7937 7944 7961 7968 7975 7992 8003 8014 8025 8036 8047 8058 8065 8079 8090 8097 8111 8118 8132 8143 8154 8165 8176 8187 8198 8209 8220 8231 8242 8253 8264 8275 8286 8297 8308 8319 8330 8341 8352 8363 8374 8385 8396 8407 8418 8429 8440 8451 8472 8479 8486 8493 8500 8507 8514 8521 8528 8535 8542 8549 8556 8563 8623 8630 8647 8654 8671 8678 8695 8702 8719 8726 8743 8750 8767 8774 8791 8798 8815 8822 8839 8846 8863 8870 8888 8895 8902 8909 8916 8923 8930 8937 8944 8951 8958 8965 8972 8979 8986 9049 9056 9073 9080 9097 9104 9121 9128 9145 9152 9169 9176 9193 9200 9217 9224 9241 9248 9265 9272 9289 9296 9314 9321 9328 9335 9342 9349 9356 9363 9370 9377 9384 9391 9398 9405 9412 9419 9426 9433 9505 9512 9529 9536 9553 9560 9577 9584 9601 9608 9625 9632 9649 9656 9673 9680 9697 9704 9721 9728 9745 9752 9770 9792 9799 9806 9813 9820 9827 9834 9841 9848 9855 9862 9869 9876 9883 9890 9953 9960 9977 9984 10001 10008 10025 10032 10049 10056 10073 10080 10097 10104 10121 10128 10145 10152 10169 10176 10193 10200 10217 10224 10242 10249 10256 10263 10270 10277 10284 10291 10298 10305 10312 10319 10326 10383 10390 10407 10414 10431 10438 10455 10462 10479 10486 10503 10510 10527 10534 10551 10558 10575 10582 10599 10606 10624 10631 10638 10645 10652 10659 10666 10673 10680 10687 10694 10701 10708 10765 10772 10789 10796 10813 10820 10837 10844 10861 10868 10885 10892 10909 10916 10933 10940 10957 10964 10982 10989 10996 11003 11010 11017 11024 11031 11038 11045 11052 11059 11066 11073 11080 11143 11150 11167 11174 11191 11198 11215 11222 11239 11246 11263 11270 11287 11294 11311 11318 11335 11342 11359 11366 11383 11390 11408 11415 11422 11429 11436 11443 11450 11457 11464 11471 11478 11485 11492 11499 11506 11513 11520 11589 11596 11613 11620 11637 11644 11661 11668 11685 11692 11709 11716 11733 11740 11757 11764 11781 11788 11805 11812 11829 11836 11853 11860 11877 11884 11902 11909 11916 11923 11930 11937 11944 11951 11958 11965 11972 11979 11986 11993 12000 12007 12073 12080 12097 12104 12121 12128 12145 12152 12169 12176 12193 12200 12217 12224 12241 12248 12265 12272 12289 12296 12313 12320 12337 12344 12362 12369 12376 12383 12390 12397 12404 12411 12418 12425 12432 12439 12446 12453 12460 12467 12474 12481 12488 12563 12570 12587 12594 12611 12618 12635 12642 12659 12666 12683 12690 12707 12714 12731 12738 12755 12762 12779 12786 12803 12810 12827 12834 12851 12858 18 33 48 63 78 126 141 156 171 186 234 249 264 279 294 342 357 372 387 402 450 465 480 495 510 558 573 588 603 618 666 681 696 711 726 774 789 804 819 834 882 897 912 927 942 990 1005 1020 1035 1050 8616 8640 8664 8688 8712 8736 8760 8784 8808 8832 8856 9042 9066 9090 9114 9138 9162 9186 9210 9234 9258 9282 9498 9522 9546 9570 9594 9618 9642 9666 9690 9714 9738 9946 9970 9994 10018 10042 10066 10090 10114 10138 10162 10186 10210 10376 10400 10424 10448 10472 10496 10520 10544 10568 10592 10758 10782 10806 10830 10854 10878 10902 10926 10950 11136 11160 11184 11208 11232 11256 11280 11304 11328 11352 11376 11582 11606 11630 11654 11678 11702 11726 11750 11774 11798 11822 11846 11870 12066 12090 12114 12138 12162 12186 12210 12234 12258 12282 12306 12330 12556 12580 12604 12628 12652 12676 12700 12724 12748 12772 12796 12820 12844 8462 8878 9304 9760 9782 10232 10614 10972 11398 11892 12352 14245 14252 14259 14266 14273 14317 14324 14331 14505 14512 14541 14548 14555 14562 14569 14669 14676 14683 14711 14718 14725 14732 14739 14746 14753 14760 14767 14774 14817"/></xmi:XMI>